Vinho & Saúde: aplicações biotecnológicas para promover a saúde do consumidor by Fernandes, Joana Pinto
 Universidade de Aveiro 
2017  
Departamento de Biologia  
JOANA PINTO  
FERNANDES 
 
VINHO&SAÚDE: APLICAÇÕES BIOTECNOLÓGICAS 
PARA PROMOVER A SAÚDE DO CONSUMIDOR 
 
WINE&HEALTH: BIOTECHNOLOGY TOOLS TO 
PROMOTE CONSUMERS’ HEALTH 
 
 
 
 
  
  
Universidade de Aveiro 
2017  
Departamento de Biologia  
JOANA PINTO  
FERNANDES 
 
 
VINHO&SAÚDE: APLICAÇÕES BIOTECNOLÓGICAS 
PARA PROMOVER A SAÚDE DO CONSUMIDOR 
 
WINE&HEALTH: BIOTECHNOLOGY TOOLS TO 
PROMOTE CONSUMERS’ HEALTH 
 
 
Tese apresentada à Universidade de Aveiro para cumprimento dos requisitos 
necessários à obtenção do grau de Doutor em Biologia, realizada sob a 
orientação científica da Doutora Ana Catarina Gomes, Investigadora do Instituto 
de Investigação Interdisciplinar da Universidade de Coimbra, e co-orientação 
da Doutora Gabriela Moura, Professora do Departamento de Ciências Médicas 
da Universidade de Aveiro. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Apoio financeiro da FCT e do FSE no 
âmbito do QREN – POPH – Tipologia 
4.1 – Formação Avançada 
(SFRH/BD/87649/2012). 
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Esta dissertação é dedicada aos meus pais e ao Samuel 
  
  
   
 
 
 
 
 
o júri  
presidente Doutor António Manuel Melo de Sousa Pereira 
Professor Catedrático da Universidade de Aveiro 
  
 
 Doutor Manuel António da Silva Santos 
Professor Associado da Universidade de Aveiro 
  
 
 Doutora Creina Stockley 
The Australian Wine Research Institute, Australia 
  
 
 Doutor Filipe Centeno 
Diretor de Inovação e de Produção da Proenol – Indústria Biotecnológica SA 
  
 
orientadora Doutora Ana Catarina Gomes  
Investigadora Principal, Centro de Neurociências e Biologia Celular da Universidade de Coimbra 
  
 
 Prof. Doutor João Antunes da Silva 
professor associado da Faculdade de Engenharia da Universidade do Porto 
  
 
 Prof. Doutor João Antunes da Silva 
professor associado da Faculdade de Engenharia da Universidade do Porto 
 
 
  
  
  
 
 
 
Acknowledgments 
 
To my supervisor, Ana Catarina Gomes, for her guidance and support, but also 
for providing me the opportunity to participate in such unique projects and 
experiences during this journey that made me develop so much, professionally 
and personally. Despite all the ups and downs we’ve went through, at the end, I 
am sure that everything was worth it. 
To my supervisor, Gabriela Moura, for her support during this process and 
validation of the study; 
To all my former and present colleagues at the Genomics’ Unit of Biocant, for 
being available to help, discuss and laugh with me. You are the perfect example 
that it is never impossible to succeed when you’re ready to give your best and 
work together as a real team;  
To all the collaborations that contributed to this work: M. Fátima and F. Centeno 
from Proenol, Indústria Biotecnológica SA; Adega Cooperativa de Cantanhede; 
R. Pires from the Structural Biotechnology Laboratory (CNC); P. Pitrez and L. 
Ferreira from the Biomaterials and Stem Cell-Based Therapeutic Laboratory 
(CNC); J. Pinto and B. Manadas from the Mass Spectrometry Unit (CNC); 
C.  Stockley and the Metabolomics Facility from the Australian Wine Research 
Institute (AWRI). I truly believe that innovation happens when all of us are open 
to share our knowledge and work together for a better world. 
To Creina Stockley, for the opportunity to work in her research project at the 
AWRI and for making me feel as part of such an amazing family, during my stay 
in Australia;  
To the entire Australian Wine Research Institute for sharing your team spirit, 
innovation, knowledge (and wine bottles!) with me. A special thanks to Markus 
Herderich for such interesting and constructive ideas; Natoiya Lloyd for her 
constant guidance and support; Vilma & Esther for all the help in the lab and all 
the happy moments that we have shared; 
To all my friends for supporting me during this journey.  
A special thanks to Raquel, Susana, Joaninha, Valéria, Marisa, Margarida, Sílvia 
and Dina: I have no words to describe all my gratitude! You have unique hearts 
and you have always been there for me when I needed the most. 
To my dear family, with a special thanks to Dulce, M. Ema, Isabel & António for 
their support, patience and friendship; 
To the best parents ever, Ana Paula & Fernando; 
To my love and best friend, Sam. 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
  
palavras-chave 
 
Aditivos enológicos, antioxidantes, biodisponibilidade, cancro colo-rectal, 
colagem, estabilidade proteica, extratos proteicos de levedura, polifenóis, 
resveratrol, síndrome de Progeria. 
 
resumo 
 
 
O vinho é uma mistura complexa de uma vasta gama de metabolitos, os quais 
impactam a saúde humana de uma forma sinergística. A multiplicidade de 
possíveis combinações metabólicas depende de muitos fatores, desde a 
variedade de uva e terroir até aos processos de vinificação, envelhecimento e 
armazenamento. Muitos dos constituintes do vinho foram estudados nas últimas 
décadas, pelo que é atualmente aceite que, principalmente devido ao alto teor 
de antioxidantes, o consumo regular e moderado de vinho pode proteger contra 
certos tipos de cancro, doenças cardiovasculares e neuronais. Apesar dessas 
descobertas notáveis, algumas preocupações surgiram recentemente no setor 
em termos da segurança e saúde, devido a reações alérgicas de consumidores 
que são suscetíveis a certos aditivos enológicos de origens exógenas, 
frequentemente aplicados durante a vinificação. Por outro lado, é atualmente 
necessária uma pesquisa sobre os benefícios associados a moléculas 
específicas que existem no vinho e com que eficácia estas atingem órgãos-alvo 
em humanos, após a sua passagem através da extensa via digestiva. 
 
De modo a superar as preocupações do consumidor relacionadas com a ampla 
aplicação de aditivos exógenos, estudámos novos agentes de colagem 
proteicos obtidos a partir de estirpes enológicas de Saccharomyces cerevisiae. 
Os resultados demonstraram que os extratos proteicos de levedura são 
especialmente eficazes na clarificação e estabilização de vinhos brancos, 
devido à sua superior capacidade de prevenir e tratar fenómenos de oxidação, 
quando comparadas com proteínas de origem animal. Por outro lado, 
investigámos os potenciais benefícios dos componentes antioxidantes do vinho, 
através do estudo de diferentes misturas de polifenóis e suas potenciais 
sinergias a partir de um modelo celular de envelhecimento inovador, baseado 
em células de Progeria. Os resultados obtidos indicaram que a matriz completa 
dos vinhos causa maior redução de stress oxidativo, em comparação com 
polifenóis individuais, como sendo o resveratrol. Além disso, através de um 
ensaio in vivo, explorámos a biodisponibilidade de metabolitos derivados de um 
polifenol do vinho em amostras de plasma, confirmando a existência de 
possíveis formas bioativas após 6 semanas de intervenção. 
 
Em geral, ao combinar os três eixos i) o desenvolvimento de tratamentos de 
levedura alternativos para a colagem de vinho, que substituem aditivos 
exógenos; (ii) as novas descobertas sobre o potencial antioxidante de diferentes 
tipos de vinhos; e (iii) o estudo dos potenciais benefícios anticancerígenos dos 
constituintes bioativos do vinho para a saúde dos consumidores, esta tese abre 
novos horizontes sobre como um conhecimento mais generalizado sobre o vinho 
e a saúde podem contribuir para uma indústria vinícola mundial melhorada, mais 
segura e com maior conscientização sobre a saúde do consumidor. 
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abstract 
 
Wine is a complex mixture of a vast range of metabolites that synergistically 
impact human health. The vast array of possible metabolic combinations 
depends on many factors, from the grape variety and terroir influence to the 
winemaking processes, aging and storage. Many of these wine constituents have 
been studied over the last decades, so it is currently accepted that mostly due to 
a high antioxidant content, a regular and moderated consumption of wine may 
protect against certain types of cancer, cardiovascular and neuronal diseases. 
Despite these remarkable findings, some safety and health concerns have been 
recently raised among the sector due to allergic reactions of susceptible 
consumers to some oenological additives from exogenous sources that are 
frequently applied during winemaking. On the other hand, further research is 
necessary on the benefits of specific wine bioactive molecules and to what 
extend they reach the target organs in humans after their passage through an 
extensive digestive pathway. 
In order to overcome the consumer’s concerns on the extensive application of 
exogenous additives, we have studied novel proteinaceous fining agents 
obtained from oenological Saccharomyces cerevisiae strains. Results exposed 
that these yeast protein extracts are especially efficient for white wines 
clarification and stabilization, due to their superior capacity to prevent and cure 
oxidation phenomena when compared to animal fining proteins. On the other 
hand, we have investigated the potential benefits of wine antioxidant components 
by studying different polyphenolic mixtures and their potential synergies in an 
innovative aging cell model based in Progeria cells. Results demonstrated that 
the whole wine matrix increases oxidative stress reduction when compared to 
individual polyphenols, such as resveratrol. Further, through a human study we 
explored the bioavailability of polyphenolic metabolites in plasma samples and 
confirmed their existence in possible bioactive forms after 6 weeks of 
intervention. 
Overall, by combining the three axis i) the development of alternative yeast-
based treatments for wine fining that substitute exogenous additives; ii) the 
findings on the potential antioxidant of different types of wines; and iii) the study 
of the potential anti-carcinogenic benefits of wine bioactive constituents to 
consumers’ health, this thesis sheds new lights on how an extended knowledge 
on Wine&Health may contribute for a better and safer global wine industry, with 
a raised awareness on the consumer’s health. 
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I. Wine History and cultural impact 
Wine is a fermented beverage originated from Vitis vinifera grapes, whose first 
evidences were found from the age of the Persian cultures (3000-4000 BC). In some 
countries such as Rome, Greece and Egypt, the winemaking has been expanded 
when people started to cultivate crops instead of exclusively hunting (Kennedy et al. 
2006; Fehér et al. 2005). Importantly, at those ancient times, wine had several 
purposes, not only as a beverage, but also as a disinfection, sedation and purgative 
agent, or even as a treatment to asthma, constipation, dyspepsia and epilepsy 
(Fehér et al. 2005; Jackson 2008). 
Afterwards, references indicate that wine production arrived in Africa and Southern 
Europe around 1500BC, followed by India and China (500BC). Later, Romans were 
recognized to introduce the use of wood barrels to store the wines (200-400BC). 
The first plantation of vines in countries like South America, Australia or California 
only occurred in the 1500-1700s, due to the influence of Spanish and Dutch settlers. 
At that point, more sophisticated tools and techniques were also implemented in 
Western Europe, especially for storage and aging purposes (eg. use of glass bottles 
and cork sealing), which contributed to the wine quality improvement and further 
expansion. 
Despite a severe phylloxera louse infestation (late 1900s) that almost destroyed all 
vineyard cultures in Europe (Banerjee et al. 2010; Du et al. 2011), the winemaking 
tradition subsisted and more knowledge about the vine fragilities and resistance to 
diseases was acquired. In addition, the investigation of the climate and soil impact 
on different grapevine varieties contributed to improve the wine yield and quality.  
Along with the rapid evolution of both viticulture and winemaking processes, wine 
became an important component on human’s diet (Fehér et al. 2005). In fact, across 
the history of mankind, wine always played an important role as a food complement 
and as a unique symbol of social living, culture, art and history.  
 
 
 
 
 Outline  
  
Wine&Health: Biotechnology tools to promote consumers’ health 3  
 
II. Grapevine biodiversity and terroir: impact on wine bioactive 
composition  
Worldwide, about 1400 different varieties of grapevine are used to produce wine 
(Santos et al. 2014). Alongside the evolutionary history of each grapevine variety, a 
high level of genetic variations occurred, resulting in the existence of various 
grapevine clones. These sources of biodiversity are highly valuable within the 
sector, as they permit the creation of distinct wines all over the world. By other side, 
the environmental conditions from each specific region (terroir) differently impact on 
the final wine characteristics. In brief, the climate conditions, soil, microbial activity 
and winemaking practices play a crucial role on the wine final style and identity.  
The complex interplay resultant from both grapevine biodiversity and influence of 
terroir allows for the production of unique wines, since these factors cause variations 
on the concentration of the wine constituents as water, sugars, alcohol, but also on 
the vast range of organic and inorganic components. Among these elements, wines 
hold complex mixtures of important bioactive compounds as resveratrol, quercetin 
and gallic acid. Their variable concentration might originate different impacts on 
consumers’ health (Alén-Ruiz et al. 2009; Muselík et al. 2007; Singh et al. 2016). 
Indeed, the potential synergies between individual polyphenols or between 
polyphenols and other wine constituents are still not fully understood. 
Taken together, this raises the hypothesis that different varieties and/or clones 
should have different health impacts, raising an opportunity to further explore high-
value bioactive combinations from grape and wine. Over long term, this would 
broaden the application of grapevine varieties, thus contributing to their sustainable 
conservation.  
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III. Winemaking processes and oenological additives 
Winemaking is based in a natural process known as fermentation, where 
endogenous yeast and enzymes transform grape juice into wine. Despite being 
considered a rather traditional process, the wine production has largely benefitted 
from industrial evolution. Indeed, the industrialization of the fermentation process 
allowed for a more accurate monitoring and control of the processes (e.g. pH, 
temperature dissolved oxygen). The large-scale implementation of innovative 
biotechnological tools has opened an opportunity to standardize procedures, thus 
minimizing the occurrence of negative deviations to the process that cause 
unexpected losses in both yield and quality. As a result, winemaking was extended 
to its premium levels all over the wold, since wines ensured higher levels of quality 
and became more commercially attractive. 
From harvest to fermentation, clarification, maturation and bottling, several 
winemaking techniques were developed to produce unique combinations of 
flavours, sweetness, dryness, alcoholic strength (Jackson 2008). In particular, 
several types of oenological additives were created not only to improve the 
fermentation efficiency, but also to prevent and correct aroma, texture and colour 
defects. The primary types of additives used in the wine industry originally included 
different formulations of fermentation nutrients, enological tannins, inactive yeasts, 
and fining agents. 
Of these, fining agents are essential to enable the removal of undesired particles 
and/or molecules suspended/diluted existing in wine before bottling. Traditional 
fining practices involved the addition of elementary substances into wine, such as 
egg whites, blood, milk and isinglass. Afterwards, some of these products were 
banned due to health concerns (eg. Blood after the outbreak of bovine spongiform 
encephalopathy, BSE). Others, were refined, resulting in the general use of 
improved formulations, mainly protein-based, such as albumins derived from egg 
whites, caseins derived from milk, pork gelatines or fish isinglasses. Although most 
of these protein formulations are still widely used in winemaking, recent concerns 
have been raised among the wine industry due to: (I) their allergenic potential to 
susceptible individuals; (ii) dietary restrictions of vegetarian and vegan consumers; 
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(iii) environmental issues. At present, their production and application in wine 
became more restricted, according to the recent health and safety legislations 
defined by the International Organisation of Vine and Wine (OIV) and the Codex 
Alimentarius International Code of Standards. 
Altogether, the development and implementation of innovative techniques and 
additives in winemaking is continuously required in order to avoid safety concerns 
and to fulfill the emerging consumption diets and trends. 
 
IV. Wine chemistry 
Wine is a complex alcoholic beverage, composed by more than one thousand 
different chemical compounds. Major wine components are water (80-85%) and 
ethanol (around 12-14%), followed by a wide diversity of other complementary 
molecules including organic acids, sugars, phenolic and volatile compounds. The 
combination between these wine constituents determine its aroma, colour, taste, 
mouthfeel and stability characteristics. 
Wine aroma is highly influenced by the presence of volatile molecules, such as 
alcohols, esters, terpenes and thiols.  Depending on their origin, volatiles are 
classified as (i) primary/varietal aromas if directly extracted from the grapes and 
thus, variable according to each grapevine variety and specific terroir; (ii) secondary 
aromas if generated during the fermentation processes through the action of yeasts 
and bacteria; (iii) tertiary aromas if produced during maturation and aging stages, 
either in vessel, barrel or bottle. In addition, non-volatiles as polyphenols and 
organic acids contribute to the overall levels of bitterness and acidity. Indeed, major 
organic acids as tartaric, malic and citric are important for taste, but also prevent 
harmful bacteria growth during and after fermentation. 
Otherwise, wine mouthfeel and colour characteristics are strongly related to 
polyphenolic components. In particular, tannins are specific polyphenols derived 
from the grape skin and seeds that have the ability to precipitate salivary proteins. 
Higher tannic contents, mostly present in red wines, increase wine complexity, 
bitterness and astringency, a dry and rough mouthfeel sensation. By other hand, 
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polyphenolic plant pigments, named anthocyanins, define its colour intensity and 
hue. During wine maturation and aging, monomeric anthocyanins tend to polymerize 
to form more complex derived pigments, such as   pyranoanthocyanins, resulting in 
hue changes and colour stabilization. 
Altogether, the key components - alcohol, acidity, tannin, sweetness and aroma - 
should be well balanced to guarantee a correct wine elegance degree and stability 
over time. From fermentation until aging stages, wine chemistry must be followed 
by sensory analysis and analytical techniques to control chemistry and 
microbiological features.  
 
V. Health benefits of regular and moderate wine consumption 
Recent studies have highlighted the potential health benefits of the moderate wine 
consumption in different illness conditions, such as various forms of cancer, 
diabetes, cardiovascular and neurological diseases (Berlett & Stadtman 1997; Lippi 
et al. 2010; Rodrigo et al. 2011; Yochum et al. 1999; Obrenovich et al. 2010; Cooper 
et al. 2004). Those effects are mainly attributed to a high polyphenolic wine content, 
especially present in red wines.  
In particular, research has been focused on the health benefits of resveratrol, a well-
known antioxidant proved to be a strongly antioxidant that prevents cellular DNA 
damage and  induces cellular differentiation (Zamora-Ros et al. 2015). Despite the 
evidences from previous studies showing that some wine-derived polyphenols are 
efficiently absorbed into the human blood (Walle 2011; Vitaglione et al. 2005a), it is 
still unclear to what extent these molecules preserve their biological activity when 
reaching the targeted organs (Manach et al. 2005).  In fact, bioavailability studies 
only identified residual concentrations of the free form of resveratrol in plasma, after 
intake of either red wine or resveratrol tablets (Vitaglione et al. 2005a; Rotches-
Ribalta et al. 2012). Besides, other authors have identified other resveratrol derived 
metabolites in plasma that might also possess bioactive functions in the human body 
(Juan et al. 2010). 
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Considering this, a single analytical technique is insufficient to access the 
metabolome of the wines or plasma samples. Therefore, holistic approaches as 
metabolomics are being developed, by combining high resolution techniques, data 
processing and multivariate statistics (Roullier-Gall, Witting, et al. 2014; Cozzolino 
2016). This strategy allows the identification of a wider range of compounds with 
potential interest to health research. 
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Objectives 
Health concerns have been recently raised among the wine sector on the impact of 
wine consumption to consumers. New strategies are currently required to reduce 
the application of exogenous additives, which are potentially harmful to consumers 
and to environment. On the other hand, the benefic effects related to wine moderate 
consumption need to be further validated and explored as most of the current 
studies are contradictory, or not conclusive. 
In this thesis we have tackle these concerns under different and yet complementary 
perspectives, that ranged from the oenological additives to the consumers’ health. 
Therefore, this work is presented divided into two distinct parts: 
 
PART I. Endogenous alternatives for wine fining 
Wine might cause intolerances and allergies to susceptible individuals, due to the 
residual presence of specific fining agents applied during clarification and 
stabilisation stages of the winemaking process (Vassilopoulou et al. 2011). To 
overcome this concern, novel strategies and oenological products need to be 
developed as substitutes to the traditionally fining practices. 
In Part I, the main objective is to develop novel endogenous alternatives for wine 
finning and clarification from oenological yeasts origin. To achieve this main 
objective, three specific objectives were defined: 
 
I. a) to benchmark the impact of the currently used fining agents from varied origins, 
comparing with yeast protein extracts produced at laboratorial scale; 
I. b) to select the most efficient yeast protein extracts and validate their efficiency; 
I. c) to develop a specific tool to detect unstable proteins in white wines. 
 
 
Accordingly, the general introduction of Part I is addressed in Chapter 1 and each 
of the specific objectives is presented in the following chapters.   
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PART II. Benefits of wine moderate consumers’ health  
Moderate wine consumption is recognized to bring health benefits to consumers due 
to the wine content in important bioactive molecules, such as powerful antioxidant 
molecules. However, research is needed to further explore which compounds might 
be potentially applied in other industries as nutraceutical, pharmaceutical and 
cosmetics. Indeed, it is also unclear to what extent those compounds are absorbed 
and metabolised in the human body and, therefore, keep their bioactive functions.  
In the Part II of this work, the main objective is to explore the cellular effects of 
polyphenolic mixtures and wines, as well as their bioavailability in human plasma 
after moderate consumption of red wine. To achieve this, two specific objectives 
were defined: 
 
II. a) to assess the cellular impact of different polyphenols, polyphenolic complex 
mixtures and wines by using a Progeria cell model; 
II. b) to explore the bioavailability of resveratrol metabolites and other compounds 
in human plasma after a dietary intervention study in humans.  
 
Accordingly, the general introduction of Part II is addressed in Chapter 5 and each 
of the specific objectives is presented in the following chapters.   
  
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
PART I 
ENDOGENOUS ALTERNATIVES 
FOR WINE FINING 
 
 
 
 
  
    
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Chapter 1  
PART I - General Introduction and Objectives 
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1.1. Winemaking process 
The winemaking process plays a crucial role in the shape of the wine characteristics 
and, consequently, in the achievement of the desired wine style. In brief, 
winemaking is composed by five main stages: (i) harvesting; (ii) production of grape 
juice; (iii) must fermentation; (iv) post-fermentation techniques; (v) aging and bottling 
(Fig 1.1). 
 
 
Fig. 1.1 - Scheme of winemaking steps for white and rosé wines. 
 
1.1.1. Grape harvesting 
During grape maturation, the accumulation and metabolism of a wide range of 
molecules occurs. Firstly, water, sugars and nitrogen compounds are transported 
via the plant phloem into the grape berries, where sucrose is hydrolysed to glucose 
and fructose and the synthesis of aroma precursors as flavonoids and volatile 
compounds starts.  
Optimal ripeness is often determined by the correct biochemical ratio between sugar 
content, pH and varietal components such as aroma, flavour and colour compounds. 
For an accurate prediction, viticulturists and winemakers rely on the sensory 
analysis of the berries, combined with biochemical methodologies. In specific, 
standard methods are applied to measure potential alcohol content (°Brix), to verify 
the chemical stability (pH and total acidity) and to determine the total polyphenolic 
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content of the grapes. However, the most accurate harvest moment also varies 
according to each grape variety, climate and desired wine style.  
The physical preservation and phytosanitary status of the grapes are also critical 
factors at this stage. When performed mechanically, harvest might cause damage 
of the grape skins, leading to excessive colour maceration that affects in particular, 
the production of white wines.  Moreover, the skin damage leads to oxidation and 
accelerates fermentation phenomena that later compromise the aromatic quality of 
the wines. To avoid these, mechanical harvest is frequently performed overnight, 
since the lower temperatures reduce fermentation and contamination rates. The 
traditional alternative is the hand-picked harvest that assures a more accurate 
selection of the berries and less overall damage.  
 
1.1.2. Production of grape juice 
Once transported to the wineries, grapes are firstly sorted to guarantee the 
exclusion of unripe or rotten berries. Depending on the type of wine to be produced, 
different decisions are taken at the winery concerning downstream production 
processes, such as those related to destemming, crushing and pressing. During 
these steps, primary/varietal aroma compounds are released from the berries, 
including terpenes, C13-norisoprenoids and C6 compounds (Zalacain et al. 2007) 
White wines are normally crushed and pressed in the presence of the grape stems 
and both of these steps are performed before the start of fermentation. During 
pressing, the white must is separated from the grape skins to avoid the extraction 
of an excessive amount of yellow pigments and/or undesired flavours. Contrarily, in 
red wine production, grapes are crushed right after sorting, but only pressed at a 
later stage or at end of primary fermentation. At that point, the fermented liquid is 
separated from the grape skins and other remaining solids. Herein, pressing is 
performed without including the grape stems, to avoid the extraction of excessive 
tannins, a type of polyphenols that are already abundant in the red grapes. It is also 
important to avoid the extraction of the 2-methoxy-3-isopropylpyrazine, which might 
add an undesirable vegetable aroma to wine. After the pressing step, the red juice 
is then left to macerate with skins during several days or even weeks to extract the 
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desired colour pigments, varietal aromas and polyphenols. Along this stage, dead 
yeast cells (lees) and other small particles precipitate to the bottom of the vessel, 
where a deposit is formed. Later, the wine is transferred to a clean vessel where 
additional fermentations or treatments might still be carried out.  
To produce rosé wines, an intermediate process between white and red styles is 
applied. Red grapes are pressed straight after sorting and fermentation is firstly 
completed. Fermentation is then followed by a brief maceration period, to extract 
only a small portion of tannins and pigments that respectively confer its typical 
phenolic structure and pink tonality. 
 
1.1.3. Wine fermentation 
Grape juice is transferred to clean barrels or stainless steel tanks to start the 
fermentation process. At this step, winemakers might decide on a natural 
fermentation, performed by endogenous yeast strains naturally derived from the 
grapes skin and air. Indeed, the wine juice naturally holds a complex microbiota, 
where both Saccharomyces and non-Saccharomyces species co-exist (Fleet 1990). 
Conversely, fermentation might be forced to occur by the addition of specific 
Saccharomyces yeast strains that are commercially available, such as S. cerevisiae 
or S. bayanus. These cultured yeast strains are specifically selected due to a greater 
capacity to boost the whole process and, therefore, facilitate its forecast and 
efficiency.  
S. cerevisiae is the most common yeast strain associated with wine fermentation. 
Although initially rare during the start of a natural fermentation, it gradually 
dominates until the end of the process. This yeast is responsible for the conversion 
of grape sugar into alcohol and CO2, but also plays an important role in the 
enzymatic conversion of grape aroma precursors to wine secondary metabolites, 
such as esters, aldehydes, ketones and higher alcohols  (Swiegers et al. 2005; 
Pretorius 2000; Falqué et al. 2002). During a typical fermentation completed by 
Saccharomyces cerevisiae, 95% of the sugar is converted to ethanol and carbon 
dioxide. Among the remaining sugar, 1% is converted to cellular material, and 4% 
to other products (Lambrechts & Pretorius 2000; Pretorius 2000). 
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Red wines commonly undergo a secondary fermentation, called malolactic 
fermentation, to convert the excess of malic acid into lactic acid, resulting in a softer 
- less coarse or tannic - and more complex taste on the palate. For that purpose, 
winemakers add lactic acid bacteria (LAB) to wine, such as Oenococcus oeni, which 
initiate decarboxylation, promoting the release of carbon dioxide and the de-
acidification of the wine. 
 
1.1.4. Post-fermentation processes 
After the fermentation stages, wine is still turbid due to the presence of residues 
from grape skins and dead yeast cells. Therefore, different clarification and 
stabilization processes are applied to remove undesired components as yeast cell 
walls, oxidized pigments, colloids and excessive tannins.  
The most common post-fermentation procedures are racking, filtration and fining. 
All of these techniques allow for the separation of the clarified wine from its 
sediment, gradually formed at the bottom of the vats. 
 
Racking 
The simplest and most traditional post-fermentation technique is racking and 
consists in the separation of the wine from its sediment into a clean container by the 
force of gravity. This technique is applied at various winemaking stages and it is 
most commonly used to clarify impurities in wine musts (e.g. dust, cell walls, soil, 
bacteria and fungi).  
Despite being technically simple and cheap, this process implicates extensive 
settling periods that delay the overall production process and increases the risk of 
wine losses by its dilution with the sediment left behind. Moreover, the filling of the 
tanks has to be closely supervised, as excessive disruptions to wine resting might 
promote wine oxidation (Christaki & Tzia 2002) and/or aroma deterioration.  
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Filtration 
Filtration is another common technique for wine clarification and stabilization, 
usually applied just before bottling. Several materials are accepted in winemaking 
filtration as diatomaceous earth precoat, cellulose sheets, synthetics polymer 
membranes, or more recently, inorganic and organic membranes. The most 
frequent membranes pore size are 0.1 and 0.22 μm for white wines and 0.2 μm for 
red wines (Urkiaga et al. 2002). The smaller the micron rating, the more particles 
the filter removes (Wilson 2015). Nevertheless, the use of smaller pore size 
membranes can introduce undesirable flavour and colour changes in the treated 
wines (Ferrando et al. 1998). In particular, a reduction of important wine components 
has been previously registered, specifically in tannins (4.8%), anthocyanins (2.4%) 
and polyphenols (10%) (Arriagada-Carrazana et al. 2005). Contrarily, if the 
membrane pore size is too large, undesired compounds might pass through the 
filtration membranes, compromising the clarification quality and both aromatic and 
phenolic profiles of the wine.  
 
Fining  
Considering the disadvantages of racking and filtration, fining is considered as the 
only available solution to achieve a more selective and efficient wine clarification. 
Fining consists in the addition of oenological compounds - fining agents, to the wine 
promoting flocculation and sedimentation of its undesired components. Fining is 
used with different purposes, such as: (i) to accelerate wine clarification; (ii) to 
remove targeted molecules or particles in excess; (iii) to increase stability and 
limpidity over time; (iv) to improve the organoleptic quality; (v) to facilitate the 
filtration process after fining; or (vi) to enhance the compactness of the resultant 
lees/sediment (Harbertson 2008;  a. Braga et al. 2007; Castellari et al. 2001; 
Iturmendi et al. 2010).   
The common application of a wide-range of exogenous fining agents, derived from 
different origins and sometimes at excessive dosages, has raised health concerns 
among both winemakers and consumers. Indeed, research is required to improve 
this technique and develop alternative fining agents that minimize health concerns 
 Wine&Health: Biotechnology tools to promote consumers’ health 21  
 
to consumers and that comply with the recent European Regulations [European 
Regulation (EU) No 579/2012]. 
 
1.1.5. Wine aging and bottling 
During the last stage of wine production, wines might be retained inside oak barrels 
to age during few months to several years. Important volatile and non-volatile 
constituents from the wood are incorporated into the wine matrix, contributing to the 
improvement of the wine flavours and quality. Specifically, the oxidizing and 
reducing conditions, enzymatic reactions and oak contact regulate the formation of 
tertiary metabolites, including aldehydes, acids, oak lactones and volatile phenols. 
Oak barrels also allow for a controlled oxidation of the wine, which is important for 
the colour stabilization and the reduction of astringency in red wines. At the end of 
the winemaking process, bottles are filled and closed using natural corks or screw 
caps.  
The final wine is a complex mix of metabolites, extracted and produced during the 
different stages of winemaking. The multiplicity of factors associated to grape 
varieties, environmental conditions, viticulture practices, yeast strains and 
winemaking methodologies directly influences the final wine chemical composition, 
which explains the existence of distinctive wine styles all over the word (Atanassov 
et al. 2009). 
 
 
1.2. Applications of wine fining  
 
1.2.1. Fining agents 
A wide-range of additives, named ‘fining agents’, is used to interact with the 
undesirable particles/macromolecules dissolved or in suspension within the wine 
and remove them (Fig. 1.2). Existing fining agents are powder minerals and solid 
materials (e.g. bentonite clays), synthetic polymers (e.g. polyvinylpolypyrrolidone - 
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PVPP), animal proteins (e.g. casein, gelatine, ovalbumin and isinglass), or even 
vegetable proteins (e.g. wheat, rice, maize and potato proteins) (A. Braga et al. 
2007; Cosme et al. 2009; Weber et al. 2007; Gambuti et al. 2012; Tschiersch et al. 
2008). According to each fining purpose, wine type or market, the most suitable 
fining agents are selected by the winemakers (Tschiersch et al. 2008). Different 
combinations of fining agents are available on the market and they are formulated 
either as a single compound or as a mixture  (A. Braga et al. 2007; Tschiersch et al. 
2010; Cosme et al. 2012; Vincenzi et al. 2013; Fernandes et al. 2015). 
 
 
 
 
 
 
 
 
Fig. 1.2 - Scheme representing the fining process in a winery vat. 1) Addition of the fining agent 
in an untreated wine; 2) Formation of aggregates between fining agent and unstable compounds; 3) 
Complete sedimentation of the aggregates. Formation of sediment at the vat’s bottom. 
 
The physical and chemical properties of each fining agent are determined by its 
composition. In specific, their features, such as chemical or molecular nature, 
density, isoelectric point (pI) and molecular weight directly impact on the overall 
effect and efficacy of the fining process (Cosme et al. 2007).  
Fining agents are presented in powder or liquid formulations and manufacture 
instructions must be rigorously followed before their application into wine. While 
liquid formulations are frequently ready-to-use products, some preparative steps are 
necessary before usage of the powder formulations, such as the resuspension with 
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distillate water or wine and a good homogenization. In general, the usage conditions 
and application limits should follow the regulations described in the International 
Oenological Codex (OIV 2015). 
 
1.2.2. Preliminary fining trials – laboratorial scale 
Preliminary fining trials are usually performed by winemakers in order to test for the 
proper quantities and fining conditions before applying these treatments at industrial 
scale. Fining trials consist in laboratorial-scale experiments that attempt to 
reproduce distinct fining conditions, using small glass tubes/flasks, vertically set in 
a laboratory bench. Small volumes of wine are used to perform these laboratorial 
experiments (usually 50 – 500 mL per assay) and thus, a higher number of replicates 
might be tested in parallel. Also, a wide range of wines, fining agents, proportions 
(in the case of fining mixtures) and concentrations can be further tested.  
Overall, preliminary fining trials allow an accessible prediciton and selection of the 
most efficient fining agents and dosages to be later applied at the wineries 
(Tschiersch et al. 2008). Moreover, this procedure avoids the application of a 
surplus of the fining agent that usually leads to an over-fining effect. In that case, 
wine becomes highly turbid and it might acquire undesired off-flavours directly 
derived from the applied fining agent. Besides, the excess of treatment might cause 
removal of varietal aroma characteristics, loss of wine structure and colour 
destabilisation. 
 
1.2.3. Fining applications considering wine types 
Fining is differentialy applied, according to the wine type and winemaking purpose. 
For this reason, it is important to highlight the main applications of this technique in 
white, rosé and red wines. 
 
 
1.2.3.1. White and rosé wines 
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Both white and rosé wines have comparable physicochemical properties as a low 
or residual concentration of tannins, colour pigmens and the existence of unstable 
proteins. Therefore, the fining process is similarly applied in both wine types to 
prevent oxidation reactions and haze formation after bottling. (Andrade et al. 2001; 
Monteiro et al. 2001; Cosme et al. 2008).  
In these wines, oxidation is frequent as wine polyphenols (eg. catechins, 
proanthocyanidins, hydroxycinnamic acids and their derivatives) tend to be rapidly 
oxidize, compromising their colour, taste and aroma (Bonilla et al. 2001; Li et al. 
2008; Gómez et al. 1995; Spagna et al. 2000). Although this reaction is slow at the 
pH of wine, the presence of metals, such as iron or copper, may accelerate oxidation 
(Oszmianski et al. 1996). Contrarily, redox-active constituents as SO2 and ascorbic 
acid might reduce these reactions (Sioumis et al. 2006).  
Due the complexity and difficulty to forecast these reactions, it is important for the 
winemakers to rapidly prevent oxidation by applying fining agents, namely: 
• Animal proteins - Casein, potassium caseinate and swim bladder isinglass. 
These proteins were shown to interact with flavenol monomers and low molecular 
weight procyanidins, removing the oxidized species in suspension (Cosme et al. 
2008). In particular, pigments are efficiently removed after the addition of casein 
and potassium caseinate, decreasing browning and preventing oxidation 
reactions (Cosme et al. 2008).  
• Synthetic fining agents – Polyvinylpolypyrrolidone (PVPP). This agent has the 
capacity to adsorb browned pigments and phenols when added to white wine. In 
fact, previous studies showed that wines treated with PVPP contain lower 
anthocyanin levels and colour density, becoming more stable during storage 
(Castillo-Sánchez et al. 2008; Castillo-Sánchez et al. 2006).  
The haze formation after bottling is a visual defect, which is often accompanied by 
the production of off characters. It is caused by the presence of specific grape 
proteins that remain until the end of fermentation, such as chitinases and thaumatin-
like proteins (Dufrechou et al. 2012). Haze-forming proteins are generally removed 
by the application of mineral clays, namely bentonites, which interact 
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electrostatically with unstable proteins, promoting their flocculation (Ribéreau-
Gayon et al. 2006). Importantly, bentonite treatments are not selective enough for 
these proteins and might cause a decrease of the quality in final wines. In fact, 
previous studies highlighted several problems concerning the usage of bentonite 
such as (i) losses of wine volume (1-3%), (ii) environmental costs of bentonite 
disposal, (iii) wine colour alteration and (iv) aroma losses (Falconer et al. 2010; 
Sauvage et al. 2010).  
Moreover, several studies demonstrated that haze-forming proteins also interact 
with other wine components, such as  phenolic compounds, polysaccharides and 
metal ions (e.g. sulfate cations), all of which play important roles in protein stability 
and aggregation (Hsu et al. 1987; E.J. Waters et al. 1995; Falconer et al. 2010). 
Chemical and physical factors such as ethanol concentration, wine pH, protein 
molecular weight and protein pI also play a critical role in the haze phenomena 
(Waters et al. 2005). Indeed, each wine requires adapted fining treatments not only 
according to its biochemical characteristics and existence of specific proteins and 
other interfering molecules, but also according to the desired wine style as defined 
by the winemaker. 
 
1.2.3.2. Red wines 
Red wines are rich in phenolic compounds, mainly derived from the grape skin and 
seeds.  Depending on their chemical structure and composition, phenolic 
compounds play a role on different red wine properties. In specific, the astringency 
is caused by the presence of polymeric flavan-3-ols or tannins; the bitterness 
conferred by the catechins; and the colour resulting from its composition in 
anthocyanins (Waterhouse 2002). Overall, the oenological practices and the 
storage period are the main factors influencing the colour and phenolic compounds 
in wines (Gómez-Plaza et al. 2000).  
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Astringency 
Astringency is a complex mouth sensation of friction and dryness, perceived after 
the intake of  young red wines, where the tannic content is still high (McRae & 
Kennedy 2011). Tannins are polymeric flavan-3-ols (proanthocyanidins) that 
interact with proteins through hydrogen bonds, formed between the phenolic 
hydroxyl groups and the peptide bonds; or through and hydrophobic interactions 
(Fig. 1.3) (Vincenzi et al. 2013). Proline-rich proteins (PRP) - are the most prone to 
bind tannins, as the proline residues fold, confering a characteristic three 
dimentional structure to the protein that results in a ‘string-like’ arrangement 
(Granato et al. 2010; Marangon et al. 2010). 
Indeed, such PRPs are present in human saliva and connective tissue (Harbertson 
2008). Therefore, the formation of insoluble tannin–salivary protein aggregates 
decreases the oral lubrication, simultaneously increasing the overall friction 
perception during and after the wine tasting – the astringency sensation. Due to 
genetic differences, the amounts of PRPs in human saliva is highly variable between 
individuals. Accordingly, different persons possess different rates of protein-tannin 
aggregation after red wine intake and consequently, different levels of perception 
and tolerance to astringency. For this reason, it is important to reduce excessive 
tannins through the application of fining agents. 
Again, winemakers commonly use animal origin proteins, as egg albumins, caseins 
and gelatines. All of those proteins are positively charged at the acidic wine pH, so 
they can efficiently flocculate the negatively charged tannins (McRae & Kennedy 
2011).   
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Fig. 1.3 - Protein-tannin interaction (Santos-Buelga, Celestino Freitas 2008). 
 
Colour 
Colour is a crucial characteristic in red wines and is determined by the presence of 
anthocyanin molecules with coloured forms at the wine pH (Rodrigues et al. 2012). 
Along the aging stage, the anthocyanin units tend to condensate and form long and 
stable polymeric chains. Fining agents, such as gelatine derivatives with lower 
molecular weight (with polydispersion below 43.0 kDa) are recognized to efficiently 
decrease colour intensity in young red wines, without significantly affecting the 
colour hue (a. Braga et al. 2007). Conversely, isinglasses were previously described 
to promote a softer reduction of colour density and hue when compared to caseins 
or gelatines (Bonerz et al. 2004).  
The referred animal fining agents are commonly obtained through chemical 
hydrolysis, so the final products are composed of protein fractions with dissimilar 
molecular weights. The molecular weight directly impacts on the protein ability to 
 
 Wine&Health: Biotechnology tools to promote consumers’ health 28  
 
bind different categories of tannins and thus, to promote different effects on red 
wine. For instance, lower molecular weight gelatines (liquid form) are described to 
better reduce the polymeric tannin content, whereas the higher molecular weight 
gelatines (solid form) easily attach the oligomeric components (Cosme et al. 2007).  
Besides, this interaction is strongly influenced by the tannic composition of each 
wine. Previous studies demonstrated that tannins with higher degree of 
polymerization (dP) and higher esterification with gallic acid units are more prone to 
stablish tannin-protein interactions (McRae & Kennedy 2011). According to this, 
wines with different tannic contents require the application of different and suitable 
gelatine-based products. 
 
1.3. Exogenous vs. Endogenous fining agents  
 
1.3.1. Exogenous fining agents: Health and environmental concerns 
 
Animal fining agents 
Currently, exogenous clarification and stabilization agents such as animal origin 
proteins raise increasing health and environmental concerns on wine consumers. 
According to the European Food Safety Authority (EFSA), wines fined with albumin, 
casein, caseinate or milk-based products may trigger adverse reactions in 
susceptible individuals. In particular, the incidence of allergic responses to albumin 
is around 0.3% in adults among the general population (The EFSA Journal 2005). 
Importantly, in recent years, consumers have become more and more informed and 
aware about the usage of these type of proteins in winemaking, and consequently 
there was an increase on its relevance within the wine sector.  
Indeed, a previous study identified residual amounts of dried albumin in treated wine 
samples using the enzyme-linked immunosorbent assay (ELISA) procedure, 
confirming that adverse allergic reactions could not be excluded in sensitive 
individuals (Weber et al. 2007). However, Weber’s results are not consensual, as 
they were not reproduced in other labs, who have not identified casein, isinglasses 
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nor egg proteins in latter studies, by using similar laboratorial methods as ELISA or 
Polymerase Chain Reaction (PCR) kits (Deckwart et al. 2014; Vassilopoulou et al. 
2011). Despite this, Vassilopoulou et al. did report a residual allergenic response 
using the skin prick and basophil activation tests (Vassilopoulou et al. 2011), which 
proofs the presence of the allergens within the tested wines. Indeed, analytical 
methods with higher sensitivity as Liquid chromatography-mass spectrometry, LC-
MS, did confirmed the presence of residual albumin in red wines, previously treated 
with only 5 g/hL of different egg-derived fining agents.  
Altoghether, the existing studies on this topic are contradictory as different  dosages 
and practices are being used in different countries, hindering the transferability of 
the results, and limiting the extent of their conclusions. Further investigation is 
therefore necessary to evaluate the presence of possible allergenic residues in fined 
wines. As result of the current concerns, European legislation has stablished new 
regulations in order to increase the awareness of producers and consumers about 
the use of these products. Accordingly, and since 2012, the presence of residual 
milk and/or egg based-products in final wines must now be declared on the label 
[European Regulation (EU) No 579/2012]. 
 
 
Mineral and vegetable fining agents 
Alternatively, wine treatments with mineral and vegetable fining agents have been 
investigated over the last decades. Regarding mineral agents, it has been 
demonstrated that the use of bentonite clays (the mostly used) adversely affect the 
organoleptic properties of wines, causing aroma loss and colour alteration 
(Dufrechou et al. 2012). Moreover, its disposal raises significant environmental 
concerns such as oxygen deficiency (anoxia) in the soils, destruction of the soil 
absorption system and clogging of drainage systems (Fernando N Salazar et al. 
2006; EPA (victoria) 2004).  
Likewise, gluten and other vegetable derivatives were tested as potential substitutes 
to animal fining agents. Indeed, a first study has shown that the application of these 
compounds, in a dosage of 6 and 18 g/hL, promoted an efficient clarification of 
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Burgundy wines, as final turbidity was in the range of the values obtained with 
gelatine or egg protein treatments (Marchal et al. 2002). Nevertheless, gluten has 
also raised safety concerns to consumers susceptible with coeliac disease or gluten 
allergies (Simonato et al. 2011; Cattaneo et al. 2003; Restani et al. 2002). Although 
a preliminary study concluded that gluten residues were harmless to celiac 
individuals, no conclusions were taken concerning other allergy forms (Restani et 
al. 2002). Posteriorly, Cattaneo et al. (2003) and his co-authors proposed the use 
of gluten coupled with bentonite adjuvants in order to facilitate the removal of this 
immunoreactive protein from the white wines. More recently, mass spectrometry 
based methods, with lower detection levels, assured the presence of different forms 
of gluten proteins in red wine after fining with both partially hydrolyzed and 
nonhydrolyzed glutens in a dosage down to 1 g/hL (Simonato et al. 2011).   
 
Alternativelly, recent comparative studies tested the effects of some novel fining 
agents from other vegetable origins, including:  
 
• Rice proteins: Previous reports exposed lower effects on red wine colour, but 
efficient reduction of bitterness and astringency (Tschiersch et al. 2010).  
• Corn zeins: The effect of corn proteins seems to be comparable to gelatine 
as regards to turbidity reduction, phenolic compounds removal and colour 
preservation of red wines (Simonato et al. 2009).  
• Pea proteins: Results indicate that although this could be a potential 
alternative for potassium caseinate, it is less effective in reducing browning 
potential in white wines. (Cosme et al. 2012).  
• Potato proteins: Later, the impact of potato protein (patatin) also appeared to 
reduce grape phenolics, brown pigments and also turbidity in white musts. 
The described effect was comparable or/and superior than registered by 
applying potassium caseinate (Gambuti et al. 2016). 
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1.3.2. Novel endogenous alternatives for wine fining 
Yeast-based products 
The intense use of the exogenous fining proteins has put aside the fact that both 
grape and wine hold a natural microbial population with a hidden potential as 
regards to possible biotechnology applications. Thousands of different yeast 
proteins, from the extensive myriad of yeast species that naturally colonize grape 
skins, are present throughout the entire fermentative process and embed a natural 
potential for fining and stabilizing the produced wines (Jolly et al. 2014). Therefore, 
it is crucial to acquire more knowledge about this fungal community and to stablish 
a link to the final wine properties and quality (Bokulich et al. 2011; Bokulich et al. 
2014).  
Indeed, endogenous yeasts play a central role for the Oeno-biotechnology stream, 
concerning the development of a wide range of yeast derivative products, with 
potential for winemaking applications. Currently, yeast derived-products applied to 
wine might include Inactivated Dry Yeast (IDY), Yeast Autolysate (YA), Yeast 
Extract (YE) or Yeast Mannoproteins (YM) (Petruzzi et al. 2015; González-Royo et 
al. 2013; Juega et al. 2012; Pozo-Bayón et al. 2009). 
For example, inactive dry yeasts or their respective fractions might be used in 
enological processes to flocculate pigments or to enrich the sensory characteristics, 
the colour and the colloidal stability of wines (Mekoue Nguela & Vernhet 2015). 
Some authors also propose a possible contribution of these formulations to the 
enrichment of the wine antioxidant potential (Ángeles Pozo-Bayón et al. 2009; Pozo-
Bayón et al. 2009; Jose et al. 2014). Recently, an innovative study also studied the 
possible use of IDY in the vineyard, through its directly application on the grapes. 
Results have shown benefits to the production and preservation of the final wine 
aroma, specifically with an increase of the wine sweetness and roundness  (Šuklje 
et al. 2015). 
Dead yeast cells (or lees) are also commonly used (Delgado de la Torre et al. 2015; 
Mazauric & Salmon 2006; Del Barrio-Galán et al. 2011). Lees consist in the 
sediment formed at the bottom of the wine vats resulting from fermentative or 
clarification steps. In general, red wine is left to age over lees in order to acquire 
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more complex aromas, reduce its astringency and increase colour stability (Delgado 
de la Torre et al. 2015; Bonilla et al. 2001).  
Similarly, yeast mannoproteins - glycoproteins extracted from the yeast cell walls, 
which are composed from 15 up to 90% of mannose groups per weight - are 
commonly applied to stabilization processes (Guadalupe et al. 2010; Rodrigues et 
al. 2012; Juega et al. 2012). Previous studies tested the impact of these 
mannoproteins in red wines, but no positive correlation was found between their 
application and colour stabilization (Rodrigues et al. 2012; Guadalupe et al. 2010). 
Contrarily, it has been observed an important decrease of astringency and increase 
of sweetness and roundness, which suggests formation of tannin-mannoprotein 
aggregates, followed by precipitation (Guadalupe & Ayestarán 2008; Rodrigues et 
al. 2012). 
 
Grape derived fining agents 
The recent use of grape seed proteins was compared against exogenous fining 
proteins, and a positive reduction in red wine astringency was observed. 
Neverthless, gelatine had the greatest effects in most cases (Vincenzi et al. 2013). 
Similarly, Cell Walls (CW) from different varieties of grape pulp were recently tested. 
Pomace CWs from Monastrell grape presented a great adsorption capacity for high 
molecular weight proanthocyanidin  (condensed tannin) and thus, to reduce red 
wine astringency (Bautista-Ortín et al. 2015). Nevertheless, further investigation is 
needed to confirm the fining potential of these vegetable origin treatments, obtained 
from grape seeds and pulp. 
Overall, these evidences indicate that there is a clear opportunity for the oenology 
industry to explore and to develop potential alternative fining agents from 
endogenous origins, such as yeast, grape or must. Contrary to the current practices 
of adding exogenous compounds, these substitutes seem to be safer for consumers’ 
health and more aligned with the current dietary trends.  
The unmet need of these type of endogenous fining agents was in fact the trigger 
of this thesis, as it was driven by a challenge posed by the industrial partner of this 
work, Proenol – a Biotechnology SME willing to produce this type of alternatives. 
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1.2. Objectives 
 
Main objective 
In the Part I of this thesis, the main objective was to select efficient biological fining 
agents, naturally obtained from oenological yeast strains, which were previously 
isolated from natural wine fermentations.  
 
To achieve this, the following specific objectives were defined: 
a) to benchmark the impact of a wide range of exogenous fining formulations from 
animal, mineral and vegetable origins in different types of wines and compare these 
effects with novel alternatives produced at laboratorial scale, the yeast protein 
extracts; 
b) to select the most efficient yeast protein extracts and validate their specific 
efficiency to stabilize and clarify white wines, when compared to the traditional fining 
agents; 
c) to develop a specific immunological tool to target unstable proteins in white wines 
as chitinases and thaumatin-like proteins, which cause haze after bottling. 
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A Comprehensive Evaluation of Fifty-Five Fining Agents: 
Comparison with an Endogenous Alternative 
 
 
This Chapter aims at fulfilling the specific objective of this thesis “to benchmark the 
impact of a wide range of exogenous fining formulations from animal, mineral and 
vegetable origins in different types of wines and compare these effects with novel 
alternatives produced at laboratorial scale, the yeast protein extracts”, whose results 
were submitted in “Journal of Agricultural and Food Chemistry”, an international 
reviewed journal, from the ACS Publications. 
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Abstract 
A large range of fining substances is commonly used in the winemaking industry to 
improve the organoleptic quality and long-term stability of wine. This study 
overviews the impact of exogenous commercially-available fining agents on three 
different types of wine. Altogether, fifty-five reference fining agents were grouped by 
their respective sources (caseins, albumins, gelatines, glutens, isinglass and 
bentonites). In parallel, four oenological yeast protein extracts (YPEs) were 
developed at laboratory scale and tested as a possible alternative to these 
exogenous products. YPEs had a similar effect on the chromatic characteristics of 
white and rosé wines, when compared with isinglass or bentonites. In red wines, 
YPEs promoted a reduction of colour intensity and polyphenol content, a 
comparable impact to that obtained using gelatines. Altogether, this study is 
regarded as the first benchmark on fining agents, and also indicates that 
endogenous yeast-based treatments could be a promising alternative to the 
commonly used fining agents. 
 
Keywords: Allergenic, benchmarking, chromatic analysis, clarification, 
endogenous, fining agents, oenological yeasts. 
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2.1. Introduction 
A variety of undesired particles and/or macromolecules remain in the wine after 
fermentation and their natural settlement is normally both time-consuming and 
unsuccessful.  In contrast, the permitted fining technique of adding specific 
substances to wine efficiently gathers and flocculates the unstable undesirable 
material.  
A widespread range of fining formulations is available on the market and various 
types of treatments can be added, at different dosages, alone or in combination. 
The decision of which fining agent(s) to apply, normally depends on the clarification 
or stabilization objective, desired style of the wine and destination market. In 
particular, fining is used to increase the limpidity, to correct the final colour and to 
guarantee an efficient stabilization of white and rosé wines (Neill 2002). It is mainly 
applied in red wines, however, to reduce excessive bitterness and astringency 
(Castillo-Sánchez et al. 2008; Iturmendi et al. 2010).  
Animal proteins, such as gelatin or egg albumin are commonly used to interact with 
negatively charged species through the formation of hydrogen bonds (e.g. removal 
of aggressive tannins from young red wines) (Chagas et al. 2012). Apart from those, 
caseins and casein-derived products, prevent wine oxidation and bitterness due to 
their recognized ability to interact with very oxidized phenols (Braga et al. 2007). 
Other products such as isinglass - a collagen preparation from fish bladder – are 
similarly applied to clarify the yellow color of white wines, since they also remove 
phenolic compounds that are susceptible to oxidation (e.g. catechins, 
proanthocyanidins and hydroxycinnamic acids) (Cosme et al. 2008). The efficiency 
of the proteinaceous fining agents might be connected to their amino acid 
composition, isoelectric point, superficial charge density and molecular weight 
(Cosme et al. 2008). As an alternatively to proteinaceous fining agents, mineral 
substances such as bentonites are applied in white and rosé winemaking to remove 
specific unstable proteins that remain in wine after fermentation and cause haze 
problems after bottling (Pocock et al. 2011).  
Although efficient, research studies suggest that consumers are increasingly 
concerned as well as informed about environmental and health problems involved 
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with the application of exogenous additives to wine. Therefore, a more sustainable 
and healthier need has been raised in the winemaking sector and novel 
environmentally-friendly fining agents are recently starting to be developed, such as 
vegetable proteins from gluten, pea, potato, grape seed or rice (Gambuti et al. 2012, 
Vincenzi et al. 2013). In addition, the application of yeast-based compounds has 
also been explored as possible alternative to the application of pork-derived gelatins 
in red wines (Iturmendi et al. 2010).  
Exogenous fining additives of animal or even vegetable protein origin may cause 
adverse reactions in susceptible individuals (Vassilopoulou et al. 2011, Deckwart et 
al. 2014) and according to the European Food Safety Authority (EFSA), it is still 
difficult to stablish a clinical threshold to specific fining agents such as ovalbumin or 
egg white (European Food Safety Authority (EFSA) 2011). In contrast, endogenous 
alternatives such as yeast protein extracts (YPEs) are not required to be labelled as 
a potential allergen as are egg or milk derived products and their application in 
winemaking has already been approved by the International Organization of Vine 
and Wine, OIV (OIV-OENO 417-2011). 
Herein, we have carried out an exhaustive analysis of the impact of different fining 
agents on the very same wine matrix, in which is, to the best of our knowledge, the 
first benchmark on several reference fining formulations, derived from wide-ranging 
sources. Further, we have tested YPE as potential fining alternatives in different 
wine types, and compared it against the most commonly used fining agents. 
 
2.2. Material and Methods 
2.2.1. Wines 
Three young (Portuguese blends) white, rosé and red wines were provided by 
Proenol (Canelas, Portugal). At the end of their fermentations, a total of 50 L from 
each wine was stored in a bag-in-box, filled to the top to avoid oxidation. All wines 
were transported to the laboratory at room temperature and then stored at 14 ± 2ºC. 
Wines were very turbid and unstable, so sulphur dioxide was rectified to 40 mg/L of 
free SO2, using potassium metabisulfite in powder form.  
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2.2.2. Reference fining formulations 
Overall, samples of 55 different fining agents were acquired to their respective 
manufacturers. Treatments were categorized by sources: bentonites, isinglass, 
caseins, vegetable proteins, gelatins, albumins and mixtures (formulations with 
compounds derived from two or more distinct sources). As recommended by the 
suppliers, 29 fining agents were applied in both white and rosé winemaking and the 
other 26 were applied in red winemaking (Table 2.1). All samples were received as 
powder formulations, excluding the isinglasses and 12 samples of gelatines which 
were provided in liquid solutions. More detailed information about each individual 
fining formulation is provided as Table S2.1 (Annex II). 
 
Table 2.1 - Fining formulations used in this study and respective application dosages. 
White / rosé wines Red wine 
Category Code 
Num. of 
samples 
Dosages 
(g/hL) Category Code 
Num. of 
samples 
Dosages 
(g/hL) 
Bentonites B 8 5 - 120* Gelatines G 18 5 - 120* 
Isinglasses I 9 0,5 - 120* Albumins A 4 5 - 12* 
Caseins C 2 20/100 Isinglasses I 1 5/100 
Veg. Prot V 1 10/30 Veg. Prot V 2 5 - 30* 
Mixtures M 9 5 - 120* Mixtures M 1 5/10 
TOTAL  29  TOTAL  26  
*Values diverge within the dosage range presented 
 
2.2.3. Yeast protein extracts  
Four different yeast strains were selected from a diverse collection of oenological 
yeasts, which were previously isolated from spontaneous wine fermentations. The 
respective YPEs were produced at laboratorial scale through a confidential 
methodology and further obtained in optimized liquid solutions. All the YPEs were 
tested in the three wines.  
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2.2.4. Characterization of the protein fining agents  
Protein samples were prepared in Laemmli Sample Buffer 5X (pH 6.8) - containing 
10% SDS, 10 mM β-mercaptoethanol, 20% (v/v) glycerol, 0.2 M Tris-HCl and 0.05% 
bromophenol blue. Polyacrylamide resolving gels (12,5%) were used and the gel 
was afterwards stained using Coomassie Blue R250 reagent. Gel electrophoresis 
was performed on a Bio-Rad Protean II apparatus. Protein content was accessed 
using BCA Assay kit from Pierce.  
 
2.2.5. Fining experiments 
Glass tubes of 250 mL total volume were set vertically and filled with 200 mL of the 
tested wine type (white, rosé or red). Trials were performed in triplicates, during 48 
hours at a temperature of 20ºC ± 2ºC. Overall, 576 individual fining assays were 
performed: (((29+4) white wine + (29+4) rosé wine + (26+4) red wine) x 2 dosages 
x 3 replicates). Due to the large number of assays, each wine was tested in a 
different round. 
After fining, the clarified wines were transferred to clean, glass bottles, using a large-
volume pipette to avoid disturbing the lees formed at the bottom of the tubes. In 
parallel, the samples were all filtered through qualitative filter paper (Q100, from 
Millipore) with pore size of 11 μm. For reference products, minimum (min) and 
maximum (max) dosages were defined according to suppliers. Optimal dosages of 
YPEs were defined after results obtained in previous trials extensively performed at 
laboratorial scale: 10 g/hL and 20 g/hL for white and rosé wines; 30 g/hL and 40 g/hL 
for red wine. 
 
2.2.6. Fining efficiency  
After 24 hours of fining – middle point of the process — two independent people 
separately observed each fining test and registered a qualitative evaluation in a 
scale of 0-5 about the following parameters: size of the particles, comparative lim-
pidity and sedimentation rate.  
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After application of the fining agents in white wines, 1 mL samples were carefully 
collected from each wine surface (~1 cm to the top). Turbidity was then evaluated 
along time, from 5 min after fining until 48 h after fining (10 time points), by recording 
the samples absorbance at 540 nm in 1-cm path length quartz cells, using a Cary 
100 BIO UV-Visible spectrophotometer  (Batista et al., 2009). Values were then 
used to compare the sedimentation profile during the first 24 hours after fining using 
the different fining agents. 
 
2.2.7. Conventional oenological parameters 
Free and total SO2, density, alcohol content, titratable acidity (TA), volatile acidity 
(VA), malic acid, tartaric acid, and pH were controlled using a FOSS Wine-Scan 
(FT-120) infrared Fourier-transform spectrometer. The phenolic content was 
expressed as Total Phenolic Index at 280 nm (TPI), according to the OIV method n. 
ENO/SCMAV/04/298 (2006).  
 
2.2.8. Chromatic characterization 
The absorption spectrum of each wine was recorded using a Cary 100 BIO UV-
Visible spectrophotometer and the Cary WinUV Scan software. Absorbance was 
scanned over the range of 280-750 nm, using quartz cells of 1-cm path length. The 
chromatic coordinates of C* (chroma or ‘saturation’), L* (‘brilliance’ for white/rose 
wines; ‘clarity’ for red wine), a* (redness), and b* (yellowness) were calculated using 
the CIELab system in the MSCV® software (Pérez-Magariño & González-Sanjosé 
2003).  
 
2.2.9. Statistical analysis  
Statistical analysis was performed in the GraphPad Prism software, version 5.0. 
Standard deviation calculations, linear regression and One-way ANOVA analysis 
were performed. Differences of p<0.05 were considered significant. Principal 
Component Analysis was performed in the Primer software, version 6.1.16 (Clarke 
and Gorley, 2006). 
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2.3. Results and Discussion 
2.3.1. Characterization of the fining agents 
The common molecular weight (MW) profile of each protein fining agent category is 
presented in Fig. 2.1. For the gelatines and mixtures formulations, more than one 
characteristic protein pattern was observed. All isinglasses exposed two major 
individual bands, detected above 94 kDa (~100 and ~140 kDa), which might 
correspond to collagen  components (β and α chains) (Pati et al. 2010; Chandra, 
M.V. Shamasundar 2015). A minor band (72 kDa), probably corresponded to elastin 
and lower MW bands (~40-45 kDa and <17 kDa) might correspond to gelatine 
degradation (Chandra, M.V. Shamasundar 2015).  
No evidence of parvalbumin (~13 kDa), a fish allergen, were detected (Pati et al. 
2010). Casein samples presented two intense bands at MW of ~30 and ~35 kDa, 
respectively, corresponding to β and α caseins (phosphoproteins). A weaker signal 
was observed at 75 kDa, probably derived from milk fat globule membrane 
(Murgiano et al. 2009). Lower MW bands might correspond to residual milk proteins 
such as β-lactoglobulin (~17 kDa). In contrast, liquid gelatines showed a low MW 
polydispersion (below 15 kDa), indicating substantial hydrolysis of these products 
(Braga et al. 2007). However, this pattern was not verified for all the gelatine 
powders, which presented a higher MW polydispersion, situated between ~30-250 
kDa.  
No differences were identified within the group of albumins. For these formulations, 
intense protein bands were identified within the range of 35-50 kDa, probably 
corresponding to ovalbumin. An intense band was also detected at ~74 kDa, 
possibly associated to ovotransferrin (Tolin et al. 2012). Concerning vegetable 
proteins, all samples presented a wide range of individual protein bands, a profile 
that correlates to typical wheat gluten extracts (Marchal et al. 2002).  
The protein profile of mixtures shown different correspondences to protein fining 
agents, such as caseins (4 samples), wheat glutens (3 samples), gelatines (2 
samples) and isinglass (1 sample). These indications confirm the high heterogeneity 
among this Category. 
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Fig. 2.1 - SDS-PAGE profile of the protein fining agents. Proteins were separated on a 12.5% 
SDS-polyacrylamide gel and stained with Coomassie brilliant blue R-250. MW: molecular weight 
marker, I: isinglass, C: casein, G: gelatines, A: albumin (egg white), VP: vegetable protein (gluten), 
M: mixtures (formulations containing compounds derived from two or more distinct sources), YPE: 
yeast protein extract. The numbers following the referred letters, correspond to specific samples of 
reference fining agents (specified in Table S2.1 – Annex II). Gelatines G1 and G6, respectively 
correspond to samples provided in liquid and powder forms. 
 
The electrophoretic profile of the YPEs revealed several individual protein bands 
(~10-100 kDa). In general, proteins exposed a MW from ~30-60 kDa and were well-
defined (without smear appearance). Concerning protein composition, YPEs 
presented protein content (w/w%) above 50%, as required in the OIV regulation 
concerning the use of yeast protein extracts (OIV-Oeno 494-2012) (Table 2.2).  
The mixture category presented the lower protein content, while albumins presented 
the highest protein content. More detailed information about each specific fining 
agent is presented as supporting information in in Table S2.1 (common fining 
agents) and S2.2 (YPEs) (Annex II). 
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Table 2.2 - Fining agents used in this study and respective protein content. 
 
 
 
 
 
 
2.3.2. Fining efficiency  
Visual qualitative evaluation - after 24 hours fining 
After 24 hours of fining, a qualitative evaluation was performed by two independent 
observers on each experiment (including all triplicates). Since the colour of the red 
wine samples was excessively opaque, the visual evaluation was only performed 
for white and rosé wines. Particle size, sedimentation rate and comparative limpidity 
were evaluated in a scale from 0-5.  
In both wines, positive correlations were found between the evaluated parameters 
(Fig. 2.2). Indeed, a higher sedimentation rate and an improved comparative lim-
pidity were found to be consistently linked to the formation of larger particles/clus-
ters. In fact, the Stokes Law mathematically describes that settling velocity depends 
on the squared radius of the particle (r), density of the liquid (dl) and density of the 
particle (dp) (Ribéreau-Gayon et al. 2006), showing that the higher the ability of each 
fining complex/protein to bind the undesired particles/macromolecules, the greater 
the size of the aggregates and sedimentation rate (Equation 2.1). 
 
Equation 2.1. Stokes Law: 
v =
2(dl − dp)r
2g
9μ
 
Category of fining agents 
Protein content (w/w%) 
Mean ± SD 
Isinglasses (n=10) 24,89 ± 11,85 
Caseins (n=2) 56,90 ± 4,33 
Gelatines (n=18) 30,50 ±12,02 
Albumins (n=4) 67,49 ± 5,82 
Vegetable (n=3) 56,01 ± 5,06 
Mixtures (n=10) 16,92 ± 15,4 
Yeast protein extracts (n=4) 54,20 ± 3,32 
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This qualitative evaluation revealed that after 24 hours fining, the application of 
bentonites, caseins and YPEs promoted the formation of the largest particles, along 
with faster sedimentation processes.  Indeed, YPEs promoted the formation of 
medium-large particles and efficient precipitation in both white and rosé wines.  
Considering results obtained for the common fining agents, previous suggestions 
were confirmed. Casein formulations are widely recognized to completely 
precipitate at wine pH (low over-fining probability), so the settling phenomenon was 
already expected to occur at a high rate by application of the maximum dosage. In 
addition, bentonites are also known to rapidly adsorb proteins or other positively 
charged particles in white and rosé wines and rapidly settle, creating a ‘flaky’ 
deposit, especially if no interfering colloidal material is present (Ribéreau-Gayon et 
al. 2006). Also, as expected, the application of the dissimilar mixtures resulted in a 
high heterogeneity in terms of the particles size. The application of isinglass and 
vegetable proteins (glutens) mostly produced low-medium size particles and, 
accordingly, the settling of the aggregates and limpidity was much lower. Previous 
fining studies actually reported that isinglass produces very light aggregates that 
settle slowly at the vats bottom (Ribéreau-Gayon et al. 2006). Apart from these, it is 
also known that other factors such as wine composition, particles charge, superficial 
density and protective colloids might play a role on the fining efficiency of each 
specific treatment (McRae & Kennedy 2011). 
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Fig. 2.2 - Visual evaluation of the fining trials performed in white and rosé wines. Each point 
represents an average evaluation of each fining assay (in triplicates). Two dosages were considered 
per treatment, but that distinction is only detailed herein for the YPEs.  Values are given in arbitrary 
units (a.u.).  
 
Sedimentation profile – during 48 hours fining 
In the white wine trials, turbidity was recorded during the 48 hours after fining by 
measuring absorbance at 540 nm (Fig. 2.3). Results validated the previous 
qualitative comparison of fining efficacy, showing that YPEs are capable to 
efficiently reduce the turbidity levels along time, with a sedimentation rate similar to 
caseins or bentonites. In fact, it was observed that after 5 min of the fining 
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intervention, wines with isinglasses, mixtures and vegetable proteins, were still 
clearly more turbid than the others. Moreover, data also revealed that turbidity 
values recorded after 24 h fining, were already considerably low when YPEs were 
applied, confirming that less time is required to achieve an effective clarification 
treatment.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.3 – Sedimentation profile of the fining trials performed in the white wine. Values were 
recorder in 10 different time points, from 5 min to 48 h of fining. Mean and standard deviation values 
were calculated per category and dosage (min/max). Turbidity was evaluated by measuring the 
absorbance at λ = 540nm. 
 
Lees thickness 
After 48 hours, the clarified wines were carefully transferred to clean glass bottles. 
Results of the lees thickness revealed that some bentonites and gelatines produced 
the largest sediments in comparison with the other fining categories, in white/rose 
wines and red wines, respectively (15-23 mm) (Fig. 2.4). Also, the application of 
maximum dosages of bentonites was found to produced fluid and unstable deposits. 
Instead, minimum dosages produced more compact and steady sediments. The 
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application of casein and albumin induced the formation of medium-size lees (10-
16 mm and 12-15 mm, respectively) and the aspect of the sediments was found to 
be slightly flexible, but still very homogeneous. Although the application of 
isinglasses could promote the formation of medium size lees (10-18 mm), more 
dispersed sediments were visualized at the bottom of the tubes.  
 
Fig. 2.4 - Lees thickness for each type of wine. Mean and standard deviation values were 
calculated per Category and dosage (min/max). Different letters correspond to significant differences 
(p<0.05). 
 
Overall, the application of vegetable proteins (wheat glutens) and YPEs promoted 
the smallest lees (4-16 mm and 4-14 mm, respectively), which also had a superior 
level of firmness. This evidence was confirmed in the three types of wine. Previous 
studies also mentioned that yeast-based treatments produced smaller lees when 
compared with reference substances (Iturmendi et al. 2010; Fernandes et al. 2015). 
This finding might also increase the industrial interest of using YPEs as potential 
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alternatives to the remaining additives, due to the possibility to reduce wine losses 
during the racking stage.  
 
2.3.3. Chromatic analysis 
Results obtained through the chromatic analysis of white wine samples revealed 
that the application of some vegetable proteins and mixtures generated the less 
brilliant and the most saturated treated samples. Contrarily, wines treated with 
casein revealed the highest levels of brilliance (L*>96) and minor distinction was 
found between the groups of YPEs, bentonites, mixtures and isinglasses (Fig. 2.5 
Fig. 2.5A1).As regards to colour impact, the application of casein formulations also 
promoted the highest decrease of the yellow colour component, which is in line with 
previous studies (Castillo-Sánchez et al. 2008). By other side, the impact of the 
YPEs is closer to the one obtained by applying bentonites or isinglasses (Fig. 2.5 
A2). Similarly, the clarification effect of YPEs was verified in the rosé wine (Fig. 2.5 
B1-B2). Isinglasses exposed the lowest potential to improve brilliance and reduce 
the wine saturation. Contrarily, the maximum dosages of caseins, confirmed its 
capacity to improve the final brilliance index (L*). In addition, YPEs revealed an 
important capacity to reduce the yellow intensity when compared with reference 
fining agents as bentonites, isinglasses or mixtures, and that was mostly marked 
with the application of YPE1 and YPE2. 
Considering the red wines, the effect of the YPEs was also found to be similar to 
some common isinglasses, mixtures or caseins treatments. Gelatines did not 
considerably improve the clarity of this untreated wine and some products from this 
category promoted an undesired increase on saturation (circled in Fig. 2.5C1). 
Besides this fact, all treatments applied in red wine promoted a reduction in the red 
colour component. Indeed, the addition of YPEs promoted the most accentuated 
general colour reduction. As revealed for the brilliance analysis, colour 
measurements showed that wine samples treated with albumins, isinglasses and 
mixtures had similar effects (Fig. 2.5C2). 
 
 Chapter 2 
 
Wine&Health: Biotechnology tools to promote consumers’ health 57  
 
 
Fig. 2.5 - Colour analysis in white, rosé and red wines. Brilliance and Saturation, (L* vs. C*) and 
Colour components green (a*<0), red (a*>0) and yellow (b*>0). Experiments were performed in:  A) 
White wine; B) rosé; C) Red wines and include the results for the respective untreated wines. Arrows 
indicate the general fining tendency; Samples treated with YPEs are highlighted (in black). 
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2.3.4. Other oenological effects 
Conventional oenological parameters 
The conventional enological parameters were controlled using Fourier transform 
infrared spectroscopy. In general, the principal component analysis revealed that 
the treatment using YPEs in the three types of wine tested in this study, did not 
induce negative or unexpected impacts, when compared with the reference 
substances (Fig 2.6). 
 
Fig. 2.6 - Principal component analysis (PCA) of the impact of different fining treatments on 
important oenological features in white, rosé and red wines. The two principal components, 
PCA1 and PCA2, respectively explained 49% and 25% (white wine); 42% and 31% (rose wine); 62% 
and 14% (red wine). The variance was plotted considering all treatments tested (in two different 
dosages). Arrows indicate the contribution of each conventional oenological parameter. The different 
groups are indicated by different colours; YPEs are circled in brown; NT: Not treated wine. 
 Chapter 2 
 
Wine&Health: Biotechnology tools to promote consumers’ health 59  
 
As regards to white wines, results showed that all treatments reduced the levels of 
lactic acid in the untreated wine, but no considerable variance was caused on total 
acidity or other types of organic acids. Similarly, no important grouping was verified 
for the rosé wine, but it is visible that YPE2 had a different effect, when compared 
to the remaining YPEs, which caused a higher deviation from the untreated wine. 
Since it has distinct characteristics, different features were evaluated on the red 
wine and results showed that the effect of YPEs was located in between to what in 
could be obtained by applying all the other treatments. 
 
Polyphenolic reduction 
Total polyphenolic index (TPI) was measured in all the samples of untreated and 
treated red wine to understand their capacity to reduce the respective polyphenolic 
content, which is normally associated to high levels of astringency in young red 
wines. Results revealed that all treatments could reduce the phenolic content of the 
untreated wine (Fig. 2.7) and in average, the application of the YPEs caused 
superior levels reduction (12.2-15.6%).  
 
 
 
 
Fig. 2.7 - Total phenolic index (TPI) in 
red wine before and after different 
fining treatments. Mean and standard 
deviation values were calculated for 
each fining category and include results 
of both minimum and maximum 
dosages. Asterisk indicates a significant 
difference from Untreated wine and 
values were calculated using One-way 
ANOVA test. One asterisk (p<0.05); 
Three asterisks (p<0.0006); Four 
asterisks (p<0.0001).  
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Nevertheless, when comparing between categories (through a multi-comparison 
One-way ANOVA test), the effects caused by this alternative fining treatment were 
not significantly different from the one caused by gelatines, isinglasses or vegetable 
protein (p>0.05), an indication that corroborates with other fining study where yeast 
extracts were tested against gelatines (María Remedios et al. 2010). Contrarily, the 
decrease on TPI caused by YPEs was significantly higher, when compared to both 
mixtures (p<0.0007) and albumins (p<0.003).  
 
2.4. Conclusions 
Overall, this work has provided the first overview of the fining potential of a large 
range of currently available fining agents in comparison with potential new fining 
alternatives, namely the oenological yeast protein extracts (YPEs). After a first 
assessment on the fining potential of YPEs, results revealed that these novel 
materials were capable of efficiently improving the final colour of white and rosé 
wines in comparison with the reference formulations. Moreover, benefits were also 
observed regarding the sedimentation rate of the general fining process and the 
compactness of the resulting lees. Red wine samples treated with YPEs also 
presented improved levels of colour saturation and a reduced polyphenolic content, 
which was comparable with gelatine treatments. Besides the positive effects, it is 
also important to note that lower concentrations of these extracts (10- 40 g/hL) were 
sufficient to promote similar or superior effects when compared with higher dosages 
of the reference products. In particular, among all the tested extracts, YPE1 and 2 
provided the most interesting results for all wines. 
In future work, fining assays should be performed at a larger scale, along with more 
detailed post-treatment analysis as regards to each wine type, in order to confirm 
the obtained results. It is also necessary to support these preliminary results by 
testing different wine matrices in replicate laboratory trials. Contrarily to exogenous 
additives such as allergenic proteins, YPEs could be marketed as natural fining 
alternatives for wine clarification and/or stabilization. 
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Unveiling the potential of novel yeast protein extracts in white 
wines clarification and stabilization 
 
 
This Chapter aims at fulfilling the specific objective of this thesis “to select the most 
efficient yeast protein extracts and validate their specific efficiency to stabilize and 
clarify white wines, when compared to the traditional fining agents”, whose results 
were published in Frontiers in Chemistry, an international reviewed journal, from the 
Elsevier Group (doi: 10.3389/fchem.2015.00020). 
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Abstract 
Fining agents derived from animal and mineral sources are widely used to clarify 
and stabilize white wines. Nevertheless, health and environmental problems are 
being raised, concerning the allergenic and environmental impact of some of those 
fining products.  
In this study, our aim is to validate the potential of yeast protein extracts, obtained 
from an alternative and safe source, naturally present in wine: the oenological 
yeasts. Three untreated white wines were used in this work in order to evaluate the 
impact of these novel yeast protein extracts (YPEs) in terms of the wine clarification 
and stabilization improvement. Two separated fining trials were thus conducted at 
laboratory scale and the yeast alternatives were compared with reference fining 
agents, obtained from mineral, animal and vegetable origins. Our results indicate 
that yeast protein extracts were capable to promote (i) brilliance/colour 
improvement, (ii) turbidity reduction (76-89% comparing with the untreated wines) 
and (iii) production of compact and homogeneous lees (44% smaller volume than 
obtained with bentonite). Additionally, after submitting wines to natural and forced 
oxidations, YPE treatments revealed (iv) different forms of colloidal stabilization, by 
presenting comparable or superior effects when particularly compared to casein. 
Overall, this study reveals that yeast protein extracts represent a promising 
alternative for white wine fining, since they are resultant from a natural and more 
sustainable origin, at present not regarded as potential allergenic, according to the 
Regulation (EC) No. 1169/2011. 
 
Keywords: Browning potential, clarification, fining agents, oxidation, protein 
content, white wine, yeast protein extracts. 
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3.1. Introduction 
The wine industry is one of the most competitive sectors all over the world.  
Accordingly, innovative oenological products and techniques constantly need to be 
optimized in order to produce high quality wines that are able to fulfill the demanding 
consumers. Particularly, white wines should present high levels of brilliance, a non-
oxidized and pleasant final colour and a balanced organoleptic profile. In order to 
promote efficient clarification and stabilization processes, fining is still one of the 
most traditionally used techniques and therefore, a wide range of diverse fining 
agent formulations have been developed during the last decades (Braga et al., 
2007; Cosme et al., 2007; Marangon et al., 2012; Lucchetta et al., 2013). Currently, 
fining products might be composed by animal, mineral and vegetable particles or 
macromolecules (Iturmendi et al., 2010; Gambuti et al., 2012) or even by mixed 
formulations that combine a miscellaneous of distinct compounds, trying to 
simultaneously promote parallel effects on wines.  
Animal fining agents as casein and caseinates are well characterized to efficiently 
interact with problematic oxidizable compounds, due to their affinity to specific 
flavanol monomers and low molecular weight procyanidins (Cosme et al., 2008). By 
removing these undesired compounds that remain in the wine matter after 
fermentation, they are able to prevent the browning phenomenon after bottling. 
Despite their efficiency, some animal origin products as casein were shown to cause 
allergenic concerns on the consumers’ health (Patzl-Fischerleitner and Eder, 2012; 
Schumann et al., 2013; Deckwart et al., 2014) and therefore, recent European 
legislations have already been adopted stating that if egg or milk derived proteins 
are detected on final wines, they must be declared on the respective bottle label 
[regulation (EU) No 579/2012]. On the other side, bentonite (montmorillonite 
mineral) is a non-protein fining agent that reduces the haze phenomenon in white 
through electrostatic adsorption to unstable proteins positively charged at wine pH 
(Blade and Boulton, 1988; Achaerandio et al., 2001; Sauvage et al., 2010; Pocock 
et al., 2011). These specific grape proteins remain in the wine until the end of 
fermentation, due to their highly resistance to proteases and to the low wine pH, but 
can aggregate into light-dispersing particles under elevated temperatures during 
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wine storage or transportation (Waters et al., 1992; Pocock et al., 2000; Le Bourse 
et al., 2011; Marangon et al., 2011). Although it is one of the most used fining agents, 
bentonite is already described to reduce essential aromatic compounds and 
consequently to compromise the wine final quality (Armada and Falque, 2007). 
Other problems involved with bentonite fining include long settling times, the 
associated manual handling requirements and the environmental costs for disposal 
of its waste (Hsu and Heatherbell, 1987; Marangon et al., 2012; Lucchetta et al., 
2013).  
In order to overcome the health and environmental concerns related with the use of 
the animal and mineral origin products, biological and more environmental-friendly 
alternatives should be further investigated (Marchal et al., 2002; Iturmendi et al., 
2010; Patzl-Fischerleitner and Eder, 2012; Schumann et al., 2013). In fact, the wine 
sector has already made some efforts trying to find an efficient alternative to animal 
and mineral origin products. The application of particular vegetable fining 
alternatives extracted from wheat, pea and potato origin was already authorized by 
the International Organization of Vine and Wine (OIV) [Resolution OIV-OENO 495-
2013]. More recently, proteins extracted from potato and grape seed actually 
showed some promising results in reducing harshness and astringency in red wines 
(Gambuti et al., 2012; Vincenzi et al., 2013). Regarding white wines, no efficient 
fining alternatives were still found to simultaneous clarification and stabilization, 
without necessity to add enological adjuvants during the fining process (Marchal et 
al., 2002; Cosme et al, 2012; Gambuti et al., 2012).  
Alternatively, former studies explored novel fining treatments based in the 
application of yeast derivatives (e.g. cell wall components or yeast proteins), which 
have resulted in wine improvements such as a turbidity decrease, an astringency 
reduction and a stabilization potential (Dupin et al., 2000a; Bonilla et al., 2001; 
Caridi, 2006; Iturmendi et al., 2010). In fact, yeast plays a primary role in the 
winemaking process and thus, after fermentation, its autolysis naturally leads to a 
release of diverse cell compounds as enzymes, mannoproteins, fatty acids, 
nucleotides, peptides and free amino acids (Zhang et al., 2011). Nevertheless, 
Saccharomyces cerevisiae extracts are known to contain some particular proteins 
that are potentially involved in allergic responses (Lindberg et al., 1992) 
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(Kortekangas-Savolainen et al., 1993; Nermes et al., 1995; Savolainen et al., 1998; 
Nittner-Marszalska et al., 2001), namely  the glycolytic enzymes, Enolase 1 (ENO1) 
and Enolase 2 (ENO2) that  are involved in carbohydrate metabolism and therefore, 
intrinsic to the wine fermentation process (Varela et al., 2005; Kornblatt et al., 2013), 
contrary to all the exogenous products that are commonly applied and already 
described to raise both health and environmental problems. 
In this work, our aim is to evaluate the potential of two alternative yeast protein 
extracts (YPEs), derived from a wine native source - oenological yeasts - as 
potential alternatives to problematic reference fining agents commonly used in white 
wines. For that purpose, the impact of the YPEs was measured in terms of different 
oenological parameters as turbidity, chromatic characteristics, lees volume, protein 
content, browning/oxidation prevention and curative potential after wine oxidation. 
The production of these two previously selected YPEs is currently being 
implemented at industrial scale to efficiently confirm their potential as innovative and 
natural fining agents for application in white wines, already authorized by the 
European Union [regulation (EU) No 144/2013]. 
 
3.2. Material and Methods 
3.2.1. Wines and fining agents  
Three young white wines (2013) were intentionally selected from three distinct 
Portuguese regions - Dão, Lisbon and Algarve - in order to cover different wine 
patterns and characteristics.  
Those wines were received 1 week after wine alcoholic fermentation was completed 
and therefore, they were still turbid and unstable. Until used, they were stored at 14 
± 2ºC and the sulphur dioxide was rectified to avoid their premature evolution. Four 
fining products were used as reference for the fining experiments and prepared 
according to the supplier recommendations. These enological products were 
composed by different elements, respectively: Bentonite, Casein, 
Polyvinylpolypyrrolidone - PVPP and Vegetable protein derived from hydrolyzed 
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wheat gluten. Wines and fining agents were kindly provided by Proenol (Canelas, 
Portugal). 
  
3.2.2. Yeast Protein Extracts (YPEs) 
According to our preliminary fining trials, two specific yeast strains were selected 
from a diverse collection of oenological yeasts, all isolated from spontaneous wine 
fermentations. The corresponding protein extracts, namely BCV1 and BCV5, were 
produced through a confidential methodology developed at laboratory scale. Those 
protein yeast extracts were obtained in optimized liquid solutions with the final 
protein concentration of 50g/L.  
 
3.2.3. Fining experiments  
After alcoholic fermentation  
After receiving the three untreated wines, the reference fining agents (x4) and the 
yeast protein extracts (x2) were simultaneously tested. Fining assays were 
conducted in triplicates, during 48 hours, using glass bottles of 275 ml of total 
volume. Just before the fining trials, each bottle was filled in with 250 ml of wine and 
the experiments were conducted at a controlled temperature of 22ºC ± 2ºC. For the 
application of the reference fining agents, the dosages (minimum and maximum) 
were defined according to the supplier recommendations. In the case of the two 
YPE, the fining dosages were determined per the previously fining experiments 
performed at laboratory scale. The tested dosages are presented in Table 3.1. 
Fining substances were left to flocculate and sediment to the bottom of the bottles 
during 48 hours. Clarified wine samples (supernatants) were then gently pipetted 
and filtered through a qualitative paper filter, pore size 11 μm (Whatman™ Grade 
1) to new, clean bottles. Wine samples were posteriorly analyzed by the following 
wine analytical methodologies. 
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After oxidation during 5 months 
A volume of 5 L from each untreated wine barrel was purposely reserved in the large 
wine vessels (20 L) and stored at room temperature during 5 months. During this 
period, wines had natural contact with oxygen and no additional rectification with 
sulphur dioxide was performed. After 5 months, a second experiment of fining trials 
was performed, on the resultant highly oxidized and turbid wines. Again, the fining 
trials were conducted during 48 hours, but this time in glass bottles of 550 ml of total 
volume. Each glass bottle was filled in with 500ml of wine and the assays performed 
in duplicates, in this case, only testing the effect of YPEs (BCV1 and BCV5) and 
casein. After 48 hours fining, wine samples were processed according to the 
methodology previously described (section 2.3.1). 
 
Protein fining agents characterization  
As described by Vincenzi et al. (2005), a 10% stock solution of sodium-dodecyl 
sulphate (SDS) was prepared and then added to wine to achieve final 
concentrations of 0.1%. Samples were gently mixed during 2 min and then heated 
in a boiling water bath for 5 min. Potassium chloride (KCl) (2 M) was added to each 
sample to attain a final concentration of 200 mM. Samples were set to incubate for 
1 hour and protein pellets were recovered by centrifugation at 14,000 g for 15 min 
at 4°C (Vincenzi et al., 2005). Pellets were further dissolved in 1x phosphate 
buffered saline, pH 7.4 (PBS buffer). Protein content (%w/w) was further accessed 
using BCA Assay kit from Pierce. Further, the protein molecular weight profile of 
Table 3.1 - Fining agents and respective dosages tested. 
 
Fining products 
Minimum dosage 
(g/hL) 
Maximum dosage 
(g/hL) 
Bentonite 10 60 
PVPP 10 80 
Casein 20 100 
Vegetable protein 20 60 
BCV1 10 20 
BCV5  10  20 
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each protein fining agent was acquired by SDS-PAGE electrophoresis in 
concordance with the OIV resolution [Resolution OIV-OENO 452-2012]. Gel 
electrophoresis was performed on a Bio-Rad Protean II apparatus with power supply 
set at 100V/gel for the stacking gel and 150V/gel for the resolving gel. Protein 
samples were equally prepared in Laemmli Sample Buffer (5X) and boiled at 95ºC 
during 5 min. 12.5% polyacrylamide resolving gels were used to process the 
samples and the gel was afterward stained using Coomassie Blue R250 reagent. 
The isoelectric point of the protein fining agents and YPE was measured using the 
Stabino Charge Titration System, measured in triplicates. 
 
3.2.4. Wine Analysis 
Conventional oenological parameters 
Free and total SO2, density, alcohol content, titratable acidity (TA), volatile acidity 
(VA), malic acid, tartaric acid, pH, and glycerol content were controlled using a 
FOSS Wine-Scan (FT-120) infrared Fourier-transform spectrometer and a 
WineScan software Version 2.2.1 (FOSS, Hillerod, Denmark). The phenolic content 
was expressed as Total Phenolic Index at 280 nm (TPI) according to the OIV method 
n. ENO/SCMAV/04/298 (2006). According to Batista et al. (2009), final turbidity was 
measured at 540 nm in 1-cm path length quartz cells (Batista et al., 2009).  
Lees volume 
Lee volume was acquired by directly measuring the thickness of the sediment in the 
glass bottles after the fining trials were completed. Results were expressed as 
percentage of the initial volume of wine (%v/v).  
 
Chromatic characteristics 
The absorption spectrum of each wine was recorded through a spectrophotometry 
methodology in a Cary 100 BIO UV-Visible spectrophotometer, using the Cary 
WinUV Scan software. Absorbance was scanned for each sample over the range of 
280-750 nm, using quartz cells of 1-cm path length. The absorbance values were 
recorded at 10 nm intervals. Following, the chromatic coordinates of C* (chroma or 
‘saturation’), L* (lightness or ‘brilliance’), a* (redness), and b* (yellowness) were 
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calculated using the CIELab system in the MSCV® software, from Grupo de Colour 
de La Rioja, Logroño, Spain) (Perez-Magarino and Jose, 2002).  
 
Wine unstable proteins 
Protein content present in wine samples was measured by BCA kit methodology 
(Bio-Rad) using bovine serum albumin as the standard. The protein molecular 
weight pattern of each wine sample was assessed by SDS-PAGE electrophoresis, 
performed after protein precipitation with the KDS-method, according to Vicenzi et 
al, 2005 (Vincenzi et al., 2005).  
 
Heat instability  
Heat instability was accessed by the heat test methodology described in other 
studies (Fusi et al., 2010; Benucci et al., 2014) and also recommended by OIV (OIV-
Oeno 494-2012) with small modifications. In brief, wine samples of 10 ml volume 
were set in test tubes and closed using screw caps. The tubes were heated at 80ºC 
in a water bath for 30 minutes and then allowed to cold to room temperature during 
2 hours. The increase in turbidity was detected by spectrophotometry (Cary 100 BIO 
UV-Visible spectrophotometer and Cary WinUV software) at 540 nm in 1 ml quartz 
cuvettes and expressed as ∆A540nm. All measurements were performed in triplicate. 
 
Browning prevention effect: Forced and Natural oxidation 
Browning prevention was tested in two separated assays. In the first test, browning 
potential was measured by submitting the wine samples to oxidize during 3 days. 
Two different tubes were prepared for each wine sample: In tube A (control), 15 ml 
of each wine sample was introduced into a 15 ml falcon tubes and carefully nitrogen-
sparged during 2 minutes. In tube B, 10 ml of each wine sample was introduced into 
a 15 ml falcon tubes and 3% (w/v) hydrogen peroxide (Merck, Millipore) was added, 
without nitrogen addition (Cosme et al., 2008). All the tubes were left to incubate at 
room temperature during 3 days. In a separated experiment, the natural oxidation 
of the wines was also tested. This test was performed by simply leaving the wines 
treated with YPEs and casein in totally filled glass bottles of 200 ml volume during 
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5 and 9 months. For both tests, the browning variation was accessed by measuring 
the optical density variation at 420 nm (∆A420nm). 
 
Curative test  
For this experiment, the three base wines were stored to naturally oxidize during 5 
months. After that period, the oxidized wines were treated with YPEs and casein in 
500 ml fining assays. After fining, wine samples were analyzed by CIELab 
methodology and the achievements compared with the first fining trials, performed 
after alcoholic fermentation. 
 
3.2.5. Statistical analysis 
Statistical analysis was performed in Primer software, version 6.1.16 (Clarke and 
Gorley, 2006). Standard deviation values calculations and One-way ANOVA tests 
were performed. Differences of p<0.05 were considered significant. 
 
 
3.3. Results and Discussion 
 
3.3.1. Protein fining agents  
The physicochemical characteristics of the protein fining agents used in this study 
are presented in Table 3.2. Both YPEs (BCV1 and BCV5) presented isoelectric 
point values (pI=4.4 and 4.5) close to casein (pI=4.6).  
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Table 3.2 - Fining agents used with the respective physicochemical characteristics 
 
In terms of protein composition, YPEs presented protein contents (%w/w) above 
50% as required in the OIV regulation regarding yeast protein extracts fining (OIV-
Oeno 494-2012). The low protein content presented by the vegetable protein fining 
agent, might indicate that this product probably contains other fining compounds on 
its formulation. In addition, SDS-PAGE analysis shows that 50% of the total yeast 
protein is located above 15 kDa of molecular weight, which is also in accordance 
with the OIV demand (Fig. 3.1). The distribution of the protein bands was observed 
between the molecular weight range of 10-150 kDa and the electrophoretic profile 
revealed low signs of protein degradation. Proteins detected at 48 kDa might 
correspond enolases (ENO1 and ENO2). 
Casein presented intense individual bands located at 18, 30 and 34 kDa, probably 
respectively corresponding to the whey protein β-lactalbumin, αs-Casein subunit and 
β-Casein subunit (Gambuti et al., 2012; Fleminger et al., 2013). Regarding the 
vegetable protein (VP) from gluten origin, the protein bands varied from 10-70 kDa 
of molecular weight. This protein profile corresponds, as expected, to hydrolyzed 
wheat proteins and the different bands correspond to distinct glutenin subunits 
(Chinuki et al., 2013). 
 
Fining products Isoelectric point 
(mean ± SD) 
Protein content 
(% w/w) 
Bentonite - - 
PVPP - - 
Casein 4,6 ± 0,1 65,3 
Vegetable protein 5,2  ± 0,0 19,5 
BCV1 4,5  ± 0,2 62,4 
BCV5 4,4  ± 0,1 60,1 
 Chapter 3 
 
Wine&Health: Biotechnology tools to promote consumers’ health 77  
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.1 - Protein molecular weight profile. Protein samples of the fining agents used in this 
study by Comassie-stained SDS-PAGE. (VP: Vegetable protein). 
 
3.3.2. Clarification potential 
Final turbidity 
After the fining trial performed in 250 ml glass bottles, the impact of the YPEs and 
reference fining agents was first compared. No significant differences were detected 
regarding the conventional oenological parameters accessed by infrared Fourier-
transform spectrometer. Contrarily, YPEs revealed a superior capacity to reduce 
turbidity, comparing with the efficiency of all the reference fining agents tested in 
this study (Fig. 3.2). Indeed, both extracts shown ability to clarify the most turbid 
wines as Wine 1 (reduction of 89%) and Wine 2 (76% reduction), but also to reduce 
the turbidity of the least turbid wine (79% reduction). In agreement to this, previous 
studies concerning the application of reference fining agents from animal, mineral 
and vegetable origins show comparable or inferior percentages of turbidity reduction 
when compared with the effect of our YPEs (Bonilla et al., 2001; Marchal et al., 
2002; Braga et al., 2007; Sauvage et al., 2010; Lucchetta et al., 2013). 
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Fig. 3.2 - Final turbidity. Not treated wine: NT. Treated wine samples: Yeast protein extracts (BCV1 
and BCV5); Bent (Bentonite); Cas (Casein); PVPP (Polyvinylpolypyrrolidon); VP (Vegetable protein). 
Bars indicate mean ± SD (n = 3). 
 
Other study tested the effect of YPEs in red wines and also proved their ability to 
reduce wine turbidity to values that were comparable to gelatines (Iturmendi et al., 
2010). Regarding the three different wines tested in this study, the final turbidity 
values obtained by YPE fining were located in a range of AbsA540nm between 0.007 
to 0.023 a.u. (absorbance units), a result that could not be obtained by the 
application of any reference fining agent herein tested. It is important to remark that 
the maximum dosage used for YPE (20 g/hL) was 3 to 5 times smaller than the 
reference products (60 g/hL – 100 g/hL).  
The impact of the fining agents on the conventional oenological parameters is 
presented as supplementary information (Annex III, Tables S3.1 and S3.2 and Fig. 
S3.1). Concerning these results, no significant differences were identified between 
the effect of the common fining agents and YPE. 
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Colour characterization 
As shown in Figure 3.3, the CIELab methodology used in this study revealed that 
when Wine 1 was treated with YPE presented a superior increase of brilliance (L*), 
along with a superior reduction of saturation (C*). Colour improvement was also 
verified for the wine treated with both yeast extracts, when compared to the 
reference fining agents. The final samples were found to be more greenish (-a*) and 
simultaneously less yellowish (b*), when compared with the other wine samples. 
 
 
Fig. 3.3 - Chromatic characterization using CIELab system: A) Saturation (C*) vs. Brilliance 
(L*); B) Green (-a*) vs. Yellow (b*) values. Results were obtained before and after treatment of 
Wine1 with YPE and different fining agents. Two dosages were tested by treatment (Min.-minimum; 
Max.-maximum). 
 
Lees volume 
This also demonstrated that YPEs have the ability to remove undesired yellow 
pigments contained in the wines matter and that could cause oxidative problems 
after bottling. Only by applying the maximum dosage of casein comparable results 
were achieved and this could indicate that YPE might represent a good alternative 
to this animal origin product. CIELab data with the results obtained in terms of 
turbidity reduction and were also confirmed in the three different wine patterns 
tested in this study. See Fig. S3.2 and S3.3 of Annex III to consider the results 
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obtained in wine 2 and 3. As presented in Figure 3.4, the lees formed after the YPE 
application were visually more compact and homogeneous than the lees obtained 
by using of the reference fining agents. In terms of final volume and homogeneity, 
the YPE lees were found to be similar with those obtained with vegetable protein 
application. Accordingly, the volume percentage measured in relation to the wine 
initial volume was approximately 22%, 31% and 44% smaller than the lees 
respectively obtained with casein, PVPP and bentonite application (Table 3.3). 
 
 
 
 
 
 
 
This evidence agrees with the results reported by Iturmendi et al. (2010) in red wines 
fining, showing a correlation between lower lees volume and the proximity of protein 
pI to a value of 4.43 (isoelectric point of: BCV1 = 4.5 ± 0.2; BCV5 = 4.4 ± 0.2). This 
study also refers that YPEs produced smaller lees in red wines fining when 
compared with the impact of gelatine (Iturmendi et al., 2010). The final aspect and 
thickness of the lees produced by YPEs increase their potential use as alternative 
clarification agents, since are appreciated characteristics for the industrial 
clarification process implementation. Overall, YPEs seem to be promising 
technological tools that contribute to prepare wine for filtration and also reduce the 
wine loss on the vats bottom. In addition, since they are harmless and 
Lees volume (v/v%) Mean ± SD 
Fining products Min. dosage Max. dosage 
Bentonite 5,91% ± 0,12 6,87% ± 0,00 
PVPP 5,00% ± 0,10 5,71% ± 0,01 
Casein 4,29% ± 0,05 5,00% ± 0,05 
Vegetable protein 2,86% ± 0,00 3,75% ± 0,02 
BCV1 3,37% ± 0,02 3,53% ± 0,02 
BCV5 3,42% ± 0,02 4,09% ± 0,05 
Table 3.3 - Lee volume percentage values obtained after fining trials with the different fining agents 
and YPE. Mean and standard deviation values were calculated concerning the three wines. 
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biodegradable, have no constrains in terms of process handling or dregs disposal, 
contrary to bentonite or PVPP.  
 
 
 
 
 
 
 
 
 
Fig. 3.4 - Aspect of the lees produced by the application YPE or fining agents. (A.1 and A.2) 
Yeast protein extract BCV1 - similar result was obtained with BCV5; (B) Casein - 100g/hL; (C) 
Bentonite - 60g/hL; (D) PVPP - 80g/hL; (E) Vegetable polymer - 60g/hL. 
 
3.3.3. Stabilization potential 
Protein haze protection 
The results of the SDS-PAGE analysis performed in the wine samples show, as 
expected, that unstable proteins, specifically, thaumatin-like proteins (MW ~20-25 
kDa) and chitinases (MW ~32 kDa), have only been removed from the wines treated 
with bentonite (Fig. S3.4 of Annex III). By having an isoelectric point superior to wine 
pH, the yeast extracts became positively charge when added to wine and therefore, 
they were not able to interact with the positively charged unstable proteins, contrarily 
to the negatively charged bentonite clay. (Pocock et al., 2000; Marangon et al., 
2011). Moreover, no bands of residual fining yeast proteins were detected in SDS-
Page gels, which might indicate that most of the yeast proteins have been 
precipitated. This evidence correlates with the clarification potential results 
previously presented in this study, which indicate that flocculation seems to have 
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occurred very efficiently. Nevertheless, a more sensitive method as ELISA or mass 
spectrometry methodologies should be further used to analyze the probable 
presence of some residual yeast proteins on the final wines. Although the wine 
unstable proteins have not been removed by the YPE fining, the results of the heat 
test (Fig.  3.5) indicate that heat instability was significantly reduce (p<0.05) after 
the fining treatment in comparison to the untreated wines. 
 
 
 
Fig. 3.5 - Heat test. Instability was measured according to the variation of absorbance at 
540nm, by spectrometry methodology (ΔA540nm). Not treated wine: NT. Treated wine samples: 
Yeast protein extracts (BCV1 and BCV5); Bent (Bentonite); Cas (Casein); PVPP 
(Polyvinylpolypyrrolidon); VP: (Vegetable protein). Bars indicate mean ± SD (n = 3). 
 
Data obtained in wines treated with YPE and casein were not significantly different 
(p<0.05) and as expected, bentonite was the fining agent that promoted the higher 
instability reduction due to its capacity to flocculate the problematic wine unstable 
proteins. A recent study also tested the effect of reference fining agents on white 
wines protein haze and demonstrate that casein, egg albumin, isinglass, chitosan, 
chitin, and PVPP did not significantly affect the tendency of the wine to form protein 
haze (Chagas et al., 2012). Although the haze protection mechanism is still very 
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unclear in the literature (Moine-Ledoux and Dubourdieu, 1999), the stabilization 
effect promoted by YPEs application is possibly explained by the presence of some 
residual haze-protective material on our extracts. In particular it is probable that the 
YPEs still contain mannoproteins (glycoproteins containing 15 to 90% mannose by 
their weight) derived from the yeast cell walls which are already well described to 
prevent the haze phenomenon in white wines (Dupin et al., 2000a; Dupin et al., 
2000b; Caridi, 2006). Indeed, some studies previously showed that wine aged on 
yeast lees presented reduced haze potential and lower bentonite requirements for 
protein stability than wine aged without lees but containing the same level of 
unstable protein (Moine-Ledoux and Dubourdieu, 1999). In addition, mannoproteins 
might also promote a positive impact in terms of wine body and volume 
enhancement (Caridi, 2006).  
 
Browning prevention 
Tests were performed to understand the tendency of the untreated and treated 
wines to oxidize. Casein was used as control to these tests, since it is a phenolic 
reactive agent often used to reduce oxidizable flavonoid and non-flavanoid fractions, 
and therefore to reduce the probability of the wine to oxidize (Schneider, 1995; 
Cosme et al., 2012). In the first test, wines were stored under natural oxidative 
conditions, without sulphur dioxide supplementation, during 5 and 9 months. Results 
show that YPEs could prevent the three wines to naturally oxidize (Fig. 3.6) 
Their efficiency was significantly (p<0.05) similar or in some cases superior when 
compared with the results obtained by using casein. In particular, wines 2 and 3 
became significantly less oxidized with YPE treatment than the ones treated with 
casein after the 9 months. To compare two distinct procedures, the untreated and 
treated wines were also submitted to the presence of a strong oxidizer, 3% (w/v) 
hydrogen peroxide during 3 days. In this case, results revealed no significant 
differences (p<0.05) between the impact obtained with YPE or casein. Both 
treatments herein presented seem to be efficient in preventing the browning 
phenomenon even after contact with extreme oxidation conditions. Wines 2 and 3 
showed to be the more susceptive to the browning phenomenon. 
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Fig. 3.6 - Browning evaluation after natural and forced wine oxidations. (A)Yellow colour 
(expressed as A420nm) was measured after 0, 5, 9 months of oxidation, respectively: T0, T5, T9. (B) 
Oxidation was evaluated before and after oxidation using a solution of 3% (w/v) hydrogen peroxide. 
Different letters represent significant differences (p<0.05). Bars indicate mean ± SD (n = 3). 
 
Curative capacity 
In Fig. 3.7 a comparison is presented between the effects of the fining treatments 
performed in the wines received after alcoholic fermentation (T0) and fining 
treatments regarding the intensively oxidized wines (after 5 months - browning).  
In both fining trials, YPE promoted similar tendencies and achievements towards 
brilliance and colour improvement, proving that they efficiently correct wine 
browning, independently from the oxidation starting point or pattern of each wine. 
For both experiments, CIELab indexes show increase of Brilliance (L*) to values 
above 95 units along with saturation reduction to values below 10 units. In parallel, 
YPE treatment promoted a clear yellow colour reduction (b*) especially obvious in 
the extremely oxidized wines, 1 and 2. Moreover, a parallel increase in terms of 
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green (-a*) was verified in the case of the oxidized wine 3. Although browning is 
normally difficult to correct in excessively oxidized wines, casein is recognized by 
its curative capacity to uncolour the oxidized wines, contributing to colour 
refreshment while also refining gustatory characteristics (Braga et al., 2007). In 
comparison to casein, YPE revealed superior capacity to correct the browning 
regarding the three wines and with both dosages tested in our study (10 and 20 
g/hL). Bonilla et al. (2001) previously tested a correction treatment using baker’s 
yeasts in white wines and reported that the use of yeast at 1 g/L as a fining treatment 
was able to correct browning with similar results in terms of A420nm decrease in 
comparison with a traditional treatment based on activated charcoal application 
(Bonilla et al., 2001). In agreement with this fact, other study revealed that whole 
yeasts or yeast cell walls present the capacity to efficiently adsorb phenolic 
compounds and browning products and thus decrease the yellow-brown colour 
levels after white wines fining (Razmkhab et al., 2002).  
Overall, our data suggests that YPEs also have a preventive and curative capacity 
to correct white wines. Similarly to casein, yeast extracts might probably have the 
capacity to remove some oxidizable and oxidized species as phenolic compounds, 
in particular flavan-3-ol derivates, considered primarily responsible for oxidative 
aging of white wines, since small amounts of these molecules might generate 
browning (Schneider, 1995).  The presence of other compounds as iron, copper, 
acetaldehyde or tartaric acid might also contribute to accelerate different types of 
condensation and oxidative reactions, contributing to the production brown 
compounds (Razmkhab et al., 2002). Based on this, further research is necessary 
to better understand the protective and corrective mechanism behind the YPE fining 
potential. 
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Fig. 3.7 - Test of curative potential using  chromatic characterization. Not treated samples were 
fined after 5 months oxidation and effects were compared with the previously obtained results (T0). 
Arrows indicate the direction of the impact obtained after the respective treatments. 
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3.4. Conclusions 
In this work, we revealed the potential of novel yeast protein extracts towards white 
wine clarification, stabilization and curative processes. Particularly, two yeast 
protein extracts previously selected and optimized for this study, could promote a 
significant brilliance increase, turbidity reduction and final colour improvement when 
compared with the reference fining agents available on the market. The lees 
produced after the YPE treatment were indeed found to be more compact and thick 
than the obtained with reference formulations, conferring to these yeast by-products 
an extra technological advantage in terms of the industrial fining validation. A 
protective effect to protein haze was also verified in samples fined with YPEs, 
although they were not able to interact and remove unstable proteins as bentonite 
did.  YPE treatment also revealed a superior effect on browning prevention and 
curative ability when compared to casein, an animal origin product, already well 
recognized in the literature to efficiency reduce oxidation and browning in white 
wines (Cosme et al., 2008).  
Overall, in this study we present an innovative fining alternative that can efficiently 
contribute to improve white wines final quality. Indeed, YPEs represent a novel tool 
for the wine sector, since they are obtained from a completely native source. This 
treatment represents a more sustainable alternative when compared to the 
exogenous substances from mineral, animal proteins or wheat origins. In future 
work, is our aim to further investigate the impact of these YPEs in terms of sensorial 
analysis and to test their potential implementation at industrial scale. 
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New immunological-based methods for detection of unstable 
protein in white wines 
 
 
This Chapter aims at fulfilling the specific objective of this thesis: “to develop a 
specific immunological tool to target unstable proteins in white wines as chitinases 
and thaumatin-like proteins, which cause haze problems after bottling in this wine 
type”. 
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Abstract 
White wine unstable proteins, specifically chitinases and thaumatin-like proteins, 
cause stability and clarity problems mainly during the transportation and storage of 
wines. Indeed, traditional predictive methods such as the heat test have been 
applied in order to forecast the haze in bottled wine caused by such unstable 
proteins, however, this is a rather imprecise approximation, which often leads to the 
use of over-estimated dosages of bentonite clays causing technical, environmental 
and health concerns. To tackle this, we have developed immunology-based 
techniques to specifically detect the unstable proteins causing haze in white wines, 
allowing for its precise quantification. 
The results herein presented confirm that these methods are valuable tools to 
quantify the amount of unstable proteins in white wines, helping winemakers to 
determine the lowest dosage of bentonite required to stabilize the wine. Moreover, 
the developed method is fast, simple and intuitive, and thus could be readily 
transferable to wineries.  
 
Keywords: Chitinase (CHT), ELISA, heat test, haze, stability, thaumatin-like 
proteins (TLP), VVTL1 
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4.1. Introduction 
Pathogenesis-related (PR) proteins are present in grapes to counter fungal infection 
and possibly other plant stresses (Falconer et al. 2010; Ferreira et al. 2004). During 
grape berry maturation (vérasion), sugar accumulation increases along with the 
rapid production of this type of proteins. Typically, PR proteins consist of chitinases 
(CHT) and thaumatin-like proteins (TLP), which have low molecular weight (12–30 
kDa), low pl (4.1-5.8) and are highly resistant to proteolytic degradation (Ferreira et 
al. 2004).  
In red wines, due to their high content of tannins, all proteins are precipitated. 
Conversely, white wines preserve a protein content of 10-500mg/L (Santoro 1995), 
which are the major cause of protein haze (Hsu et al. 1987; Dawes et al. 1994). 
Denaturation of these proteins and formation of insoluble aggregates might occur 
under the storage and transportation of wines (e.g. storage at higher temperatures) 
(Marangon et al. 2011). As a result, haze occurs, resulting in an unpleasant 
appearance for consumers of white wine.  
To solve this, haze-forming proteins are generally removed by applying bentonite, 
a mineral fining agent that interacts electrostatically with unstable proteins, 
promoting flocculation (Ribéreau-Gayon et al. 2006). However, bentonite treatments 
are not selective and might cause a decrease of the quality in final wines. Further, 
previous studies highlight several problems concerning the usage of bentonite such 
as losses of wine volume (1-3%), environmental costs of bentonite disposal, wine 
colour alteration and aroma losses (Falconer et al. 2010; Sauvage et al. 2010). It 
fact, a mass spectrometry study has recently confirmed that bentonite also has 
affinity for β-glucosidases, which are crucial enzymes for the hydrolysis and 
consequent release of aroma precursors (Jaeckels et al. 2015).  
At present, researchers are investigating possible alternatives for bentonite 
treatments based in ultrafiltration, addition of pectins or incubation with specific 
proteases associated with a heat treatment (Pocock & Waters 2006; Fernando N. 
Salazar et al. 2006; Marangon et al. 2012). Despite these efforts, there are still no 
authorized methods available on the market that might efficiently substitute 
bentonite. 
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Predictive assays have been explored in order to give better haze estimation and to 
avoid the application of extreme bentonite dosages (e.g. heat test, Bentotest, 
ethanol precipitation test and tannin precipitation test). These procedures normally 
force the protein aggregation and precipitation phenomena to occur faster (Pocock 
& Waters 2006, Harbertson 2008). However, some authors consider these tests 
biased towards the over-estimation of required bentonite dosages and expose 
concerns about the technical inaccuracy of the protocols (Pocock & Waters 2006; 
Sauvage et al. 2010).  
Herein, immunological methods were developed to detect unstable proteins in white 
wines, which were based on western and dot-blotting. These procedures enable 
producers to rapidly and specifically identify and quantify the presence of unstable 
proteins in white wines, facilitating a more accurate determination of the necessary 
dosage of bentonite to apply during the stabilization step.   
 
4.2. Material and Methods 
 
4.2.1 Wines 
White wines were provided from Portuguese producers and received in closed glass 
bottles. Wine samples were collected before and after clarification treatment with 
bentonite, performed by the producer (using unknown concentrations) and named, 
‘Untreated wines’ and ‘Treated wines’, respectively.  Wines were stored at room 
temperature for a short period of time (one-week maximum) and opened just prior 
the analysis.  
 
4.2.2 Bentonite fining trials 
Laboratorial fining assays were performed in 15 ml Falcon tubes. For each wine 
sample, a group of 9 falcon tubes were prepared with 10ml of total wine volume and 
accordingly, 9 different concentrations of bentonite were tested (0, 2, 4, 8, 12, 20, 
40, 60 and 100 g/hL). A bentonite solution at a concentration of 50 g/L was prepared 
immediately before its addition by dissolving the clay in distilled water. After 
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bentonite addition, fining trials were simultaneously performed during 48 hours, 
protected from light and kept at room temperature.  
 
4.2.3. Heat Test 
Heat instability was assessed by the heat test methodology described in other 
studies (Fusi et al., 2010; Benucci et al., 2014) and also recommended by The 
International Organisation of Vine and Wine (OIV) [Oeno 494-2012] with small 
modifications. In brief, wine samples of 10 ml volume were set in test tubes and 
closed using screw caps. The tubes were heated at 80 ºC in a water bath for 30 min 
and then allowed to cool to room temperature during 2 hours. The increase in 
turbidity was detected by spectrophotometry (Cary 100 BIO UV-Visible 
spectrophotometer and Cary WinUV software) at 540 nm in 1 ml quartz cuvettes 
and expressed as ∆A540nm. All measurements were performed in triplicate. 
 
4.2.4. Protein precipitation 
As described by Vincenzi et al. (2005), a 10% stock solution of sodium-dodecyl 
sulphate (SDS) was prepared and then added to wine to achieve final 
concentrations of 0.1%. Samples were gently mixed for 2 min and then heated in a 
boiling water bath for 5 min. Potassium chloride (KCl) (2 M) was added to each 
sample to attain a final concentration of 200 mM. Samples were  incubated for 45 
min and KDS-protein pellets were recovered by centrifugation at 14,000 g for 15 min 
at 4°C (Vincenzi et al. 2005). After removing the supernatant, pellets were dissolved 
in 1x phosphate buffered saline, pH 7.4 (PBS buffer). 
 
4.2.5. Protein analysis 
Protein Quantification  
The protein content of wine samples was measured using the BCA kit methodology 
(Bio-Rad), using bovine serum albumin as standard. The protein molecular weight 
pattern of each wine sample was assessed by SDS-PAGE electrophoresis, 
performed after protein precipitation with the KDS-method, according to Vicenzi et 
al, 2005 (Vincenzi et al., 2005).  
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SDS-PAGE 
The molecular weight profile of wine proteins was determined by SDS-PAGE 
electrophoresis in accordance with the OIV resolution [OENO 452-2012]. Gel 
electrophoresis was performed on a Bio-Rad Protean II apparatus with power supply 
set at 100 V/gel for the stacking gel and 150 V/gel for the resolving gel. Protein 
samples were prepared in Laemmli Sample Buffer (5X) and boiled at 95ºC for 5 min. 
12.5% polyacrylamide resolving gels were used to resolve proteins. Coomassie 
staining was performed using Blue R250 reagent. 
 
4.2.6. Immunological methods and detection  
Antibodies 
Polyclonal primary antibodies against chitinase and thaumatin-like proteins were 
acquired from Abcam (AT2; Chicken polyclonal anti-thaumatin2) and Agrisera (AC1; 
Rabbit Polyclonal Anti-Chitinase Class I), respectively. The anti-VVTL1 antibody 
was in-house produced by the Structural Biotechnology Laboratory (Center for 
Neuroscience and Cell Biology, Coimbra). Briefly, the antibody was generated 
in Coturnix japonica using as immunogen a recombinant version of Vitis vinifera 
thaumatin-like protein-1 (VVTL-1). Specific anti-VVTL1 antibodies were collected 
and purified from egg-yolk extracts of immunized hens using standard 
chromatographic methods. The antibody efficiency was characterized against both 
recombinant VVTL1 and native (wine) samples.  
Goat anti-Chicken IgY H&L (Agrisera) (#as09606) and Goat Anti-Rabbit IgG H&L 
(abcam) (#ab6722), both ALP conjugated, were used as secondary antibodies. 
 
Western Blotting 
Proteins in polyacrylamide gels were transferred to a Polyvinylidene difluoride 
(PVDF) membrane (Trans-Blot® Turbo™ Midi PVDF Transfer Packs). A Trans-
Blot® Turbo™ Transfer System was used and a current of 2,5 A x cm2 was applied 
for 7 min. To prevent non-specific interactions, saturation was performed using a 
solution of 3% non-fat dry milk in Tris-buffered saline (TBS), for 2 hours with gentle 
agitation. Afterwards, membranes were washed twice for 5 minutes in 1x TBS with 
gentle agitation. Following this, the VVTL-1 primary antibody was added to the 
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membranes in a solution of 3% non-fat dry milk in 1x TBS, for 2 hours at 4 ºC with 
agitation. Membranes were washed twice for 5 minutes with 1x TBS to remove 
unbound primary antibody. A secondary antibody conjugated with alkaline 
phosphatase was then added and incubation occurred for 1 h at room temperature 
(RT) with agitation. Protein-immunoreactive bands were developed using the 
Enhanced Chemifluorescence (ECF) detection system (GE Healthcare) and 
visualized in a Molecular Imager FX System (Bio-Rad). 
 
Dot-Blotting 
A volume of 5 μl of wine protein samples was placed on a Polyvinylidene difluoride 
(PVDF) membrane. After 15 min drying, the membrane was saturated with 3% non-
fat dry milk in TBS at RT with agitation. Primary detection was performed against 
the target proteins using commercial antibodies (AT2, AC1) or alternatively, the new 
VVTL-1 antibody in a 3% non-fat dry milk in 1x TBS solution for 2 h at RT. After 
washes with TBS-Tween (TBS-T), a secondary antibody conjugated with alkaline 
phosphatase was applied in 1x TBS solution for 1hour at RT. Afterwards, membrane 
was washed again 3 times with 1x TBS-T. Revelation was made with BCIP/NBT 
substrate, which contains 5- bromo-4-Chloro-3’-Indolyphosphate (BCIP) p-
Toluidine Salt and Nitro-Blue Tetrazolium Chloride (NBT). BCIP/NBT 1-Component 
AP Membrane Substrate reacts with alkaline phosphatase, and a bluish-purple 
reaction product is developed. Images of the membrane with coloured spots were 
registered using a Gel Doc™ EZ System. The signal of the background area around 
the dots was collected, and dot signal intensities were then normalised against that 
mean. Each analysis was performed in triplicate. 
 
 
4.3. Results and Discussion 
 
Comparison: traditional (heat test) and immunological-based methods  
Twenty-seven white wines were subjected to immunological detection of TLP and 
CHT unstable proteins, using commercial antibodies. In parallel, the traditional heat 
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test was also performed to measure heat instability. Results of the dot-blotting 
experiments revealed lower intensities of the dots for most the ‘treated wines’. 
Contrarily, some of the ‘untreated wines’ exposed the highest intensity values, 
indicating greater contents of the unstable proteins in the wines (Fig. 4.1A).   
 
 
 
Fig. 4.1 - Comparison of methods to access protein instability in white wines. A) Dot blotting 
detection using both commercial antibodies against TLP and Chit; B) Linear regression between 
results obtained in both tests: heat test (instability A540nm) and dot blot analysis (dot relative intensity 
(%). 
 
These tests have exposed the existing low correlation between intensity of dots 
(unstable proteins) and haze formation after heat test (heat instability) (Fig. 4.1B). 
In fact, this information exposes the limitations of the heat tests to predict the 
existence of unstable proteins and reinforces empiric findings obtained at the 
wineries that suggest biased results caused by an accelerated temperature-induced 
oxidation and condensation between phenolic compounds and proteins (Sarmento 
et al. 2000). Indeed, these results are also consistent with other studies that 
demonstrated the interaction between haze-forming proteins and other wine 
components, affecting their denaturation, precipitation and consequently, the haze 
development (Hsu et al. 1987; E.J. Waters et al. 1995; Falconer et al. 2010). In 
particular, phenolic compounds, polysaccharides and metal ions (e.g. sulfate 
cations) might play an important role in protein stability and aggregation 
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mechanisms. Moreover, the haze phenomenon is known to be influenced by 
additional chemical and physical factors such as ethanol concentration, wine pH, 
protein molecular weight and protein pI (Waters et al. 2005). Altogether, these 
results revealed that the existence of TLP and CHT proteins could not be directly 
assessed by a haze estimation.  
 
Optimization of the immunological detection of TLP – New VVTL1 antibody  
Under the framework of the previous observations, and given the inexistence of a 
reliable method for detection of unstable proteins in white wines, we have developed 
a new immunological-based method for analysis of protein instability, which involved 
the development of a new VVTL1 antibody. 
To optimize the immunological methodologies required for TLP-detection with the 
in-house developed antibody, four untreated white wines - not submitted to any 
clarification or stabilization treatment - were collected immediately after 
fermentation. Protein wine samples were subjected to SDS-PAGE analysis followed 
by Coomassie blue staining. 
Results of the SDS-PAGE (Fig. 4.2A) indicated varied amounts of total protein 
between the wines and all samples presented two bands in common: a main band 
at 22-24 kDa (TLP) and a minor band with higher MW (~65 kDa). No CHT proteins 
were detected using SDS-PAGE (band ~32 kDa) (Le Bourse et al. 2011).  
Western blots were then performed using the anti-VVTL-1 antibody against TLP as 
a primary detection antibody at an optimal dilution of 1:2000. A band corresponding 
to TLP was detected, especially for wines 1, 2 and 4. Although barely visible using 
SDS-PAGE analysis, several smaller proteins were also present in wines 1 and 4, 
which might correspond to degradation products of the main TLP (Falconer et al. 
2010). Variations on the TLP content might be likely caused by several factors such 
as grape varieties used, distinct winemaking processes, bottling and posterior 
storage conditions (Sarmento et al. 2000). Further, the same samples were applied 
on a PVDF membrane for dot blot detection, using different concentrations of 
primary antibody (1:4000; 1:2000; 1:500).  A dilution 1:500 of VVTL1 was required 
to detect the range of protein concentrations, previously observed by Western blot. 
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Using optimal concentrations, a positive correlation was found between the signal 
intensity obtained through both dot and western blotting techniques, revealing a 
consistency between the methods.  
 
 
Fig. 4.2 - Optimization of Thaumatin-like proteins detection and comparison between 
methodologies. Four different untreated wines (1, 2, 3 and 4) were subjected to protein precipitation 
followed by protein detection analysis using the three different presented methods: A) SDS-PAGE; 
B) Western blotting and C) Dot blotting. Dot blot primary detection using antibody for VVTL-1 was 
optimized for different concentrations: 1:4000, 1:2000, 1:500 (with secondary antibody 1:5000 
dilution to all tests). 
 
Wine protein samples were applied on a PVDF membrane for dot blot detection, 
using different concentrations of primary antibody (1:4000; 1:2000; 1:500).  A 
dilution 1:500 of VVTL1 appears to be required to detect the range of protein 
concentrations, previously observed by Western blot. Using optimal concentrations, 
a positive correlation was found between the signal intensity obtained through both 
dot and western blotting techniques, revealing consistency between the methods. 
These results demonstrate that its methodology could be easily transferable to a 
production environment through the usage of dot-blotting, which requires only 
simple equipment and faster steps, thus overcoming the technical requirements 
required to carry out Western-blots at the wineries. 
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Effect of increasing application dosages of bentonite in different white wine matrices 
The previously optimized immunological-based methods were herein applied to 
assess the impact of increasing dosages of bentonite in different wine matrices and 
therefore, to understand their capacity to expose different protein removal profiles 
and efficiencies. 
Two untreated wines were tested against one final bottled wine, which was 
previously treated with bentonite by the winemaker (unknown dosage). After 
receiving these three wines, increasing dosages of a commercial bentonite (0-100 
g/L) were applied, simultaneously, to all the wines through laboratorial fining trials. 
Protein analysis was then performed on all samples using the immunological 
methods. Again, total protein analysis revealed a major band at 22-24 kDa in both 
untreated wines, corresponding to TLP (Fig. 4.3). In contrast to the untreated wines, 
and as expected, no signal of these specific proteins was detected in the wine 
previously treated at the winery. Faint bands at ~65-70 kDa were also observed in 
all SDS-PAGE gels, probably corresponding to invertase proteins (Sauvage et al. 
2010). Through this experiment, it was possible to demonstrate that the increased 
application of bentonite resulted in a progressive reduction of total protein in the 
untreated wines 1 and 2. These tendencies are also clear trough the measurement 
of the main band intensity in the SDS-PAGE gels, along the gradual increase of 
bentonite dosages (Graphs in Fig. 4.3). Indeed, the pattern of this reduction slightly 
varied between the two previously untreated wines. In untreated wine 1, protein loss 
seems to be more efficient as the main band was almost fully removed after addition 
of 40g /hL of bentonite (~85% removal).  
Although, the untreated wine 2 required 60 g/L bentonite to achieve that removal 
percentage, 100 g/L of bentonite (maximum dosage normally applied in the sector) 
seems to efficiently remove a greater proportion of protein (~85-95%).  
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Fig. 4.3 - Detection of total protein and Thaumatin-like proteins after addition of different 
dosages of bentonite. A) Two untreated wines (1 and 2) and a Treated wine were fined with 0-100 
g/hL of a commercial bentonite prior to analyses. B) SDS-PAGE gels were stained using Coomassie 
and bands intensities are respectively shown (intensity v/v%). Each band intensity was calculated in 
relation to the first band (0 g/hL). Due to the lack of bands in the Treated wine, no graph is presented 
for that experiment. C) Both Western and Dot blotting experiments were performed using the primary 
antibody against VVTL-1. 
 
Western and dot blotting of the targeted TLP exposed that one of the wine matrices 
(untreated wine1) originally contained higher signal intensity for the main TLP and 
both revealed similar removal efficiencies after bentonite treatment of the untreated 
wines. Consistent with the previous results, it was also possible to detect TLP of 
lower molecular weights and the pattern and amount of these proteins/protein 
fractions also differed between the two untreated wines. No signal of unstable 
protein was detected in the treated wine. 
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Taken together, these results indicate that different wine matrices have different 
protein content and respectively, different precipitation behaviours after addition of 
bentonite. Indeed, these findings highlight the importance to implement 
immunological-based methods at the wineries that could more accurately follow-up 
the removal of unstable proteins when different application dosages of bentonite are 
applied in distinct wine matrices and/or under different production conditions (eg. 
temperature, light exposure, sedimentation period). Accordingly, our results 
demonstrated that these tools enable a more accurate assessment of the essential 
amount of bentonite required to eliminate the unstable proteins in the untreated 
wines. 
  
 
4.4. Conclusions 
Heat instability tests traditionally performed at the wineries are influenced by 
complex chemical and physical factors, leading to biased predictions on the amount 
of bentonite required to remove unstable proteins. In this study, we implemented 
specific immunological-based assays to specifically target this type of proteins in 
white wines. Indeed, a novel antibody was raised to target Vitis vinifera TLP, which 
causes major problems after denaturation in bottled wines.  
Our results revealed that immunological-based assays allowed for an accurate and 
simple detection of these haze-forming proteins and consequently, providing useful 
tools to determine the minimum amount of bentonite to eliminate them, with evident 
efficiency and environmental gains. In particular, we believe that the dot-blotting 
approach could be easily transferred to the winery to facilitate the detection of TLP 
and CHT in a wide-range of samples and conditions in parallel, either from white 
wines or grape juices. Moreover, the protein removal efficacy of different treatments 
(bentonite clays) and amounts can be rapidly tested as a complement of each fining 
trials performed in the wineries, avoiding the application of over-estimated dosages 
at large scale. 
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5.1. Benefits of wine polyphenols intake for consumers’ health  
The “French Paradox” was firstly perceived in the 90’s, through the study of the 
Mediterranean culture, stating that wine moderate consumption plays a direct role 
on human’s health (Renaud S et al. 1998). Indeed, Serge Renaud and his co-
authors observed that despite the pronounced consumption of high saturated fats, 
the myocardial infarction rate among the French population was found to be 40% 
lower when compared to other European countries (Renaud S et al. 1998; 
Fernández-Mar et al. 2012; Katalinić et al. 2004; Schrieks et al. 2013). This 
inconsistency was then attributed to the regular and moderated red wine 
consumption (1 or 2 glasses of wine per day) registered in France, which was later 
found to induce cardiovascular protective effects (Katalinić et al. 2004; He et al. 
2008). Since then, successive evidences confirmed the potential of wine moderate 
consumption in the prevention of cardiovascular and neurodegenerative diseases 
and certain types of cancer (Giacosa et al. 2014; Kuppusamy et al. 2014).  
Although the health benefits of wine moderate consumption might be attributed to a 
wide-ranging variety of bioactive molecules, ranging from sugars, vitamins, minerals 
to volatile compounds (Mas et al. 2014), recent evidences support a fundamental 
role for wine polyphenols in cardio-protection, cognitive, anti-inflammatory, anti-
carcinogenic, antiviral and antibacterial functions (Arranz et al. 2012a; Ružić et al. 
2011; Cíz et al. 2008). Moreover, some polyphenols were shown not only to 
stimulate the growth of beneficial bacteria in gut, but also to inhibit the pathogenic 
ones (Dueñas et al. 2015).  
 
5.1.1. Wine polyphenolic content 
Polyphenols represent the most abundant, diverse and widespread group of 
secondary metabolites produced among the Plant kingdom and are recognized to 
be the ‘archetype of bioactive phytochemicals’ due to their recognized benefits for 
human health. (Lorrain et al. 2013). Contrarily to other alcoholic beverages, wine 
encloses a large variety of polyphenols, naturally originated from the skins, seeds 
  
Chapter 5 
 
Wine&Health: Biotechnology tools to promote consumers’ health 121  
 
and stems of the white and red grapes - 4 g and 5.5 g per kg of bunches, respectively 
(Basha et al. 2004).  
In the grapevine, these molecules not only play an active role in the primary 
metabolism and function, protecting the plant against biotic and abiotic stresses, but 
also contributing to its fertility and growth. Other biological functions include 
bactericide and antioxidant properties, which are of high value to the nutraceutical 
and pharmaceutical industries.  (Ribéreau-Gayon et al. 2006; Lorrain et al. 2013). 
Depending on the structural arrangement of the molecules, phenolic compounds 
can be categorized as flavonoids or non-flavonoids (Fig. 5.1) (Cartea et al. 2011).  
 
 
 
- Flavonoids are the most concentrated natural antioxidants in the grape berry, 
including the sub-families of anthocyanins and proanthocyanidins (or ‘condensed 
tannins’), which influence the wine colour and mouthfeel, respectively  (Kennedy et 
al. 2002).  
Fig. 5.1 - Principal polyphenols present in wine. Image adapted from Dueñas et al, 2015 
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- Non-flavonoids include important stilbenoids, as resveratrol or piceatannol 
and phenolic acids as benzoic, caffeic and cinnamic acids (Moss et al. 2013; Zhu et 
al. 2007; Arranz et al. 2012). Indeed, hydroxycinnamic acids are the major phenolics 
in white wine and might be present in their free or esterified forms. 
 
So far, the health benefits of wine moderate consumption have been mostly 
connected to flavonols (myricetin and quercetin), flavan-3-ols (catechin and 
epicatechin), proanthocyanidins, anthocyanins and phenolic acids (Giacosa et al. 
2014).  However, resveratrol, a stilbene largely present in the skins of red grapes is 
still being considered the “Golden Bullet” among the wine bioactive components. 
Resveratrol is known to stimulate cardio- and neuroprotection, antioxidant and anti-
inflammatory responses (Athar et al. 2009; Moss et al. 2013; Beher et al. 2009; 
López-Vélez et al. 2003; Kovářová et al. 2010; Artero et al. 2015; Schrieks et al. 
2013). In fact, its therapeutic potential was already exposed towards numerous 
illnesses, such as ischemia, cardiovascular diseases (CVD) and cancer (López-
Vélez et al. 2003; Moss et al. 2013; Artero et al. 2015). These effects have been 
linked with biological functions as cell signalling , enzyme modulation, metal 
chelation and antioxidant potential (Rodrigo et al. 2011).  
 
5.1.2. Variability factors: from grapevine to winemaking 
The polyphenolic profile is markedly distinct among different wines. Overall, 
differences are dependent on several factors as varietal and clonal variability within 
Vitis Vinifera (Mitić et al. 2010; Katalinić et al. 2004). Moreover, the terroir and 
phenolic maturity of the grapes during harvest play a crucial role on the final 
physicochemical characteristics and polyphenolic profiles of wines (Liu et al. 2016). 
Importantly, during the crushing of the grapes at the winery, oenological processes 
or reactions occurring during aging and storage, polyphenols are prone to structure 
change due to winemaking conditions related to temperature, pH, SO2, ethanol and 
possible application of protein fining agents.  
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Despite their metabolic variety, red wines contain approximately 10-fold more total 
polyphenols (~2g/L) than white wines (0.2-0.3g/L) due to a superior polyphenolic 
content in red grapes, which is leveraged by the maceration with the grape skins, a 
process that can last for several weeks (Arranz et al. 2012). Anthocyanins, flavonols, 
monomeric and phenolic acids are the most concentrated polyphenols in red wines 
(Fig. 5.2). Conversely, though having a much lower total polyphenolic content, white 
wines contain higher amounts of specific polyphenols, such as hydroxycinnamic 
acids, tyrosol and hydroxytyrosol (Fernández-Mar et al. 2012; Giacosa et al. 2014). 
However, white wines can bear increased concentrations of polyphenols by 
optimizing oenological practices as the pre-fermentative maceration to extract more 
phenols from the grape seeds, skin and stalks (Hernanz et al. 2007; Ružić et al. 
2011).  
Wines with higher polyphenolic concentrations have been demonstrated to have 
increased antioxidant activities in humans and each polyphenol has been shown to 
have different antioxidant capacities (Venturini et al. 2010).  Moreover, studies have 
unveiled synergistic reactions within complex matrices of polyphenols (Pignatelli et 
al. 2000). These findings highlight the importance to further explore the antioxidant 
benefits of different wine polyphenols and respective mixtures. 
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Fig. 5.2 - Diagram showing the concentration (average of polyphenols in red wine). 
Concentration values obtained from Arranz, et al, Nutrients (2012). 
 
5.1.3. Polyphenolic profiling  
Modern analytical techniques provide rapid, accurate and reliable methods for the 
analysis and identification of these biomolecules (Zhu et al. 2007). Due to its high 
sensitivity, mass spectrometry (MS) has been the most widely used tool for both 
targeted and non-targeted approaches and it can be performed either alone or 
coupled with liquid chromatography (LC-MS). 
In particular, these advanced methodologies have been used for wine authentication 
and to unveil the terroir impact on wine molecular composition (Rubert et al. 2014; 
Roullier-Gall, Boutegrabet, et al. 2014; Forcisi et al. 2013; Tarr et al. 2013). Indeed, 
those are useful tools to quantify important monomeric stilbenoids as resveratrol, 
piceatannol, and their glycosides, piceid and astringin (Moss et al. 2013). It is also 
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possible to unravel the structure of these molecules using tandem mass 
spectrometry (MS/MS) or multi-stage mass spectrometry (MSn) (Zhu et al. 2007). 
Furthermore, electrospray ionization mass spectrometry (ESI-MS) coupled with 
HPLC has also been increasingly used to identify and characterize anthocyanins, 
flavonols, proanthocyanidins (PAs), pyranoanthocyanins and phenolic acids 
(Lopes-Lutz et al. 2010).  
Modern holistic approaches require highly sensitive and powerful tools (Roullier-
Gall, Witting, et al. 2014) and it is still recognized that no method can describe the 
whole wine metabolome by itself (Delcambre & Saucier 2013). Novel approaches 
are currently being applied in order to give a rapid access to each wine polyphenol 
fingerprint and a novel extension of systems biology was recently proposed: 
‘Polyphenomics’. As reported by Saucier et al. (2013), the data obtained by this non-
targeted high-throughput methodology is not only highly reproducible, but also 
provides more information than previous methods, such as direct injection-ESI-MS.  
In future, novel tools are expected to be developed to provide more significant data 
about the different metabolites existing in grapes and wine, followed by reduced 
requirements in terms of sample preparation or analysis time. Altogether, these new 
approaches should not only help improving the winemaking practices, but also to 
better characterize human diets and link wine signatures to health benefits and 
potential biomarkers (Kay 2010; Engskog et al. 2016). 
 
5.2. Antioxidant capacity 
The antioxidant activity of a molecule is related with its capacity to react with reactive 
oxygen species (ROS) or to interfere with ROS production (Artero et al. 2015). 
Previous studies have indicated that resveratrol and other polyphenols act like ROS-
scavengers, by preventing the oxidation of low density lipoprotein Cholesterol (LDL) 
in vitro and, consequently, retarding the development of atherosclerosis and 
coronary heart disease (CHD) (De Whalley et al. 1990; Osada et al. 2001).  
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In particular, proanthocyanidins were referred to have 20 and 50 times greater 
antioxidant potential than Vitamin E and C, respectively (Rodrigo et al. 2011). 
Moreover, model solutions of three flavonoids and resveratrol have been proved to 
promote the decrease of ROS production in a culture of murine macrophages (Cíz 
et al. 2008). The same study has suggested that the number of hydroxyl groups 
existing on each molecule is probably correlated with the different levels of 
scavenging activity. Indeed, in a human study, polyphenols were proved to act 
synergistically with each other and consequently, benefits are surely dependent on 
the specific composition of each wine (Pignatelli et al. 2006). 
Several studies have been focused in differentiating wines as regards to total and 
specific polyphenolic composition and antioxidant capacity (Andrade et al. 2001; 
Peña-Neira et al. 2000; Mitić et al. 2010; De Beer et al. 2003; Ivanova-Petropulos 
et al. 2015). Actually, various in vitro methods might be used to evaluate the 
antioxidant ability of different wines (Zulueta et al. 2009; Re et al. 1999; Shimamura 
et al. 2014). These approaches might consist in simple scavenging assays, allowing 
a rapid high-throughput screening of isolated compounds or mixtures of polyphenols 
or even wines (Muselík et al. 2007). Amongst others, the 2,2´-azinobis-(3-ethyl-
benzothiazoline-6-sulphonate (ABTS•+) cation radical method and 2,2-diphenyl-1-
picrylhydrazyl (DPPH•) (Fig. 5.3) evaluate the capture of free radicals via 
spectrophotometry (De Beer et al. 2003; Liang & Kitts 2014).  
 
 
Fig. 5.3 - Scavenging reaction mechanism of 2,2-diphenyl-1-picrylhydrazyl (DPPH) with 
antioxidant. R:H - Antioxidant radical scavenger; R - Antioxidant radical (Liang & Kitts 2014).  
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Cellular models for oxidative stress and antioxidation protection  
Animal models and human clinical studies are highly expensive and not suitable to 
perform initial antioxidant potential screening of bioactive compounds or mixtures. 
Therefore, cell culture models are promising tools to access the bioactivity of several 
antioxidants at wide concentration ranges.  
The selection of a specific cellular model is critical to the success of the bioassay. 
The properties and sensitivity of the cells and their growth status are critical factors 
that affect antioxidant assessment, but also the lack of cytotoxic effect and a realistic 
concentration range in human diet and serum. Over the last decades, various types 
of cancer cell lines from lung, neurons, liver, colon and breast have been used to 
set up cell-based bioassays for assessing antioxidants activity of foods and dietary 
supplements. Nevertheless, none of those can mimic an aging ROS-generating 
environment per se. In this study, we have assessed antioxidant effects of wine 
polyphenols and complex mixtures by using Hutchinson-Gilford Progeria Syndrome 
(HGPS) vascular cells, which have been recently acknowledged as a reliable aging 
model (Brassard et al. 2016; Pitrez et al. 2015). 
 
Hutchinson Gilford Progeria Syndrome (HGPS) 
HGPS is a rare, genetically-encoded condition that causes premature aging in 
children, as at the age of 18-24 months they exhibit characteristics associated with 
accelerated aging. Phenotypic effects include body damage feature, such as hair 
lost, low body fat, bone density reduction, alopecia and weak muscle development 
(Pitrez et al. 2015). 
Recent studies have demonstrated that progeroid cells suffer from a persistent 
attack of macromolecule-damaging reactive oxygen species (ROS), such as 
superoxide radical (O2•−), hydrogen peroxide (H2O2) or hydroxyl radical (OH•) 
(Singh & Jialal 2006; Viteri et al. 2010; Seco-Cervera et al. 2014; Richards et al. 
2011). The reactive oxygen species (ROS) damage is highly connected with chronic 
degenerative diseases (Pelicano et al. 2004; Chen & Keaney 2012) and could be 
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formed either by enzymatic or non-enzymatic pathways in mammalian cells 
(Kamenisch & Berneburg 2009). In general, those highly reactive species cause 
oxidation of amino acid chains, formation of protein-protein cross-linkages and 
protein fragmentation. Importantly, the accumulated DNA damages induced by ROS 
are normally unrepairable causing  mutations, chromosomal translocations, or  
genetic information loss (Richards et al. 2011).   
Progeria is described as one of the most severe degenerative disorders from the 
laminopathies group, which includes rare genetic disorders caused by mutations in 
genes encoding proteins of the nuclear lamina (Richards et al. 2011). In particular, 
this disease is caused by a single mutation in the LMNA gene (1824T) (Viteri et 
al. 2010) that encodes the intermediate filament protein, lamin A. This de novo 
mutation causes alternative splicing and as result, a truncated form of this protein is 
produced, termed prelamin A or progerin (Ghosh et al. 2013). Normal lamin A is a 
major component of the nuclear matrix (NM) in differentiated cells (Richards et al. 
2011; Ghosh et al. 2013) and it is important to maintain the nuclear structure through 
nuclear support and chromatin organization (Viteri et al. 2010). Previous in vivo and 
in vitro studies proved that lamin A directly binds and activates the human sirtuin1 
(SIRT1) (Ghosh et al. 2013; Liu et al. 2012). SIRT1 is an important deacetylase, 
since it regulates several vital metabolic pathways (Liu et al. 2012) and functions 
such as genomic stability, inflammatory response, stress regulation and tumour 
suppression. Contrarily, the interaction between STIR1 and the dysfunctional 
prelamin A, (progeroid cells), is highly compromised, leading to a rapid cellular 
degeneration (Liu et al. 2012). As result, cells become more prone to senescence 
and neoplastic transformation (Seco-Cervera et al. 2014).  
Treatments of Progeria cells using ROS-scavengers have been recently proposed 
(Richards et al. 2011; Liu et al. 2012). Results indicated that a standard antioxidant, 
N-acetyl cysteine (NAC), was able to reduce the levels of DSB and improve cell 
grow (Richards et al. 2011). Further, a study from Liu et al (2012) demonstrated that 
Resveratrol (3,5,4’-trihydroxystilbene) improved the binding between prelamin A 
and SIRT1, enabling its proper localization in the NM and consequently, enhancing 
its activation (Liu et al. 2012). Indeed, it has also been suggested that the resveratrol 
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treatment might contribute to stress resistance, consequently ameliorating 
progeroid symptoms and life span in mice (Ghosh et al. 2013; Liu et al. 2012; 
Demidenko & Blagosklonny 2009). Still, the efficiency of both molecules is limited 
by their toxicity at high concentrations (Demidenko & Blagosklonny 2009) and thus, 
it is important to study the impact of a large range of drugs, dosages or even different 
treatments combinations and therapeutic strategies. 
 
5.3. Anti-carcinogenic effects 
Cancer is one of the leading cause of death worldwide (Sancho & Mach 2015) and 
it may occur when damaged cells fail to undergo apoptosis and proliferation or when 
the replaced cell is also mutated and proliferates. Both cases result in a cellular 
unbalance, as mutated cells proliferate at a higher rate than apoptosis.  
Recent studies demonstrated that wine moderate consumption may have beneficial 
effects on cancer prevention and treatment. These effects have been mainly 
associated with the wine content in polyphenols (Sancho & Mach 2015; Arranz et 
al. 2012b; Angel-Morales et al. 2012; Mazué et al. 2014). Indeed, several authors 
demonstrated that flavonoids such as resveratrol present anti-carcinogenic effects, 
due to their ability to interfere with the multi-step process of carcinogenesis 
(Slamenova & Horvathova 2013; Athar et al. 2009; Giovannelli et al. 2000). Several 
anti-carcinogenic activities have been previously linked to cell signal modulation, 
control of cell cycle proteins as cyclin B1 and D1, and progress along the cell cycle 
(Gómez-Alonso et al. 2012). The consumption of flavonoids has been widely 
recognized to protect against chemically induced colon cancer, in cell and animal 
models (Alshehri & Elsayed 2012; Lambert & Yang 2003; Zaveri 2006). Further, 
phenolic acids as benzoic, caffeic and gallic acids have been related to anti-
carcinogenic activities in prostate, breast, colon, renal and thyroid cancer cells 
(Sahpazidou et al. 2014a).  
Grape stems extracts (Sahpazidou et al. 2014a), grape extracts (Shrotriya et al. 
2012), wine extracts (Briviba et al. 2002; Gómez-Alonso et al. 2012; Luceri et al. 
2002)  and wine compounds (Gómez-Alonso et al. 2012) have been reported to 
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inhibit human cancer cell growth. In fact, a recent study identified an inhibitory 
activity of grape stem extracts against growth of  colon, breast, renal and thyroid 
cancer cells (Sahpazidou et al. 2014a). In particular, quercetin and kaempferol are 
referred to inhibited A549 cell proliferation derived from a lung carcinoma by 
activating an extracellular signal-regulated kinase (Hertzog & Tica 2012). On the 
other side, a study suggests that catechin and some of its metabolized products 
have cancer chemo-preventive effects by inhibiting cyclooxygenases (COX-1 and 
COX-2) activities (Seeram et al. 2003).  
Although these results suggest that polyphenols or grape/wine extracts might act as 
promising chemo-preventive and/or chemotherapeutic agents, some authors state 
that there is no statistically significant association between flavonoids intake and 
bladder (Neuhouser 2004) or breast cancers risk (Kilkkinen et al. 2004). Besides, 
other denote inconsistent results derived from a genetic basis (McCann et al. 2002). 
Concerning this contradiction and the current lack of clinical randomized trials, more 
studies are needed to confirm these benefits for each specific type of cancer.  
 
Human studies to assess anti-carcinogenic effects 
Human interventional studies are critical research tools to assess the definite anti-
carcinogenic effects of different molecules and mixtures in the human body. 
Nevertheless, they are currently scarce and highly restricted due to short 
intervention periods, low number of individuals and sampling points. Furthermore, 
human interventions performed thus far consist in single dose experiments that only 
investigate the compound absorption rate after 4 to 24 h of consumption  (Boocock 
et al. 2007; Yiu et al. 2015). Indeed, clinical trials of longer intervention periods 
mostly focus the clinical benefits after intake, not confirming the existence of their 
metabolites in plasma (Fujitaka et al. 2011; Tomé-Carneiro et al. 2012; Bhatt et al. 
2012).  
For these reasons, a larger number of human studies are required to support the 
current cancer research, particularly concerning the most aggressive forms of the 
  
Chapter 5 
 
Wine&Health: Biotechnology tools to promote consumers’ health 131  
 
disease, such as colon cancer - one of the most dangerous types of cancer in the 
world due to a poor response to the currently available chemotherapeutic agents.  
 
Colorectal cancer 
Although its early development in the colon/rectum, this cancer type has the 
capacity to spread to other gastrointestinal organs, liver, lung and ovaries (Kim et 
al. 2006). Most colorectal cancers result from older age and lifestyle factors, but also 
from some genetic disorders. 
Whereas excessive alcohol consumption, obesity, a high-calorie diet, and a lack of 
physical activity also promote colon cancer, several nutraceuticals have potentially 
shown benefits for its prevention and treatment and their classes and uses are 
presented in Fig 5.4. In fact, previous evidences have indicated that a human diet 
rich in folates, selenium, Vitamin D, dietary fibre, garlic, milk, calcium, spices, fruits 
and vegetables is protective against this type of cancer (Aggarwal et al. 2013).  
In particular, the plant-derived nutraceuticals, such as polyphenols from fruits and 
vegetables, have been previously connected to a significant decline of colon rectal 
cancer growth and presented additional benefits of improving overall human health 
with fewer adverse effects, when compared to the other types of treatments 
(Kuppusamy et al. 2014). Despite this, some authors still consider that the colonic 
effects originated from polyphenolic intake are much less studied than the ones 
promoted by other compounds, such as carbohydrates or proteins (Serra et al. 
2012; Kuppusamy et al. 2014). Nevertheless, important chemopreventive effects of 
dietary polyphenols in colorectal cancer was previously reported by using cancer 
cell lines. In particular, quercetin has been shown to inhibit proliferation, induce 
apoptosis and cell-cycle arrest in colon cancer cells (Shan et al. 2009). Later, other 
authors confirmed that flavonols are able to inhibit colon adenocarcinoma cell 
proliferation through the blocking of G2/M cell cycle (Gómez-Alonso et al. 2012).  
Epidemiological studies revealed that the specific administration of trans-resveratrol 
might contribute to the prevention of colon carcinogenesis (Juan et al. 2012; 
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González-Sarrías et al. 2011). Previous studies support this evidence, showing that 
the wine phenolic compounds could reduce the incidence of colorectal cancer 
(Arranz et al. 2012; Sancho & Mach 2014; Sahpazidou et al. 2014).  
 
 
 
 
 
 
 
 
 
 
Fig. 5.4 - Different nutraceuticals used in colon cancer therapeutics (image adapted from 
Kuppusamy et al 2014). 
 
5.4. Bioavailability and metabolism 
 
Biological effects of polyphenols are permanently dependent on their bioavailability, 
a factor that highly diverges among these bioactive molecules.  Still, limited 
information exists about the pharmacokinetics of polyphenols in humans. 
In previous epidemiological experiments, some polyphenols, such as procyanidins, 
quercetin and flavanols have proved to be successfully absorbed into plasma 
through a passive transport process across membranes (Rodrigo et al. 2011). Still, 
this absorption was found to be dependent on a previous hydrolysis of the molecules 
by intestinal enzymes or colonic microflora, followed by an extensive modification 
pathway (Fig. 5.5). Other studies in humans and rats revealed that even though 
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resveratrol is highly absorb into the human blood, its molecules have poor 
bioavailability, water solubility and are chemical unstable (Walle et al. 2004; Wenzel 
et al. 2005; Neves et al. 2013), which suggests that health benefits might be more 
associated with the whole pool of antioxidants existing in wine. Hence, other authors 
verified a high inter-individual variability of trans-resveratrol glucuronides in human 
serum, rather than its free form (Vitaglione et al. 2005a). Indeed, there is a clear 
need to test these metabolites in ex vivo and in vitro model systems rather than just 
the native compounds that occur in food or plant extracts (Ottaviani et al. 2016). 
Altogether, while these polyphenolic molecules successfully enter in the blood, the 
underlying mechanisms are still not fully understood among the scientific community 
and more information on bio-distribution and metabolism of wine polyphenols  is still 
needed (Cíz et al. 2008).  
Indeed, current research is focused in discovering analog molecules of polyphenols, 
as methylated and glucoside derivatives of resveratrol that could have an improved 
bioavailability and thus, be useful for medicine and pharmaceutical purposes (Walle 
2011; Choi et al. 2014). Further, large-scale biotechnological approaches have been 
developed to produce such molecules, as opposed to chemical synthesis or plant 
extraction (Khanduja & Bhardwaj 2003; Kang et al. 2014; Choi et al. 2011). Also, 
nano-delivery systems are being investigated as conceivable carriers to enhance 
oral administration of resveratrol molecules (Neves et al. 2013).  
The ethanol content in wine is also described as an important feature for this 
research field. In general, patterns of regular moderate consumption are associated 
with lower risk of diseases, while episodic heavy consumption contradicts any 
beneficial health effect (Conigrave et al. 2001; Murray et al. 2002; Wharton & Harris 
2007; Ruidavets et al. 2010). These patterns confirm the J-shaped association 
between alcoholic beverages consumption and risk of diseases, such as dementia, 
obesity, cardiovascular diseases, and/or risk of mortality. In particular, the moderate 
ethanol intake might benefit the absorption of quercetin and its 3-O-glucoside 
(Dragoni et al. 2006) and it seems to indirectly contribute to the antioxidant capacity 
of wine by increasing the polyphenols bioavailability (Serafini et al. 1997). 
  
Chapter 5 
 
Wine&Health: Biotechnology tools to promote consumers’ health 134  
 
Additionally, while dealcoholized or low-alcohol wines might have significant 
antioxidant effects in humans, the results seem to be inferior to the ones achieved 
using wines with higher alcohol levels (Guilford & Pezzuto 2011). Contrary to these 
outcomes, a human intervention study described that a 4 weeks consumption of red 
wine, increases the plasma levels of a oxidative lipid damage marker, isoprostane 
8-iso-PGF2α, when compared with the dealcoholized red wine (Schrieks et al. 
2013).  
 
Fig. 5.5 – Representation of the main epicatechin metabolites existing in plasma after oral 
human intake of red wine. Adapted from Ottaviani et al. 2016. 
On the other side, the matrix also plays a key role in bioavailability. trans-resveratrol 
seem to be better absorbed from red wine or juice than from grape extract tablets 
(Stockly et al. 2012). Indeed, parameters such as pH, intestinal fermentations, biliary 
excretion and transit time have consequences for the polyphenols absorption. Also, 
enzymes and carriers involved in the absorption and metabolism may affect the 
bioavailability of such molecules.  
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Human studies focused on the bioavailability of the resveratrol are still scarce and 
in most of them it was administrated in the form of tablets, capsules or caplets 
(Brown et al. 2010; David J. Boocock et al. 2007; David J Boocock et al. 2007), 
which raises the need to further study bioavailability of resveratrol and its 
metabolites after intake. 
 
5.5. Objectives 
Main objective 
In the Part II of this thesis, the main objective was to understand the potential health 
benefits of individual polyphenols, polyphenolic mixtures and wines through the 
application of innovative methodologies and strategies. 
To achieve the main objective of Part II of this thesis, the following specific objectives 
were defined: 
a) to evaluate the antioxidant potential of different polyphenols and polyphenolic 
complex mixtures;  
b) to explore the bioavailability of potentially important anti-carcinogenic 
polyphenols;  
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Wines and individual polyphenols promote antioxidant benefits 
on a human iPSC model of Hutchinson Gilford Progeria 
 
 
This Chapter aims at fulfiling the specific objective of this thesis “to evaluate the 
antioxidant potential of different polyphenols and polyphenolic complex mixtures, by 
using a novel model based in Progeria cell lines, which originally have high levels 
of ROS production”, whose results were submitted in “Scientific Reports - Nature”, 
an international reviewed journal, from the Nature group. 
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Abstract 
Red wine moderate consumption has been reported to prevent age-related 
diseases, including Alzheimer and dementia. A variety of different wine polyphenols 
has previously demonstrated antioxidant benefits against the DNA damage caused 
by reactive oxygen species that cause these aging conditions. Still, their individual 
effects and possible synergies in complex mixtures are poorly understood. 
In this work, the cellular impact of twenty-two red wines and individual polyphenols 
was assessed in a cell model for oxidative stress, based on human Hutchinson-
Gilford Progeria Syndrome (HGPS) cells. Indeed, HGPS cells mimic an aging 
environment, rich in reactive oxygen species (ROS). In parallel, the physicochemical 
properties and polyphenolic composition of the different wines were also evaluated.  
Results indicate significant impacts as regards to cell proliferation and oxidative 
stress reduction, after cellular exposure to red wines and polyphenolic solutions 
(0.05% (v/v)). Among all the polyphenols measured in the wines, procyanidin B and 
(-)-epicatechin revealed the greater impact on the cell growth of the progeroid cells. 
Further, most of the red wines promoted greater levels of stress reduction, when 
compared to the effect of individual polyphenolic compounds, thus unveiling 
potentially important synergic effects within the components of the wine complex 
chemical mixture.  
Overall, this study clearly demonstrates that red wines and individual polyphenols 
present strong antioxidant benefits on human cell lines with aging potential, 
stressing out the importance to further explore them to develop new strategies to 
fight against aging-associated conditions. 
 
Keywords 
Antioxidant potential, Hutchinson-Gilford Progeria Syndrome (HGPS), oxidative 
stress, polyphenols, radical oxidative species, red wines, smooth muscle cells 
(SMCs).  
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6.1. Introduction 
Since the acceptance of the French paradox, it has been known that wine moderate 
consumption – 1/2 standard glasses of wine per day - provides health benefits to 
humans. Both epidemiological and laboratory research studies confirmed benefits 
associate with cardio-protection, anti-inflammatory, anti-carcinogenic and antiviral 
effects (Arranz et al. 2012; Ružić et al. 2011; Cíz et al. 2008). Moreover, others 
reported that moderate red wine drinking promotes benefits for the brain and 
nervous system, causing a delay in aging symptoms associated to Alzheimer’s 
disease and dementia (Rege et al. 2014; da Luz et al. 2012). 
Red wines normally contain 2.0 to 6.0 g/L of total polyphenols (Quideau et al. 2011), 
10-fold more than white wines (Pignatelli et al. 2006), which is explained by the 
presence of anthocyanins (pigments) and higher quantities of catechin compounds 
extracted during the maceration steps. Polyphenols have been reported to exhibit 
antioxidant activity through various endogenous and exogenous mechanisms 
(Obrenovich et al. 2010). In particular,  polyphenolic compounds such as (+)-
catechins, (-)-epicatechins or stilbenes are widely recognized for preventing the 
incidence of pathological disorders associated with DNA damage caused by 
reactive oxygen species (ROS) (Singh & Jialal 2006; Viteri et al. 2010; Seco-
Cervera et al. 2014; Richards et al. 2011; Liu et al. 2012; Villaño et al. 2005). The 
main ROS species include superoxide radical (O2•−), hydrogen peroxide (H2O2) and 
the hydroxyl radical (OH•). 
Importantly, different wines have different metabolomic fingerprints and, 
consequently, polyphenolic compositions, leading to different health effects in 
humans (Gruz et al. 2008; Delcambre & Saucier 2013; Katalinić et al. 2004). This 
variability is explained by several features: (i) the nature of the grapes (soil, grape 
varieties, appellation and climate); (ii) the vinification techniques and (iii) the wine 
evolution during storage (Mitić et al. 2010; Andrade et al. 2001; Zafrilla et al. 2003). 
Indeed, previous authors have demonstrated a high metabolic variability between 
different Vitis vinifera varieties, particularly as regards to polyphenols and volatile 
compounds (Perestrelo et al. 2014; Câmara et al. 2004; de la Cerda-Carrasco et al. 
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2014). This is of high importance and value, as world-wide more than 10000 grape 
varieties are known, which exposes a vast array of possible wine metabolic 
compositions (This et al. 2006). 
Wine is composed by ~80-85% of water, ~9-15% ethanol, and about only 3% of it 
corresponds to its metabolite fraction, which may be of more than 1000 different 
molecules (Revi et al. 2012). Given its chemical nature, wine can be regarded as a 
matrix of high complexity, where it is important to understand possible synergistic or 
antagonistic interactions between the different polyphenols or between polyphenols 
and other molecules, such as volatiles, organic acids, sugars or proteins  (Kurin et 
al. 2012; Pignatelli et al. 2000). Such complexity, already present in monovarietal 
wines, is specially leverage in blended wines, from regions where it is a common 
practice to mix different grape varieties, thus increasing the metabolic complexity 
within wines and the probability of synergistic and antagonistic events to occur at 
unknown levels. 
However, a bottleneck for the research of this topic is the existing experimental 
methods as animal and human assays present several concerns and limitations. 
Indeed, it is important to stablish simple and reliable methods to measure 
antioxidant activities in vitro. Chemical methodologies have been commonly applied 
to measure the total antioxidant potential of different compounds or mixtures in vitro 
(e.g. 1,1 –diphenyl-2-picrylhydrazyl (DPPH)) by estimating their capacity to act as a 
free-radical scavenger in a ROS-rich medium (Van Den Berg et al. 1999; Ružić et 
al. 2011; Villaño et al. 2005). Previous studies have applied these methods to 
estimate and compare the antioxidant capacity of different chemical compounds 
(Villaño et al. 2005); different wines matrices obtained from different grape varieties 
(Mitić et al. 2010); and obtained by different oenological techniques Cellular in vitro 
approaches using rat and human cell cultures have also been widely used to expose 
potential cellular impacts of wine. Indeed, these systems are closer to in vivo natural 
systems, contributing to a more accessible acquisition of knowledge So far, 
research on the cellular impact of wines has been focused on neuronal and cancer 
cell lines, such as prostate, breast, lung, colon rectal (Venturini et al. 2010; Gómez-
Alonso et al. 2012; Wallenborg et al. 2009; Leifert & Abeywardena 2008). All these 
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cell lines are suitable models for degenerative and age-related diseases, but cannot 
be regarded as aging models per se. 
Hutchinson-Gilford Progeria Syndrome (HGPS) vascular cells have been 
acknowledged as a reliable aging model (Brassard et al. 2016; Pitrez et al. 2015). 
HGPS is a rare, genetically-encoded condition that causes early-onset premature 
aging in children, whose origin remains to be fully understood, but evidences point 
towards the involvement of factors as reduced DNA-damage-repair response; 
progerin-mediated stem cell pool exhaustion; mesenchymal lineage differentiation 
defects and nuclear fragility (Zhang et al. 2011; McClintock et al. 2006).  As result, 
higher levels of free reactive oxygen species (ROS) are produced, causing an 
excessive accumulation of DNA damages in the cells (Pitrez et al. 2015; Chi et al. 
2009). To alleviate progeroid symptoms derived from Hutchinson-Gilford Progeria 
Syndrome, antioxidant treatments such as resveratrol and N-acetyl cysteine (NAC) 
have been suggested in previous reports (Richards et al. 2011; Liu et al. 2012). 
Herein, we have used HGPS cell cultures as cellular models to mimic a unique ROS-
generating environment and to test the potential ROS-scavengers among the 
different red wines, complex polyphenolic matrices and individual polyphenols as 
regards to their (i) direct effect on cells (Direct test); (ii) their ability to rescue cells 
from an additional oxidative stress (Rescue test); and (iii) potential synergistic 
effects between polyphenols present on different wine matrices.  
 
6.2. Material and Methods 
6.2.1. Reagents and solutions 
Acetonitrile (ACN), methanol (MeOH) and water (LC-MS Grade) were obtained from 
Fisher Chemical. Formic acid (FA) was obtained from Amresco®. The internal 
standards (+)-catechin, (-)-epicatechin, (+)-gallocatechin, (-)-epigallocatechin, 
procyanidin B2, procyanidin C1, trans-caffeic acid and trans-resveratrol-(4-
hydroxyphenyl-13C6) (purity ≥ 98%) were purchased from Sigma-Aldrich®. 
Standard stock solutions used for LC-MS/MS analysis were prepared in MeOH 
except for Ellagic acid that was prepared in ethanol.  
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All solutions were stored at -20°C until used. In each working day, freshly diluted 
calibration standard solutions were prepared by diluting the stock solutions in 2% 
ACN: 0.1% FA. 2,2-Diphenyl-1-picrylhydrazyl (DPPH), tert-Butyl hydroperoxide 
(TBHP) and 37% Formaldehyde solution were purchased from Sigma (St. Louis 
MO). DAPI (4′,6-diamidino-2-phenylindole) and CellROX® Deep Red Probe were 
acquired from Thermo Fisher Scientific (Waltham, Massachusetts, EUA) and the 
cells Medium (Bullet kit SMGM-2) from Lonza (Basel, Switzerland). 
 
6.2.2. Individual polyphenol solutions 
Preparation of solutions 
Single stock solutions of (+)-catechin, (-)-epicatechin, (+)-gallocatechin, (-)-
epigallocatechin, procyanidin B2, procyanidin C1, trans-caffeic acid and trans-
resveratrol were prepared in absolute ethanol and stored at -80 ⁰C. The respective 
dilutions of the individual polyphenols and the polyphenolic mix (Poli mix) were 
freshly prepared using a hydroalcoholic solution (13% ethanol). Final concentrations 
were stablished as the average concentration of these compounds in red wines, 
according to the mean value of bibliographic data from Phenol-Explorer Database, 
Version 1.5.7 (Arranz et al. 2012). A polyphenolic mixture (Poli mix) containing the 
referred polyphenols at their respective average concentrations was prepared. 
 
6.2.3. Wines preparation  
Selection 
Wine selection was performed to include a high heterogeneity of wines. The final 
wine samples included: (i) different grape varieties, including of national and 
international origin (ii) mono-varieties and blends; (iii) distinct appellations; (iv) 
different producers; and (v) different price ranges (from 2 to 50€). All wines were 
certified by their Denomination of Controlled Origin (DOC) and their complete list is 
presented in Annex VI as Table S6.2.  
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Storage 
All tested wines were received in closed glass bottles of 750 mL. Each wine was 
homogenized and divided into both 500 μL and 15 mL aliquots and stored at -80 ⁰C 
until used. To avoid repetitive thawing and freezing, a new aliquot was always used 
for each experiment. The necessary dilutions for the cellular assays were performed 
just prior to experiments using a hydro-alcoholic solution (13% ethanol). 
 
 
6.2.4. Wines analysis  
Physicochemical characterization 
Wines were characterized according to their oenological parameters. Enzymatic 
methods were used in a Miura200 chemical analyzer from TDI (Barcelona, Spain) 
to access the wine total polyphenolic content (TPC), tartaric acid, anthocyanins and 
glucose + fructose. Other parameters as Free and total SO2, density, alcohol 
content, titratable acidity (TA), volatile acidity (VA), malic acid, tartaric acid, pH, and 
glycerol content were measured using a FOSS Wine-Scan (FT-120) infrared 
Fourier-transform spectrometer and a WineScan software Version 2.2.1 (FOSS, 
Hillerod, Denmark).  
 
Solid-Phase Extraction (SPE) of the wine samples 
Internal standards - (±)-catechin-2,3,4-13C3 (0.235 ng/µL) and resveratrol-(4-
hydroxyphenyl-13C6) (0.281 ng/µL) - in a 2% FA solution (MilliQ water) were added 
to 500 µL of each wine sample. Solid-phase extraction was performed with Oasis 
HLB SPE cartridges (60 mg). Briefly, the cartridges were conditioned with 1.5 mL of 
methanol and 1.5 mL of water (both LC-MS grade). Samples were passed through 
the cartridge 3 times. The cartridges were then rinsed with 2 mL of H2O: 5% MeOH. 
The retained polyphenols were eluted with 2 mL of MeOH, partially evaporated in a 
Speedvac (Concentrator Plus, Eppendorf), and readjusted to 500 μL of 2% ACN: 
0.1%FA. Wine samples were diluted 2 and 100 times with 2% ACN: 0.1%FA, after 
centrifugation (MiniSpin Plus, Eppendorf) at 14.000×g for 5 min. 
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Quantification of Polyphenols by LC-MS/MS 
Samples were analyzed on a CTC PAL/ekspert ™ ultraLC 10 (Eksigent®) coupled 
to a hybrid triple quadrupole/linear ion-trap 4000 QTRAP® mass spectrometer and 
acquisition was performed by Analyst® (version 1.6.2, AB Sciex). The separation in 
the chromatography system was performed with a 2.6 µm Kinetex® F5 (50 x 2.1 
mm, 100 Å, phenomenex) column with a 2.1 mm SecurityGuard™ ULTRA cartridge 
for F5 UHPLC (phenomenex) as guard-column. The column was set at 40 °C. The 
mobile phase, with a flow rate of 250 μL/min, was composed by solvents A (0.1% 
formic acid in water) and B (0.1% formic acid in acetonitrile) with a gradient of 2-
30% B (0–9 min), 30–95% B (9–11 min) and 95% B (11–15 min) followed by 
cleaning and re-equilibration steps with a run of 4 min from 90 to 2% of B. 
The mass spectrometer equipped with a turbo V™ source was operated in positive 
mode for (+)-catechin, (-)-epicatechin, (+)-gallocatechin, (-)-epigallocatechin, 
procyanidin B2, procyanidin C1, trans-Caffeic Acid and p-coumaric acid detection; 
and in the negative mode for the analysis of ellagic acid and trans-resveratrol. The 
ion spray voltage was 5500 V for positive and 4500 V for the negative mode. The 
other source parameters were the same for both ionization modes: curtain gas 
(CUR), 30 psi; ion source gas 1 (GS1), 30 psi; ion source gas 2 (GS2), 20 psi; source 
temperature, 450 °C.  Parameters were optimized for each compound in multiple 
reactions monitoring (MRM) mode by direct infusion of a standard solution of each 
polyphenol at 9 µL/min. The values of declustering potential (DP), collision energy 
(CE), collision exit potential (CXP), and transitions are presented in Annex VI as 
Table S6.1. The sample volume of injection was of 10 μL, for all but the red wine in 
the negative mode, which was of 2 µL. Data was processed using MultiQuant™ 
software (version 2.1.1, AB Sciex). Quantification of each polyphenol was performed 
using calibration curves prepared in solvent with criteria for acceptance of r2 value 
of at least 0.99, and the calibrators accuracy within 80-120%. 
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In vitro free radical scavenging by DPPH 
The free radical scavenging capacity of the polyphenol standards and wines was 
accessed using the 2,2-Diphenyl-1-picrylhydrazyl methodology (DPPH) (Katalinić et 
al. 2004). All determinations were performed in triplicate and the inhibition 
percentage of the DPPH radical by the phenolic compounds was calculated 
according to the following equation (Yen & Duht 1994): 
 
Equation 6.1. 
% 𝑖𝑛ℎ𝑖𝑏𝑖𝑡𝑖𝑜𝑛 =   [
(𝐴𝐶(0) − 𝐴𝐴(𝑡))
𝐴𝐶(0)
] × 100 
 
6.2.5. Cell assays  
Cell culture 
Progeria smooth muscle cells (Progeria-SMCs) were firstly differentiated from Pro-
geria-iPSCs. Briefly, Progeria vascular progenitor cells (CD34+ cells) were isolated 
from human embryoid bodies at day 10 using magnetic activated cell sorting, as 
reported by Ferreira, L., 2007. The CD34+ cells (30,000 cells/cm2) were plated in a 
24-well plate and grown in EGM-2 media supplemented with PDGFBB (50 ng/mL) 
for Progeria-SMCs induction, followed by a maturation step in SmGM-2. Cell cul-
tures were maintained at 37 ºC, 5% CO2 in a humidified atmosphere, with media 
changed every 2 days (Ferreira et al. 2007). Normal human vascular SMCs (Lonza) 
were used as controls and named Control-SMCs.  
Preceding the oxidative assays, cells were cultured in 96-well plates using SmGM-
2 rich medium (Lonza). Progeria-SMCs were cultured at a concentration of 
104 cells/well, while Control-SMCs were cultured at 6.5 x103 cells/well. Concentra-
tions were previously optimized for each cell line to guarantee the same level of 
confluency in culture well (Progeria-SMCs are smaller when compared to the Nor-
mal cell line). Culture media was changed for both cell lines every 2/3 days until 
testing. 
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Fig 6.1 - Progeria-SMCs as a ROS-generating model. A) The differences between of nuclear 
integrity on Normal and Progeria-SMCs. In normal cells, damage is repaired by the DNA repair 
machinery. In progeroid cells, accelerated aging ensues, resulting in a ROS-generating environment 
(adapted from Ya-Hui Chi, et al, 2009. B) Cell-based assays implemented in this study. Experiments 
were performed to access the direct effect of wines and their Rescue capacity (after stress induction 
with 250μL TBHP, 2h). 
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Oxidative cellular assays 
Direct test – The cellular impact of either wines or the individual polyphenols was 
firstly investigated without any induced oxidation to cells. On each well, their final 
concentration was of 0.05% (v/v). Assays were performed in both Normal and 
Progeria-SMCs. A hydro-alcoholic solution of 13% EtOH served as a blank control 
and was added to the cells at the equivalent final concentration of 0.05% (v/v)), to 
consider alcohol contribution.  
Rescue test - The Rescue capacity of both wines and individual polyphenols was 
also investigated. After 12h seeding, oxidative stress was induced by adding 250 
μM of tert-Butyl hydroperoxide (TBHP) (a standard oxidant), followed by 2 hours of 
incubation at 37 ºC. Cells were then exposed to 0.05% (v/v) of the different wines, 
the different individual polyphenols, the blank control solution of 13% EtOH and a 
50 μM NAC standard antioxidant control. For oxidative stress determination, cells 
were stained with 5 µM of CellROX® Deep Red (Thermo Fisher Scientific) by adding 
the probe to the complete medium, followed by incubation at 37 °C during 2 hours. 
Cells were then fixed using a 2.5% Formaldehyde solution during 30 min at room 
temperature and washed twice with PBS. To access cell proliferation, nuclei were 
stained with 4', 6'-diamidino-2-phenylindole (DAPI). Final plates were examined with 
a high-content fluorescence microscope (IN Cell 2200, GE Healthcare). Assays 
were performed in quadruplicates. 
 
Image scan 
Images were recorded in each well (12/well) using a 20X objective in the IN cell 
Analyzer 2200 Imaging System (IN Cell 2200, GE Healthcare) and analyzed using 
the Analyzer Workstation 3.7.2 software (GE Healthcare). For cell viability analysis 
the number of cell nuclei were counted for each condition. For oxidative stress, the 
mean intensity of CellROX® Deep Red (Thermo Fisher Scientific) was registered in 
both cell nucleus and cytoplasm. The total value of intensity was used and 
normalized according to cell area. The variations of nuclei count and oxidative stress 
(%) were then determined, as follows:  
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Equation 6.2. Oxidative stress variation - ∆OS (%)  
∆OS(%) = 100 × (OS𝑡 − OS𝑐)/OS𝑐 
• 𝐎𝐒𝒄: Oxidative Stress registered in cells with addition of a hydro-alcoholic solution (13% ethanol) 
as control. 
• 𝐎𝐒𝒕: Oxidative Stress registered in cells with addition of each antioxidant sample (wine or 
polyphenol). 
 
Equation 6.3. Nuclei count variation - ∆NC (%)  
∆NC(%) = 100 × (NC𝑡 −  NC𝑐)/NC𝑐 
• 𝐍𝐂𝒄: Nuclei count registered in cells with addition of a hydro-alcoholic solution (13% ethanol) as 
control. 
• 𝐍𝐂𝒕: Nuclei count registered in cells with addition of each antioxidant sample (wine or 
polyphenol). 
 
 
6.2.6. Statistical analysis 
Statistical analysis was mostly performed in the GraphPad Prism software, version 
5.0. Standard deviation calculations, linear regression and t-test analysis were 
performed. Differences of p<0.05 were considered significant. Principal Component 
Analysis was performed in the Primer software, version 6.1.16 (Clarke and Gorley, 
2006).  
 
 
6.3. Results and Discussion 
 
Metabolic characterization of red wines 
The twenty-two different red wines used in this study were characterized using 
enzymatic and Fourier-transform spectrometry (FTIR) methodologies, followed by 
mass spectrometry quantification of different polyphenols. As reported by previous 
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authors, the chemical composition of the grapes and wines is highly linked to 
specific factors, such as grapevine variety, location, soil, climate and technical 
practices (Roullier-Gall, Lucio, et al. 2014; De Andrés-De Prado et al. 2007; Tarr et 
al. 2013). Nonetheless, the wine polyphenolic composition and concentration has 
been reported as being mostly dependent on the vineyard (Lampíř & Pavloušek 
2013). Herein, a broad variety of red wines - including monovarietal and blends, in 
a total of 22 wines - was tested in order to unravel the existing physicochemical 
heterogeneity of wines and their polyphenolic profile. Further details about the wines 
and respective characterization is presented in Annex VI as Figs. S6.1 and Table 
S6.3. 
 
Red wines: Impact on oxidative stress reduction 
At first, cellular assays were performed in Progeria-SMCs, using both white and red 
wines, in triplicate. The objective was to ascertain their potential antioxidant effect 
in the cells, testing a larger range of wine concentration (0.005 to 4% (v/v)). Results 
indicated that red wines had a higher potential to decrease the cellular oxidative 
stress, when compared to white wines (Fig. 6.2). This evidence was confirmed 
through the Direct and Rescue cellular tests and it became more evident at higher 
concentrations. In fact, this evidence supports previous reports showing that red 
wines originate greater antioxidant effects when compared to white wines  (Kurin et 
al. 2012; Arranz et al. 2012). 
According to this, only red wines were then selected for downstream experiments 
and an optimal dosage of 0.5%(v/v) was stablished as being the required 
concentration to achieve the same or better results when comparing to the control 
(NAC) at its standard concentration. 
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Fig 6.2  - Primary cell assays performed in Progeria-SMCs. Two wines (white and red) were firstly 
tested in the A) Direct and B) Rescue cellular assays, using a wide range of concentrations (0.005 
to 4% (v/v)). NAC 50μM was used as a standard antioxidant control. Bars indicate mean ± SD and 
experiments were performed in triplicates. 
 
Still, this concentration was 10 times lower than the one applied in a previous study 
that directly tested red wine matrices on progenitor and cancer cells (Wallenborg et 
al. 2009). The cellular impact of red wines was tested in normal- and Progeria-SMCs 
to unravel the potential of the latest as a ROS-generating model. Prior the 
assessment of the antioxidant effects, bright-field captions were registered showing 
the initial cellular morphologies (Fig. 6.3 A). Dissimilar characteristics were initially 
observed, namely Control-SMCs presented a fusiform shape and a normal nuclear 
morphology, whereas, Progeria-SMCs were characterized by an irregular, rounded 
and smaller cell shape, whose nuclear envelope integrity was found to be highly 
heterogeneous.  
Initial cell cultures were then incubated with the ROS-detecting probe (CellROX 
Red) and the cell fluorescence signals were registered before and after the addition 
of a standard oxidant (250μM TBHP). In both cases, Progeria-SMCs presented 
superior levels of fluorescence intensity. (Fig. 6.3 B-C). Moreover, more signs of 
cellular damage were observed after the induced oxidation in Progeria-SMCs (Fig. 
6.3 C2). Altogether, these evidences confirm recent reports that suggest higher 
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levels of ROS production and DNA damage in progeroid cells (Pitrez et al. 2015; 
Seco-Cervera et al. 2014; Ghosh, Liu, and Zhou 2013).  
The full set of red wines (n=22), with average ethanol content of 13.67% ± 0.69 (v/v); 
and a total acidity of 5.79 ± 0.37 g/L (H2SO4), was equally tested in both SMCs lines. 
The direct application of the wines to the cell cultures at the concentration of 0.5% 
(v/v) (Direct test) caused significantly different responses between the cell lines, 
concerning the reduction of oxidative stress (p<0.0001) (Fig. 6.3 D). Contrarily to 
what was verified for Normal-SMCs, all red wines promoted a decrease of oxidative 
stress levels in Progeria-SMCs. Importantly, these cells were shown to be 
significantly more benefited by the direct addition of the antioxidant wine samples 
when compared to the Normal-SMCs. In a parallel experiment under rescue 
conditions (Rescue test), wines were applied to the initial cells after induction of high 
ROS production - with 250μM TBHP (standard oxidant). This assay also unveiled 
different responses concerning the stress reduction verified on the two tested cell 
lines (Fig. 6.3 E). In fact, the oxidative stress reduction was significantly different 
(p<0.0024) in Progeria-SMCs - ranging from 45% to 63%. Still, all wines tested also 
caused important stress reduction in the Normal-SMCs.  
Indeed, a previous study has showed that a red wine extract protected against the 
oxidative stress in endothelial cells, after being induced by TBHP senescence 
(Botden et al. 2012). Herein, we present the first evidence that red wines directly 
promote a reduction of oxidative stress in a different cell line (Progeria) and 
confirmed this evidence with a considerably higher number of bioactive samples. 
These effects support the association of Progeria-SMCs with increased levels of 
intrinsic oxidative stress, which are currently being suggested as potentially relevant 
to the pathogenic mechanisms of HGPS (Trigueros-Motos et al. 2011; Pitrez et al. 
2015). 
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Fig 6.3 - Comparison of the wine effects on the oxidative stress of both Normal and Progeria-
SMCs. A-C) Cellular captions obtained for both cell lines during the experiments. A: Bright-field 
images; B: Cell intensity of cells without ROS induction; C: Cell intensity of cells after induction of 
ROS with an oxidant (TBHP). D-E) Boxplots with whiskers representing the variability of stress 
impacts caused by application of the red wines (n=22) on each cell line. t-test shows significant 
differences and asterisks represent: ** p<0.005, *** p<0.0001. Experiments were performed in 
quadruplicates.  
 
Correlation between total polyphenols and antioxidant capacity 
The antioxidant capacity of the red wines was assessed using the DPPH assay (Fig 
6.4 A) and through the oxidative stress reduction obtained through Progeria cell 
assays (Fig 6.4 B), to examine the existence of possible correlations between these 
parameters and the polyphenolic content of the red wines tested.   
Interestingly, the radical scavenging capacity (RSC) was apparently correlated with 
the total polyphenolic content of the red wines (r2=0.5448) (Fig.  6.4 A), which 
supports previous studies (Katalinić et al. 2004; Mitić et al. 2010). As regards to the 
cell assays, much lower correlation values were acquired between polyphenolic 
content and oxidative stress reduction. In fact, when red wines were directly added 
to the Progeria cells, the measurement of total polyphenols had no correlation with 
stress reduction (r2=0.0761) (Fig. 6.4 B) suggesting that other factors might 
contribute to these antioxidant effects through possible synergistic reactions. 
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Surprisingly, when cells were rescued, results showed a slightly higher correlation 
between total polyphenols and stress reduction (r2=0.3602), supporting the fact that 
the polyphenolic total content might be more relevant when rescuing cells that have 
been previously primed with high levels of oxidative stress. 
 
Fig 6.4 - Correlation between wine total polyphenols and the wine antioxidant capacity 
evaluated in different assays: A) DPPH scavenging test (RSC%), measured through a chemical 
experiment. B) Cell assays performed using Progeria-SMCs: B1. Direct test; B1. Rescue test. Linear 
regression R-squared values are presented for each scatter plot. 
 
Polyphenolic content: Impact on cellular proliferation 
To assess the impact of the specific wine polyphenolic content on cellular 
proliferation, polyphenols were quantified in all the red wines tested, by using 
targeted LC-MS. Results unveiled that the polyphenolic content had a relevant 
impact on proliferation assessed through nuclei count variation registered for 
Progeria- and Normal-SMCs (Fig. 6.5). Indeed, when cells were directly exposed to 
antioxidants, the total polyphenolic content had a positive effect on the variation of 
nuclei count, which was especially evident on Progeria-SMCs. Nevertheless, no 
statistically significant correlation was identified (Fig. 6.5 A1). The highest 
correlations were found to be related with the content of (+)-Procyanidin B2 and (-)-
epicatechin, which are some of the most abundant polyphenols in red wines. 
Particularly, their concentrations were significantly associated with an improvement 
in cell proliferation in this cell line (p=0.0001 and p=0.0029, respectively) (Fig. 6.5 
B1 and C1) 
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Fig 6.5 - Relation between the wine polyphenolic content on the cellular proliferation of 
Progeria-SMCs and Normal-SMCs. 1) Direct and 2) Rescue assays were performed. Results were 
plotted according to A) Total polyphenols; B) (-)-Epicatechin; C) Procyanidin B2 measured in all red 
wines. In the case of direct assays B1 and C1, orange and blue lines show significant correlation 
tendencies. 
 
Contrarily, Normal-SMCs did not expose the same level of proliferation improvement 
and two of the wines have even reduced proliferation (<10%). Again, these results 
indicate that Progeria-SMCs benefit the most with the direct addition of the wines 
when compared to Normal-SMCs. As far as we know, this is the first study that 
clearly demonstrates that the wine matrices have a potential beneficial effect, with 
enhanced results on already stressed cells.  
The polyphenolic mixtures exposed a general positive effect on the cellular 
proliferation under rescuing conditions, but this tendency was not linear (Fig. 6.5 
A2, B2 and C2). Still, Normal and Progeria-SMCs revealed a general increase on 
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proliferation levels (up to 30%) after being exposed to the different red wines, which 
confirms that their application also caused a positive cellular response under rescue 
conditions.  
On the other side, some wines (n=6, representing 27% of our samples) caused a 
reduction of cellular proliferation on Progeria-SMCs, which may perhaps be caused 
by other wine features, such as pH, acidity, sugar concentration, or due to the 
presence of possible undesirable compounds in these wine matrices. Such 
variability on the observed cellular impact of the different wine matrices highlights 
the importance for testing a large number of wines and to further study the whole 
wine matrices as possible synergistic or antagonistic reactions might also occur. 
 
Red wines vs. individual polyphenols 
Solutions of the 8 individual polyphenols and their respective Polyphenol mix (Poli 
mix) were prepared at a specific initial concentration, based on their average 
concentration in red wines (Arranz et al. 2012). Accordingly, as performed for the 
red wines, these polyphenolic solutions were equally added to cells at 0.5% (v/v), 
enabling a simultaneous evaluation of the cellular effects. As shown in Figures 6.6 
A-B, at the tested concentration, individual polyphenols are not as efficient as red 
wines matrices regarding the reduction of oxidative stress. Indeed, most of them, 
when added individually may increase the oxidative stress, thus having a negative 
impact on cells. 
Only 3 individual polyphenols, (+)-catechin, procyanidin B2 and (-)-epigallocatechin, 
and the Poli mix could slightly reduce the basal oxidative stress of the cells. 
Differently, all red wines demonstrated benefits, by reducing the oxidative stress (-
2.29 to -13.088%) and promoting proliferation (maximum of 31.804%). In particular, 
cellular benefits of adding (-)-epigallocatechin (0.6 mg/L) to cells were revealed to 
be superior when compared to resveratrol, which exists in higher amounts in red 
wine (2.7 mg/L), thus bringing to the limelight the cellular importance of other 
minority polyphenols. 
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Fig 6.6 - Cellular impact of potential antioxidants. A-B) Comparison of the cellular effects 
obtained using individual polyphenols and all set of red wines. C-D) Closer evaluation of the cellular 
effects promoted by the red wines. Direct and Rescue tests were performed in Progeria-SMCs. 
Variations of oxidative stress (%) and nuclei count (%) were calculated according to a control 
experiment where antioxidants were substituted by a hydro-alcoholic solution (13% ethanol) applied 
in the same proportion. Experiments were performed in quadruplicates.  
 
Indeed, red wines were largely more efficient than individual polyphenols in 
decreasing induced levels of oxidative stress (Fig. 6.6 B), which unveils the 
importance and the impact of synergistic action between polyphenols. Nevertheless, 
almost all the tested solutions promoted stress reduction resulting in enhanced 
proliferation. Procyanidin C1 was the only polyphenol with a slightly tendency to 
cause cell death at the tested conditions.  
These results indicate that specific wine polyphenols might be more relevant than 
others in reducing cellular oxidative stress, which is in line with previous findings 
(Mitić et al. 2010). Nevertheless, since the individual polyphenols were tested based 
on their average concentrations in red wines, it is important to take that factor into 
consideration. Under rescuing conditions, it was observed that procyanidin B2 (49.7 
mg/L) or (+)-catechin (68.1 mg/L) reduced higher levels of oxidative stress, when 
compared to resveratrol (2.7 mg/L), but these benefits might be influenced by the 
superior concentration of these polyphenols in red wines. 
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Fig 6.7 - Cellular impact of potential antioxidants. C-D) Closer evaluation of the cellular effects 
promoted by the red wines. Wines produced using a main foreign variety were identified. Direct and 
Rescue tests were performed in Progeria-SMCs. Variations of oxidative stress (%) and nuclei count 
(%) were calculated according to a control experiment where antioxidants were substituted by a 
hydro-alcoholic solution (13% ethanol) applied in the same proportion. Experiments were performed 
in quadruplicates.  
 
These data also indicate that it would be important to carry out further metabolomics 
analysis of the wine matrices to better explore possible synergies between different 
polyphenols and other bioactive molecules. Indeed, previous studies demonstrated 
important synergistic effects between specific polyphenols as quercetin and 
catechin (Pignatelli et al. 2006; Pignatelli et al. 2000). Nonetheless, other types of 
wine bioactive molecules, such as anthocyanins and aroma compounds, were 
recently  associated to health benefits for the wine consumers (Antonella et al. 2013; 
Zengin & Baysal 2014; Pojer et al. 2013). For example, some terpenes were recently 
described to increase the permeability of the cell membrane, which might facilitate 
the entrance of other important molecules into the cells.  (Mendanha & Alonso 2015; 
Camargos et al. 2014; Videira et al. 2014).  
The cellular impact of the red wines was also presented according to their main 
variety (≥ 50 v/v%) – Blend and non-Blend (Syrah, Alicante Bouschet, Merlot) (Fig. 
6.7 C-D).  
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6.4. Conclusions 
Wine moderate consumption has been associated to positive anti-aging effects, 
such as cell damage, dementia and cognitive function. Recent studies have been 
tested on the cellular impact of bioactive matrices, such as food-derived polyphenols 
and extracts, from tea, oils fruit and wines. Nevertheless, most of these were 
focused on cancer cell models, such as hepatomas, prostatic and lymphoma cell 
lines. 
This study describes the cellular effects of polyphenolic mixtures and red wines on 
a cellular aging model, based on Progeria-SMCs, a natural ROS-generating 
environment. Indeed, we have clearly demonstrated that, at the testing conditions, 
the application of polyphenols and red wines on these aged cells has caused a 
significant reduction of oxidative stress and improvement of cellular proliferation.  
Further, our results exposed that the average wine content in (-)-epicatechin and 
procyanidin B2 seem to have the highest correlation with the improvement of 
Progeria-SMCs proliferation. Possible synergies between different polyphenols and 
other bioactive compounds in wines should be further investigated, since our results 
present, for the first time, compelling evidences that the whole wine matrix causes 
a higher stress reduction in the ROS-generating environment than the individual 
polyphenols.  
Altogether, our results stress out the importance of the wine bioactive matrices and 
indicates that its polyphenols should be further explored to possible develop new 
strategies to fight against aging-associated conditions. 
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Metabolites in human plasma following consumption of  
de-alcoholised red wine enriched with resveratrol 
 
 
This Chapter aims at fulfiling the specific objective of this thesis: “to explore the 
bioavailability of potentially important anti-carcinogenic polyphenols in human 
plasma after a repetitive moderate consumption of dealcoholized wine”.  
This study was integrated in a 4-years project entitled ‘Resveratrol in the 
chemoprevention of colorectal neoplasia’, undertaken at Australia by the Royal 
Melbourne Hospital in conjunction with the Department of Colorectal Medicine and 
Genetics and the Australian Wine Research Institute.  
Further manuscripts resultant from this study are in preparation for peer-review 
publication. 
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Abstract 
The consumption of resveratrol, either as a dietary supplement or as a component 
of certain foods and beverages, has been associated with potential health benefits 
for consumers. This evidence has been mostly obtained from in vitro or animal 
studies and limited human in vivo studies, which have observed only traces of 
resveratrol in plasma post consumption below proposed efficacious concentrations. 
Hence, the bioavailability of resveratrol and presence of its metabolites in human 
plasma is still under debate.  
In this study, subjects were recruited to a dietary intervention, based on their family 
history of bowel cancer and hence increased risk for developing colorectal cancer. 
Over a six-week period, one group of the subjects received a daily dosage of 100 
mL de-alcoholised red wine containing less than 0.5 mg of trans-resveratrol and the 
other group received 100 mL of de-alcoholised wine containing 50 mg of trans-
resveratrol. A non-targeted metabolomics experiment was performed using HPLC-
QTOF-MS to explore the plasma composition of resveratrol conjugates and other 
compounds after the intervention. Results indicate that under the specific study 
conditions, significantly increased amounts of resveratrol conjugates and other 
metabolites were found in plasma after six weeks of daily resveratrol intake. Free 
resveratrol could also be identified, but only in trace amounts. No gender differences 
were observed. 
These findings demonstrate the bioavailability of resveratrol and changes to the 
plasma concentrations of a range of compounds related to the ingestion of 
resveratrol. The findings highlight the need for further investigations into i) indirect 
impacts of resveratrol ingestion on metabolite profiles in human plasma and ii) the 
underlying mechanism(s) of the potential health benefits associated with resveratrol 
and its metabolites and wine consumption. 
 
Keywords Bioavailability, de-alcoholised red wine, dihydro-resveratrol, 
metabolomics, plasma, glucuronides, resveratrol, sulfates.  
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7.1. Introduction  
Over the last three decades, research has been highly focused on the effects of 
wine consumption on human health (Arranz et al. 2012; Rodrigo et al. 2011; Mazú 
et al. 2014). Moderate consumption of wine - approximately one to two glasses per 
day - is suggested to have health benefits for consumers associated with its 
relatively high content of phenolic compounds compared to other foods and 
beverages (Lippi et al. 2010; Artero et al. 2015). Previous studies have shown 
phenolic compounds to be associated with a reduced incidence of cardiovascular 
and cognitive diseases, diabetes, and a reduced risk of certain cancers such as 
lung, colorectal, endometrial and ovarian as well as lymphomas (Sancho & Mach 
2014; Arranz et al. 2012; Angel-Morales et al. 2012). In particular, some 
epidemiological studies have demonstrated that moderate wine consumption may 
be protective against colorectal cancer, in both males and females (Patel et al. 2010; 
Park et al. 2009) and this protective effect has been confirmed in different countries, 
and associated with  different diets (Fira-Mladinescu et al. 2008; Kontou et al. 2012; 
Mazú et al. 2014). 
Resveratrol is one of the most commonly studied phenolic compounds in red wine 
in the context of its diverse biological effects. For example, some recent studies 
have suggested that resveratrol may inhibit cancers such as lymphoma, breast 
cancer and colorectal cancer by interference with different cell signalling pathways 
associated with cell proliferation, motility and survival (Patel et al. 2011; Frazzi et al. 
2013; Du et al. 2016). Also anti-proliferation and apoptosis-inducing effects have 
been shown for certain cancers (Varoni et al. 2016). In vitro data also suggest that 
5 μmol/L resveratrol is the minimum concentration required for the chemopreventive 
effects of the compound to be elicited (Boocock et al. 2007). 
Bioavailability studies have previously indicated that some wine-derived phenolic 
compounds such as resveratrol are efficiently orally absorbed (Walle 2011; 
Vitaglione et al. 2005), but it is still unclear to what extent these molecules reach the 
target organs and where they perform a biological activity (Manach et al. 2005). In 
fact, considerable amounts of potentially bioactive dietary compounds are lost along 
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the human digestive system, due to low absorption of the molecules, degradation in 
specific organ environments, or extensive metabolic modifications which mostly 
occur in the liver, and small and large intestine (Serra et al. 2011; Wenzel et al. 
2005; D’Archivio et al. 2010). These extensive modification pathways might cause 
degradation, excretion and generation of multiple and different conjugated 
metabolites, compromising the final biological activity of phenolic compounds. While 
high rates of absorption have been observed for trans-resveratrol, only trace 
amounts of the free form have previously been found in the plasma and urine (Walle 
et al. 2004). The main metabolites identified include different conjugates, such as 
resveratrol mono glucuronides and sulfates, but also dihydro-resveratrol (Goldberg 
et al. 2003; Patel et al. 2010). There are few studies on the bioavailability of 
resveratrol in humans (Tomé-Carneiro et al. 2013), and most performed thus far 
administrated the compound in tablets, capsules or caplets (Brown et al. 2010; 
David J Boocock et al. 2007). This practice avoids constraints related to alcohol 
consumption, but may also alter the normal rate of absorption and excretion when 
compared to the wine matrix intake (Rotches-Ribalta et al. 2012). Moreover, most 
studies in humans are also highly restricted by a low number of individuals (normally 
n<25) (Gresele et al. 2008; Goldberg et al. 2003), which may limit the reliability of 
the information obtained from the study. In fact, previous reports were found to 
ignore the individual variation, leading to insufficient statistical power and 
consequently, biased conclusions (Sanson-Fisher et al. 2007). 
As part of a broader study to determine if resveratrol administered in a de-
alcoholised red wine can reduce the risk of colorectal cancer in susceptible subjects, 
a double-blind, placebo-controlled dietary intervention experiment was undertaken. 
One of the additional aims of the intervention was to explore the existence of 
resveratrol and its metabolites in plasma. Here we report the results from the 
targeted profiling of resveratrol metabolites in human plasma by HPLC-MS following 
daily ingestion over a period of six weeks of de-alcoholised red wine supplemented 
with resveratrol. In addition, we discuss the results from the non-targeted 
metabolomics analysis of resveratrol-related and other metabolites in human 
plasma. 
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7.2. Material and Methods 
 
7.2.1. Chemicals 
Reference standards of trans-resveratrol, trans-resveratrol-3-glucuronide, trans-
resveratrol-4'-glucuronide, trans-resveratrol-3-sulfate, trans-resveratrol-3-sulfate, 
trans-resveratrol-3-glucuronide and trans-resveratrol-4'-glucuronide were acquired 
from   the Institute of Food Research, Norwich Research Park, UK. All reference 
analytes and internal standards were stored in the dark at –20°C to avoid 
degradation. HPLC-grade (purity>99.99%) acetonitrile (ACN) and methanol 
(MeOH), 2-propanol, ammonium acetate and formic acid (FA) and were purchased 
from Merck Millipore. 
 
7.2.2. De-alcoholised wine 
Volunteers ingested a red wine (Tempranillo, 2008), previously de-alcoholised to ca. 
0.00% alcohol v/v by a commercial winery using ‘spinning cone’ technology. The 
resveratrol content of the de-alcoholised wine was <0.5 mg as determined by 
targeted reverse phase HPLC-QTOF analysis. To half of the de-alcoholised red 
wine, resveratrol was added in a concentration of 50 mg per 100 mL of wine, 
immediately prior to bottling into 375 mL claret bottles. The added resveratrol 
consisted of 99% resveratrol extracted from grape skins by Changsha Organic Herb 
Inc., China. The dose of resveratrol was chosen after consideration of the studies 
of Goldberg et al. (2003) and Walle et al. (2004), which detected measurable 
amounts of resveratrol in plasma and urine after consumption of this dose (Walle et 
al. 2004; Goldberg et al. 2003). 
The Australian Wine Research Institute coordinated and supervised the production 
of the treatment and control products, ensuring that they complied with the 
specifications outlined in the Australian New Zealand Food Standards Code. 
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7.2.3. Study participants 
Subjects, 27 males and 43 females born between 1930 and 1985, were recruited to 
this dietary intervention, based on their family history of bowel cancer and hence 
increased risk for developing colorectal cancer. All subjects completed the ethics-
approved study after providing their informed consent. 
 
7.2.4. Interventional study design 
This intervention study was conducted by the Department of Colorectal Medicine 
and Genetics at The Royal Melbourne Hospital, Victoria according to the National 
Statement on Ethical Conduct in Human Research (2007) produced by the National 
Health and Medical Research Council of Australia.  
De-alcoholised wine (100 mL per serve) was administrated to the subjects in a 
double-blind, placebo-controlled dietary intervention. Thirty-nine subjects were 
randomly selected to receive the control wine (non-spiked resveratrol - NS) and the 
other 31 consumed the test wine (containing 50 mg of spiked resveratrol - RS). Wine 
intake occurred once per day with the evening meal over the six-week intervention 
period. Subjects were also placed on a low plant polyphenol diet for three weeks 
prior to the intervention and for the following six-week intervention period (Fig. 7.1). 
Blood samples were collected in heparinised tubes immediately after the first intake 
(T0) and after 30, 60, 90, 120 min post intake.  
After six weeks (T6w) of daily wine intake, blood was again collected from all the 
patients, 24h after the last wine intake. Samples were then centrifuged at 2000 rpm, 
straight after collection, and the plasma was aspirated and transferred to 
polypropylene cryotubes. Plasma samples were stored at -80⁰C until further 
analysis. 
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Fig. 7.1 - Scheme of the interventional human study design. 
 
7.2.5. Samples preparation 
De-alcoholised wines 
Polyphenols were extracted from de-alcoholised wine samples (with and without 
resveratrol added) using solid-phase extraction (SPE) with Phenomenex Strata-X 
33 μm 85Å polymeric reverse-phase cartridges (60 mg adsorbent in 3mL). A pooled 
mix containing an equal aliquot of each sample was also prepared to monitor 
instrument performance. Cartridges were conditioned using 1 mL methanol followed 
by 1 mL Milli-Q water. Samples were diluted 1:4 in Milli-Q water and a volume of 10 
mL was loaded on the column. Wash was performed using 1 mL of 2% methanol, 
followed by full vacuum during 2min. Both samples and calibrants were eluted with 
1mL methanol, which was then evaporated to dryness. (TurboVap® LV Zymark). 
The pellets were redissolved in 100μL of LC solvents (75%A, 25%B). Solvent A (2% 
formic acid, 0.5% methanol in Milli-Q water) and Solvent B (2% isopropanol, 2% 
Milli-Q water, 40%acetronitrile in methanol).  
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Plasma  
Polyphenols were extracted from plasma samples using solid-phase extraction 
(SPE) with Phenomenex Strata-X 33μm 85Å polymeric reverse-phase cartridges 
(60 mg adsorbent in 3mL). A calibrant mix was prepared using 100 µL of a 1 mg/mL 
solution of each standard metabolite (trans-resveratrol, resveratrol-3-sulfate, 
resveratrol-4'-sulfate, resveratrol-3-glucuronide, resveratrol-4'-glucuronide) in a final 
volume of 10 mL of 10% methanol to give 10 mg/L of each analyte. Cartridges were 
conditioned using 1mL methanol followed by 1 mL Milli-Q water. Samples were 
diluted 1:1 in Milli-Q water and a volume of 750 μL was loaded on the column. Wash 
was performed using 1 mL of 10% methanol, followed by full vacuum during 10 min. 
Samples were eluted with 1mL methanol, which was then evaporated from the 
respective fractions using the evaporation system, during 30 min. After evaporation, 
the pellets were redissolved in a volume of 150 μL of starting LC solvents 10%B, 
90%A. Solvent A (5mM ammonium acetate, 2% isopropanol in MilliQ water, pH 
adjusted to 5 with acetic acid) and Solvent B (2% isopropanol in methanol). A Master 
mix was prepared by mixing equal amounts of all the plasma samples. 
 
7.2.6. Reverse phase metabolite profiling by HPLC-QTOF 
De-alcoholised wines  
Metabolite profiling of the de-alcoholised wines was acquired on an Agilent 1200 SL 
HPLC coupled to a Bruker microTOF-Q II. Instrument control was performed with 
Bruker HyStar software and LC fitted with a Phenomenex Kinetex PFP column 
(150mm x 2.1mm ID) coupled with a SecurityGuard PFP guard column. The column 
was set at 30°C and the DAD acquisition range 190-400λ. For the mobile phase, 
Solvent A was 2% formic acid, 0.5% methanol in Milli-Q water and solvent B was 
2% formic acid, 2% Milli-Q water, 40% acetonitrile in methanol. A flow rate of 220 
μL/min was used and the gradient was as follows: 1% B (0–25min), 1-7.5% B (25–
80min), 7.5–60% B (80–125min), followed by cleaning and re-equilibration. The 
mass spectra was acquired using ESI in negative mode and the capillary voltage 
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was 3500 V. Other parameters were optimized: nebulizer pressure, 2.0 Bar; Dry gas 
flow, 8.0 L.min-1; Mass range, 50 ─ 1650 m/z; Acquisition rate, 0.5 Hz; Source 
temperature, 200 °C.  Using Bruker’s DataAnalysis (v4.3, SP4) software, mass 
spectra (line) were calibrated on ions in the range 90-1000 m/z using an in-house 
sodium formate calibration solution (5mM sodium hydroxide, 0.2% (v/v) formic acid 
in 50% (v/v) 2-propanol) introduced immediately before the sample injection via an 
inline post-column switching valve and sample loop. Bruker’s enhanced quadratic 
algorithm was used for mass calibration. 
 
Non-targeted metabolomics experiment 
Separation was performed on an Agilent 1200 SL HPLC coupled to a Bruker 
microTOF-Q II, but in this case, separation was obtained using a Waters Atlantis T3 
3 μm 150 mm x 2.1 mm column. The column was set at 45°C and the DAD 
acquisition range 190-400λ. The mobile phase, with a flow rate of 200 μL/min, was 
composed by solvents A (5mM ammonium acetate, 2% isopropanol in Milli-Q water, 
pH adjusted to 5 with acetic acid) and B (2% isopropanol in methanol) with a gradient 
of 10% B (0–2 min), 10–55% B (2–16 min), 55–98% B (16–17.5 min), 98% B (17.5–
28 min) and 10% B (29–40 min) followed by cleaning and re-equilibration steps with 
a run of 4 min from 90 to 2% of B.  
The mass spectrometer was operated in negative mode and the ion spray voltage 
was 3500 V. Other parameters were optimized: nebulizer pressure, 2.0 Bar; Dry gas 
flow, 6.0 L.min-1; Mass range, 50 - 1000 m/z; Acquisition rate, 0.5 Hz; Source 
temperature, 200°C. Using Bruker’s DataAnalysis (v4.3 SP4) software, mass 
spectra (line) were calibrated on ions in the range 90-1000 m/z using an in-house 
sodium formate calibration mix (5mM sodium hydroxide, 0.2% (v/v) formic acid in 
50% (v/v) 2-propanol) introduced immediately before the sample injection via an 
inline post-column switching valve and sample loop. Bruker’s enhanced quadratic 
algorithm was used for mass calibration. 
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MS/MS parameters 
MS/MS analysis was acquired by using an Agilent 1200 SL HPLC coupled to a 
Bruker microTOF-Q II. Experiments were performed using the following conditions: 
Negative ESI mode; Nebulizer pressure of 2 Bar; Capillary voltage of 3500V; Dry 
temperature set to 200ºC.  According to the targeted compounds, a collision energy 
of 7-40V was defined. Fragmentation data was registered for m/z 417.3202, 
403.3052, 331.0451, 449.0820, 192.9882, 419.1344, 315.0306, 375.0138, 
308.0338, 377.0330, 493.2410.  
 
 
7.2.7. Data analysis  
The files were exported in mzXML format and processed under a 64-bit Linux 
environment using the R scripting language (v3.1) and the BioConductor packages 
XCMS and CAMERA. 
The existence of possible resveratrol metabolites in the plasma samples was 
explored using an non-targeted metabolomics approach. After analysis of the 
samples, the initial data was processed using RStudio software (Version 0.98.1103). 
Parameter settings were optimised for the data acquired. Tolerance windows of 
mass (m/z) and retention time (RT) values were set to 0.01 and 30s. For each 
molecular feature (MF) a representation was obtained (png file) showing the 
appearance of the respective chromatogram. All the files were manually examined 
and signals with low intensity (<500) were generally excluded. After data curation, 
the results were exported as a tab separated base peak matrix that included the 
retention time, m/z and intensity for each molecular feature, for all samples. Principal 
component analysis (PCA) was performed using The Unscrambler.  
Fold change calculations, paired t-tests (p<0.05) and one-way ANOVA (p<0.05). 
Putative MS/MS identification was performed through databases as METLIN, 
FoodDB and Human Metabolome Database (HMDB). Statistical analyses were 
performed using The Unscrambler® software, version 10.4 (CAMO Software AS, 
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2016, Oslo Science Park, Oslo, Norway) and Minitab® software version 17.3.1 
(Minitab Inc., United States). 
 
7.3. Results  
To explore the bioavailability of resveratrol, other polyphenols and their metabolites 
in the plasma samples, the non-spiked resveratrol (NS) and the resveratrol-spiked 
wines (RS) were respectively administrated to two separated groups of individuals 
through a double-blind experiment. Consumption (100 mL) of the de-alcoholised red 
wine, with or without added resveratrol, occurred once per day with the evening 
meal, over the six-week of intervention.  
 
7.3.1. De-alcoholised wines  
Both de-alcoholised wines used in this study were first characterised using targeted 
reverse phase analysis of polyphenols by HPLC-QTOF analysis. As shown in Fig. 
7.2, the overall phenolic profile of both wines was typical for a red wine and the 
resveratrol-spiked de-alcoholised wine (RS) has substantially higher concentrations 
of cis- and trans-resveratrol (53.1 and 16.4-fold higher, respectively), compared to 
the non-spiked (NS) de-alcoholised red wine. 
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7.3.2. Non-targeted analysis of data from quantitative HPLC-MS analysis of 
resveratrol metabolites 
Data had been previously acquired for the targeted analysis of resveratrol 
metabolites from 50 participants (25 from group RS and 25 from group NR) at T0 
and T6w timepoints. This dataset was explored further using a non-targeted 
approach to reveal discriminating variables between the RS and the NS groups, 
after six weeks of regular de-alcoholised wine consumption. After alignment of the 
chromatograms, a total of 1582 molecular features were extracted using the R 
studio software. After this step the data were manually curated, resulting in 544 
molecular features (66% removed) that were subsequently submitted to statistical 
analysis. The filtered features where used to compare molecular features between 
Fig. 7.2 - Relative abundance of wine polyphenols in both wines: NS and RS de-alcoholised 
red wines. Mean values of intensity and the respective standard deviations are presented. Asterisks 
indicate significant differences between the two tested wines (p<0.05). Samples were analysed in 
triplicate. 
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the RS and NR groups, but also to assess differences in molecular features between 
the two time-points of blood collection for each group. Based on one-way ANOVA 
and multiple t-tests, a total of 9 significantly different molecular features of interest 
(MFOI) (p<0.05, fold change>2) could be identified in this dataset (Table 7.1). 
After six weeks of regular consumption of de-alcoholised wine (T6w), as expected 
higher concentrations of several well-known resveratrol conjugates were detected 
in the plasma of individuals that consumed the RS-de-alcoholised wine. In contrast, 
none of these resveratrol metabolites were detected in any T0 sample and the NS-
de-alcoholised control wine at T6w. As shown in Fig. 7.3, the resveratrol metabolites 
detected in the plasma samples of these patients after six weeks included the three 
isomeric mono sulfates, two di-sulfates and a putative glucuronide of a resveratrol 
sulfate ester. Two mono-glucuronides of resveratrol were also detected, and 
tentatively assigned as –3 and –4' isomers.  Free trans-resveratrol was also 
detected in plasma, but only in trace amounts.  
The identification of resveratrol-3-sulfate, resveratrol-4'–sulfate, resveratrol-3-
glucuronide and resveratrol-4'-glucuronide was confirmed through the comparison 
of retention times and mass spectra with reference compounds. Identity of the 
remaining resveratrol metabolites was tentatively assigned based on MS/MS 
experiments, and a comparison to related metabolites detected in this study and 
published data (Menet et al. 2014). Particularly diagnostic in the MS/MS spectra of 
the resveratrol conjugates were 307.027, 227.073, 185.061, 143.050 for resveratrol 
mono-sulfates and 403.103, 227.071, 185.061, 143.050 for resveratrol mono-
glucuronides – neutral loss of m/z 80.00 and m/z 176.01 from sulfate or glucuronide 
moieties respectively (Table 7.1). In addition, the characteristic fragment ion m/z 
227.07 from the resveratrol moiety was detected for all the resveratrol conjugates. 
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Fig. 7.3 - Examples of Extracted Ion Chromatograms of A) Resveratrol-sulfates 
(chromatograms from 2 samples are presented) and B) Resveratrol-glucuronides. Results 
obtained from plasma samples of RS patients after 6 weeks of de-alcoholised wine consumption. 
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Table 7.1 - MS/MS information for each resveratrol metabolite identified in plasma through 
preliminary LC-MS scan analysis. 
Compound Rt (min) [M-H]- MS/MS fragments Formula 
Resveratrol glucuronide-
sulfate 
4.4 483.058 483.058, 386.985, 307.027, 227.071 C20H19O12S 
Resveratrol di-sulfate1 9.8 386.985 
386.985, 307.027, 227.071, 185.060, 
143.050 
C14H11O6S 
Resveratrol-4’-glucuronide 10.1 403.103 403.103, 227.071, 185.061, 143.050 C20H19O9 
Resveratrol di-sulfate2 11.2 403.1028 
386.985, 307.027, 227.071, 185.060, 
143.050 
C14H11O6S 
Resveratrol-3-glucuronide 12.5 403.103 403.103, 227.071, 185.061, 143.050 C20H19O9 
Resveratrol-4’-sulfate 13.6 307.027 307.027, 227.073, 185.061, 143.050 C14H11O6S 
Resveratrol-3-sulfate 14.6 307.027 307.027, 227.073, 185.061, 143.050 C14H11O6S 
Resveratrol sulfate (?) 15.9 307.027 307.027, 227.073, 185.061, 143.050 C14H11O6S 
trans-Resveratrol 20.3 227.070 227.070, 143.052 C14H11O3 
 
 
7.3.3. Non-targeted profiling of metabolites in human plasma samples 
Having established the presence of resveratrol and its key metabolites in the plasma 
samples after six weeks of resveratrol consumption in de-alcoholised red wine, 
further differences between the groups were characterised through a non-targeted 
metabolomics experiment. In this case, all 140 plasma samples from 70 patients at 
T0 and T6W were analysed in random order random by HPLC-MS/MS. This 
metabolomics experiment resulted in the extraction of 1741 features from aligned 
chromatograms, which were reduced to 1010 after manual curation of the data. 
Again, Molecular Features of Interest (MFOI) were selected by filtering using a cut-
off of p<0.05 and larger than two-fold change.  
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Increased MFOI in plasma after intake for six weeks of resveratrol with de-
alcoholised red wine  
Through paired-comparisons, most differences were found between RS and NS 
groups after six weeks of intervention, with the data analysis identifying 96 
significant different MFOI. Similarly, 54 significantly different MFOIs were detected 
when comparing the two time-points, T0 and T6w, for the RS group of patients. In 
total, 31 features were common between both comparisons. In addition, principal 
component analysis (PCA) was performed with all the identified MFOIs, resulting in 
a clear separation between the RS group after six weeks and all the other defined 
categories (Fig. 7.4). 
 
 
Fig. 7.4 - Principal components analysis (PCA) scores plot of the plasma samples of 70 
individuals, considering the two different groups (RS and NS) at different time-points of de-
alcoholised wine intake (T0 and T6w). PC1 55%; PC2 17%; PC3 15%. 
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These results confirmed the data obtained earlier on resveratrol conjugates by 
HPLC-MSMS analysis of plasma of a subgroup of participants in this study. Once 
more, identification of these compounds was performed using standards, but also 
by MS/MS experiments. In Table 7.2 information is presented for detected 
resveratrol metabolites, including the MS/MS fragments and the t-test results after 
comparing the groups (RS vs. NS after six weeks) or time-points (T0 vs. T6w for RS 
group). Notably, the resveratrol mono sulfates and disulfates showed the most 
significant increase in the RS plasma samples (T6w), followed by the mono dihydro-
sulfates. Free trans-resveratrol and a putative dihydro-resveratrol were also 
identified in these samples, but only in trace amounts. 
 
Table 7.2 - Resveratrol metabolites increased in plasma after 6 weeks of RS de-alcoholised wine 
intake. 
Compound 
Rt 
(min) [M-H]
-
 
Expected 
mass 
Error 
(Da) 
Average 
MW 
Molecular 
formula 
MS/MS 
CV 
(%) 
  
RS 
T0 Vs. 
T6w 
T6w 
NR Vs. 
RS 
t test  
(p-value) 
t test  
(p-value) 
Resveratrol-3-
sulfate 
15.08 307.0276 307.0282 0.0006 308.31 C14H12O6S 
307.027, 227.071, 
185.060, 143.050 
23.779 
7.41187 
E-10 
6.99288 
E-10 
Resveratrol-4’-
sulfate 
14.34 307.0304 307.0282 0.0023 308.31 C14H12O6S 
307.027, 227.071, 
185.060, 143.050 
20.073 0.00111 0.00182 
Resveratrol-4’-
glucuronide 
10.40 403.1028 403.1035 0.0006 404.37 C20H20O9 
403.103, 227.071, 
185.060, 143.050, 
113.024 
17.806 0.00786 0.00744 
Resveratrol-3-
glucuronide 
12.98 403.1014 403.1035 0.0021 404.37 C20H20O9 
403.103, 227.071, 
185.060, 143.050, 
113.024 
18.593 0.03067 0.03976 
Resveratrol-
dihydro-sulfate 
16.53 309.0410 309.0427 0.0117 310.05 C14H14O6S 309.044, 229.087  14.693 
8.72917E-
08 
9.97918E-
08 
Resveratrol-
disulfate 
17.60 386.9847 386.9839 
-
0.0008 
387.99 C14H12O9S2 
386.985, 307.027, 
227.071, 185.060, 
143.050 
10.169 
6.0164 
E-09 
7.36045 
E-09 
trans-
Resveratrol 
 19.40 227.0713 227.0714 0.0008 228.23 C14H12O3 
227.0713, 
147.0816 
- - - 
Dihydro-
Resveratrol 
 19.40 229.0864 229.0865  0.0001 230.26 C14H14O3 
229.0864, 
149.0961 
- - - 
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Apart from resveratrol conjugates, a number of other MFOIs were also present in 
higher concentrations in the RS plasma samples after six weeks and were 
unchanged or non-existent in all the other samples. A list of putative metabolites is 
presented in Table 7.3. The obtained m/z values of these putative resveratrol-
related metabolites were searched in databases, finding possible matches for 6 
MFOI. However, when compared to commercially-available standards, no match 
was found between those standards and the targeted molecular features.   
 
Table 7.3 - Other molecular features of interest (MFOI) increased in plasma after 6 weeks of RS 
de-alcoholised wine intake. p-values are registered for each significant difference found between 
groups. 
Tentatively identified 
compound 
Rt 
(min) 
[M-H]- 
Expected 
mass  
Error 
(Da) 
Average 
MW 
Molecular 
formula 
CV 
(%) 
RS 
T0 Vs. T6w 
T6w 
NR Vs. RS 
t test  
(p-value) 
t test  
(p-value) 
 Pentahydroxy-
methoxyflavone 
15.76 331.0451 331.0459 0.0008 332.26 C16H12O8  15.26 2.04166E-07 2.88268E-07 
 Myricetin-arabinoside 14.11 449.0820 449.0725 0.0095 450.35 C20H18O12  22.04 2.31845E-07 1.72589E-07 
 Trihydroxydihydrochalcone-
glucoside 
18.00 419.1344 419.1348 0.0004 420.40 C21H24O9  21.36 7.70057E-05 3.75301E-05 
 Myricetin-galloylglucoside 
(M-2H) 
19.13 315.0306 315.0433 0.0127 632.48 C28H24O17  13.03 0.00063 0.00073 
 Dihydronaringenin-sulphate 
(M+Na-2H) 
16.29 375.0138 375.0156 0.0018 354.33 C15H14O8S  14.05 0.00047 0.00030 
 Indoxyl glucuronide 17.30 308.0338 308.0387 0.0049 309.08 C14H15NO7  14.63 0.02629 0.00050 
 
 
Additionally, the results were analysed by gender PCA to assess if gender 
contributed to differences detected in the RS group (T6w). As shown in Fig. 7.5, no 
correlation was found between gender and the presence of any particular MFOI in 
plasma.  
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Fig. 7.5 - Principal component analysis (PCA) scores plot of the plasma samples of 39 patients 
from the RS group, after 6 weeks of intake. Samples were coloured per gender, showing no 
distinction between men and women. 
 
Decreased MFOI in RS (T6w) 
While a number of resveratrol conjugates and other metabolites were increased 
after intake of resveratrol in dealcoholized wine for six weeks, two MFOI were 
significantly decreased in the plasma samples of the RS group after six weeks, as 
shown in Fig. 7.6A and 7.6B. These MFOI with [M-H]-, 403.3054 and 417.3231, co-
eluted at the same retention time (27.2 min). As presented in Fig. 7.6A, there is also 
a significant correlation between the abundance of these two MFOI in plasma from 
RS and control (NR) participants at all time points. 
To identify these features, MS/MS experiments were performed using plasma 
samples that contained the highest amounts of these features. The MS/MS 
fragmentation showed that these MFOI correspond to two different compounds (Fig. 
7.6C). When the data was searched against databases matches were found 
with dihydroxycholesterol and dihydroxycholestanone were obtained. 
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Fig. 7.6 - Details about the tentatively identified MFOI, decreased in RS T6w. A) Correlation 
between the mean intensities between the features. Samples from group RS, T6w are coloured in 
red. B) Interval plot IC 95% Dunnet test C) MS/MS spectra for each feature, presenting the parent 
ion and the respective fragments obtained. Collision energy of 7V. 
 
7.4. Discussion 
The main objective of this in vivo study was to characterise the effects of a daily 
consumption (over six weeks) of resveratrol in de-alcoholised red wine by analysing 
metabolites in human plasma with a non-targeted HPLC-MS/MS approach. 
Changes in plasma concentrations of MFOIs which were likely caused by ingestion 
of resveratrol were identified by fold-change calculations, paired t-tests (p<0.05) and 
one-way ANOVA (p<0.05) for a comparison between treatment groups, RS and NS 
at t6w, and time points for RS, t0w and t6w. 
  
Chapter 7 
 
Wine&Health: Biotechnology tools to prospect consumers’ health 198 
 
In concordance with other authors we observed high levels of variability between 
individuals in relation to the concentration of MFOIs in the plasma (Vitaglione et al. 
2005). Nonetheless, all the MFOIs were present at least in 50% of the plasma 
samples of the RS group, T6w. Notably, the increased levels of MFOIs after the six 
weeks of intervention were not significantly different between males and females, 
in-line with observations from a previous study. (Nunes et al. 2009) 
The untargeted HPLC-MS approach confirmed that consumption of resveratrol 
resulted in traces of free trans-resveratrol in human plasma (Walle et al. 2004a; 
Vitaglione et al. 2005), together with substantial increases in phase-II conjugates, 
i.e. sulfates and glucuronides of resveratrol as described previously (Boocock et al. 
2007). These observations corroborate the efficient uptake of resveratrol, its rapid 
metabolism, and the persistence of key metabolites in human plasma (Walle et al. 
2004). In addition to metabolism by phase-II conjugation reactions, some resveratrol 
was reduced to dihydro-resveratrol and dihydro-resveratrol sulfate, confirming the 
results of Menet et al, 2014 (Menet et al. 2014).  
From a mechanistic perspective, it remains to be established whether the phase-II 
conjugate dihydro-resveratrol sulfate is formed from dihydro-resveratrol, or indeed 
if the putative reductase reaction involves a resveratrol sulfates as substrate. In-line 
with earlier observations (Schroeter et al. 2015; Walle et al. 2004a), the results from 
this study emphasize the need for evaluating in greater detail the potential biological 
activities of all resveratrol conjugates.  
The existence of resveratrol conjugates in plasma such as sulfates and 
glucuronides, was previously reported in other pharmacokinetic human studies, but 
only after single dose interventions that mainly focused on resveratrol absorption 
after 4 to 24 h of consumption (Boocock et al. 2007; Yiu et al. 2015). Additionally, 
the previous open-label trials performed for longer periods (more than one month) 
only described the clinical benefits associated with the intake of resveratrol, not 
focusing on the bioavailability of its molecules in plasma (Fujitaka et al. 2011; Tomé-
Carneiro et al. 2012; Bhatt et al. 2012).  
The results from the non-targeted metabolite analysis also showed that ingestion of 
resveratrol in de-alcoholised red wine resulted in significantly higher amounts of 
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additional MFOI in human plasma after the six weeks of ingestion (Table 7.3). These 
were present only at low abundance and a database search of these MFOIs led to 
the tentative identification of polyphenols, myricetin-arabinoside, pentahydroxy-
methoxyflavone and myricetin-galloylglucoside. Myricetin has been described in red 
wine before (Gómez-Alonso et al. 2012) and it was herein detected on the based 
de-alcoholised wine through the targeted mass spectrometry analysis of 
polyphenols, hence the presence of these polyphenols in the RS-t6W plasma 
samples can be explained with resveratrol-induced changes to uptake and/or 
metabolism of other polyphenols in the de-alcoholised red wine.  Alternatively, the 
resveratrol added to the de-alcoholised red wine might have contained traces of 
myricetin and other polyphenols. 
Beyond polyphenol-related metabolites, two MFOIs could be observed in samples 
from RS and NS at all time points which were significantly reduced in the plasma 
samples of individuals from the RS group, after six weeks (Fig. 7.6). From MS/MS 
experiments and a database search, these MFOIs were found to be potential 
putative sterol derivatives. The reduction in plasma concentration of these putative 
sterols was only observed after six weeks of daily intake of a de-alcoholised red 
wine spiked with resveratrol, and this observation cannot be attributed to 
consumption typical red wine compounds such as alcohol or polyphenols. Hence 
this observation points towards a specific role of resveratrol ingestion in changing 
the profile of other human metabolites in plasma by a hitherto unknown mechanism. 
This provides further evidence of a likely biological activity of dietary resveratrol in 
humans, which should be characterised further together with the role of these 
MFOIs as biomarker candidates.  
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7.5. Conclusions 
As far as we know, this is the first in vivo study describing the presence of resveratrol 
metabolites, and resveratrol-induced changes to other metabolites, in human 
plasma after a longer period of consumption of resveratrol (50 mg/100 mL per day 
for six weeks) in a de-alcoholised wine matrix.  
Through the participation of a large number of individuals, and by using a non-
targeted metabolomics experiment, it was possible to clearly differentiate between 
the resveratrol-related metabolic responses in RS and NS (control) groups, at 
different time points. This allowed identification of a large number of MFOIs that 
were significantly different between the groups. Further research is needed to 
understand if the phase-II resveratrol conjugates found in plasma are biologically 
active in target organs, and for obtaining evidence regarding the potential health 
impact of these metabolites in humans and the implications for our daily diet. 
In addition, the observation of two putative sterol-related MFOIs which were 
decreased as specific response to resveratrol consumption points towards a specific 
role of resveratrol in changing the profile of other human metabolites in plasma by 
hitherto unknown mechanism(s). This provides further evidence of a likely biological 
activity of dietary resveratrol intake in humans. 
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S. cerevisiae protein extracts as endogenous alternatives for wine 
fining 
 
Fining practices are frequently based in the application of oenological products from 
animal and mineral origins, which currently cause health and safety concerns 
among the wine sector. Consequently, their application in wine is becoming more 
and more restricted, according to the new health legislations defined by the 
International Organization of Vine and Wine (OIV) and the Codex Alimentarius 
International Code of Standards. For all these reasons, the development of cost-
efficient, sustainable and safe fining alternatives is highly expected by the 
winemaking industry.  
Herein, we have studied and benchmarked the fining potential of a wide range of 
currently available fining agents, in comparison with potential new fining 
alternatives, the oenological Yeast protein extracts (YPEs). In particular, we have 
demonstrated that the S. cerevisiae based formulations were not only able to 
efficiently improve the wine final color and brilliance of white and rosé wines, but 
also to reduce the polyphenolic content of red wines, when compared to the effects 
of reference fining agents. Indeed, we have validated the fining potential of YPEs 
for white wines clarification and stabilization, by indicating their higher efficiency to 
prevent and treat browning phenomena when compared to casein, an animal origin 
protein. Overall, these fining agents were found to be more efficient, sustainable 
and harmless, when compared to exogenous substances from mineral, animal or 
wheat origins. 
The development of these oenological YPEs fulfils an increasing need among the 
wine sector to substitute animal proteins that might leave residues in wine and 
consequently cause allergies to susceptible individuals. Through the future 
production of these alternatives at large scale, we will support winemakers not only 
to produce less harmful wines to their consumers, but also to comply with the recent 
health and safety legislations. Such positive effects will enhance wine consumers’ 
health and well-being and support the establishment of more trustful boundaries 
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between producers, regulation authorities and wine consumers. In fact, as a new 
worldwide ‘green trend’ has been raised across the marketplace, wine consumers 
will tend to acquire a broader variety of organic, eco-friendly products and to adopt 
healthier dietary and lifestyle habits. In fact, this consumers’ segment is currently 
more informed and demanding about the origin of the oenological additives applied 
into wine. Indeed, wines treated with the presented YPEs could be easily marked 
not only as safer, but also as a solution for vegetarian and vegan individuals that 
would previously exclude wines treated with exogenous fining agents based on 
animal proteins.  
Considering the efficiency of these innovative fining agents, the production of YPEs 
at industrial scale denotes new prospects on the clarification and stabilization of 
premium quality wines and the possible creation of completely unique wine styles. 
Alongside to this, future investigations might be performed on the vast diversity of 
other oenological yeast strains and yeast-based components with post-fermentative 
applications in other types of wines. Accordingly, this study unveils other possible 
biotechnological potentialities of oenological yeasts among the sector, which go 
further beyond their primary function on conducting fermentation processes. 
Alongside the introduction of innovative fining agents, we have also developed 
immunological-based assays that allow an accurate and simple detection of these 
haze-forming proteins. Consequently, these are useful tools to determine the 
minimum, essential amount of bentonite to prevent protein hazing, avoiding the 
common over-estimated application of bentonite clays. These immunological-based 
tools present an important upgrade to the conventional methods that are currently 
being used to estimate protein haze and which cause biased results. 
In future, these novel tools will enable winemakers to test a wide-range of wine 
samples simultaneously at a winery environment. Therefore, this will reduce their 
usage in over-estimated dosages of bentonite at large scale, thus reducing the both 
fining costs and negative sensorial impact of bentonite clays on wine due to 
extensive aroma losses. 
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Wine as a functional beverage and the benefits of its polyphenols 
on consumers’ health 
 
Over the last decades, several health benefits have been associated with a 
moderate consumption of wine. Those effects have been mainly attributed to a 
complex variety of antioxidant polyphenols that are especially present in red wines. 
Despite these evidences, the potential synergic and/or antagonistic effects between 
bioactive molecules, such as individual polyphenols or between polyphenols and 
other wine constituents are still not fully understood. In fact, most of the studies have 
been focused on the effects of the specific antioxidant - resveratrol, due to its widely 
recognized bioactive potential, but knowledge is extremely scarce on the ultimate 
impact of the whole wine matrix, which comprises a complex variety of other 
bioactive molecules. In fact, while many studies highlight the beneficial health 
effects of resveratrol to wine consumers, evidences were obtained mostly from in 
vitro studies, both in animals and in humans.  
In this thesis, we have demonstrated compelling evidences that the whole red wine 
matrix causes a higher stress reduction than its polyphenol components individually, 
by using an innovative in vitro ROS-generating environment, based on Progeria-
SMCs, which stands as a cellular model for ageing. Additionally, we have observed 
that the average red wine content in (-)-epicatechin and procyanidin B2 tends to 
have a higher association with the cellular proliferation of these aging-model cells, 
when compared to resveratrol. Altogether, these findings stress out the importance 
to explore the potential bioactive impacts of the whole wine matrix and to study 
possible synergies between a wider range of its enclosed polyphenols. Moreover, 
this work emphasizes the importance to study wine as natural source of novel 
bioactive compounds, with potential applications for the nutraceutical and 
pharmaceutical industries. 
Adding to this, the bioavailability of resveratrol and its conjugates is currently under 
an extensive debate, so it is crucial to comprehend to what extend the bioactive 
metabolites reach the target organs after their passage through long digestive 
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pathways in humans. Comprehensively, human trials are highly restricted due to 
ethical concerns, and restrained by the small number of available individuals and 
the short intervention periods. As result, the reduced number of in vivo studies 
performed so far lack in statistical power and frequently do not take individual 
variation into account. 
To address this, herein we have combined a human intervention study with an 
untargeted metabolomics approach and confirmed the bioavailability of trans-
resveratrol free from, resveratrol metabolites and other unexpected molecular 
features in plasma samples from patients with higher risk of having colon cancer, 
after daily consumption of de-alcoholised red wine for six weeks. Indeed, we have 
demonstrated the existence of the after consumption of de-alcoholised red wine 
enriched with trans-resveratrol. As far as we know, this was the first in vivo study 
that has demonstrated the existence of such resveratrol metabolites in plasma after 
a longer period of de-alcoholised red wine intake. Furthermore, this bioavailability 
study was conducted in a larger number of individuals, when compared to similar 
previous reports.  
Overall, these findings underline the current need to further investigate the real 
cellular impact of resveratrol versus the impact of red-wine complex polyphenol 
matrices, as well as the bioavailability and activity of resveratrol-derived compounds 
and other important polyphenols in target organs, which altogether brings to the 
limelight the functional role of wine to the consumer’s health.  
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General conclusion and future perspectives 
The whole wine matrix encloses a complex range of bioactive metabolites, such as 
polyphenols, that may exert benefits to wine consumers’ health. On the contrary, it 
might contain exogenous residues derived from winemaking practices that raise 
safety concerns. Overall, most of these potentially positive and negative effects 
remain unknown or under profound debate among the wine sector. 
The innovative biotechnological solutions herein presented will improve the 
efficiency and safety of the current wine fining practices. In fact, the yeast-based 
alternatives developed are not only capable to fulfill the new demanding in the 
industry and in the markets, but also to support winemakers to comply with the 
current health regulations. Accordingly, the production and application of YPE 
should be implemented in future, at pilot and industrial scales, while certifying its 
quality along the production chain. Moreover, it will be important to perform a more 
detailed investigation on the sensorial impact of the YPEs in different wines and 
thus, guarantee the absence of any possible faults or off-flavours. As an important 
complement of the referred trials, the use of immunological-based methods to detect 
unstable proteins should be transferred to winery environments to efficiently 
minimize the current application of exogenous clays. 
This work also highlights the potential antioxidant benefits of different wine matrices, 
complex polyphenolic mixtures and individual. According to our findings, and 
considering the vast array of possible wine metabolic compositions, arising from 
both the vast array of existing Vitis vinifera varieties, and their combination in 
blended wines, future work should explore the specific synergistic or antagonistic 
reactions occurring between different polyphenols and between polyphenols and 
other bioactive molecules from grape juice and wines. Additionally, the full potential 
of wine matrices should be further investigated as possible sources of a large range 
of other unknown bioactive molecules, with possible nutraceutical and 
pharmaceutical applications. 
Considering our findings on the bioavailability of resveratrol, a widely recognized 
wine polyphenol, and its derived metabolites in the human body, underline the 
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urgent need to explore if resveratrol-derived compounds are biologically active in 
target organs through in vivo interventional studies. In future, clinical data should be 
acquired on the potential anti-carcinogenic effects of these metabolites and 
respective implication of implementing new dietary guidelines. 
Globally, in this thesis, we have presented novel research evidences and have 
developed biotechnological tools that support the quality, safety and innovation of 
the global wine industry. Indeed, through the development of safer and more 
sustainable practices, as well as the valorization of important antioxidant and anti-
carcinogenic wine constituents, our findings contribute to extend the current 
knowledge on Wine&Health that increases awareness from the winemaking stages 
until final consumers, thus fulfilling its ancient recognition as a functional beverage.   
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Annex II - Chapter 2. Supplementary figures and tables. 
Table S2.1 - Extensive description of the reference fining agents tested in this study.    
 
 
 
  
 
 
Table S2.2 - Description of the Yeast Protein Extracts (YPEs) tested in this study. 
 
 
 
 
 
  
 
 
 
 
 
  
  
 
 
Annex III - Chapter 3. Supplementary figures and tables 
 
 
 
Fig. S3.1 - Total phenolic content before and after the fining experiments in 250ml bottles, for the 
three types of wine tested. Untreated wine: NT. Wines treated with: Yeast protein extracts: BCV1 
and BCV5; Bent: Bentonite; Cas: Casein; PVPP: Polyvinylpolypyrrolidon; VP: Vegetable protein. 
Bars indicate mean ± SD (n = 3). 
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Table S3.2 - Conventional oenological parameters acquired by Infrared Fourier-transform 
spectrometer – Wine 2. Wines treated with: Yeast protein extracts: BCV1 and BCV5; Bent: 
Bentonite; Cas: Casein; PVPP: Polyvinylpolypyrrolidon; VP: Vegetable protein. Untreated wine: NT. 
Results are relative to fining experiments after fermentation, performed in triplicates. Values are 
presented as mean ± SD (n = 3). 
 
 
 
Table S3.3 - Conventional oenological parameters acquired by Infrared Fourier-transform 
spectrometer – Wine 3. Wines treated with: Yeast protein extracts: BCV1 and BCV5; Bent: 
Bentonite; Cas: Casein; PVPP: Polyvinylpolypyrrolidon; VP: Vegetable protein. Untreated wine: NT. 
Results are relative to fining experiments after fermentation, performed in triplicates. Values are 
presented as mean ± SD (n = 3). 
 
Wine 2
Density
(g/L)
Ethanol
(% vol)
Volatile 
acidity  
(g/L H2SO4)
Tritable
acidity 
(g/L H2SO4)
pH
Glycerol  
(g/L)
Malic
Acid 
(g/L)
Lactic
Acid 
(g/L)
Total
SO2 
(mg/L)
Free
SO2
(mg/L)
BCV1
10g/hL 989,8 ± 0,1 13,32 ± 0,15 0,60 ± 0,04 6,53 ± 0,01 3,40 ± 0,01 5,81 ± 0,03 1,15 ± 0,01 0,52 ± 0,02 113,1 ± 0,1 34,9 ± 0,5
20g/hL 989,8 ± 0,3 13,27 ± 0,17 0,60 ± 0,03 6,51 ± 0,02 3,40 ± 0,02 6,03 ± 0,02 1,19 ± 0,02 0,48 ± 0,04 114,3 ± 0,0 35,2 ± 0,4
BCV5
10g/hL 989,7 ± 0,1 13,30 ± 0,15 0,58 ± 0,00 6,58 ± 0,07 3,39 ± 0,01 6,22 ± 0,03 1,19 ± 0,01 0,51 ± 0,01 112,5 ± 0,4 34,0 ± 0,3
20g/hL 989,6 ± 0,1 13,27 ± 0,11 0,54 ± 0,05 6,64 ± 0,03 3,38 ± 0,04 6,32 ± 0,05 1,27 ± 0,03 0,50 ± 0,02 115,0 ± 0,5 32,0 ± 0,5
Bent
10g/hL 989,1 ± 0,2 13,20 ± 0,17 0,60 ± 0,00 6,64 ± 0,05 3,35 ± 0,02 6,21 ± 0,01 0,98 ± 0,04 0,35 ± 0,03 112,7 ± 0,3 34,0 ± 0,4
60g/hL 989,3 ± 0,4 13,02 ± 0,17 0,60 ± 0,06 6,44 ± 0,02 3,37 ± 0,04 6,05 ± 0,05 1,04 ± 0,02 0,41 ± 0,02 114,6 ± 0,3 37,0 ± 0,1
Cas
20g/hL 989,3 ± 0,2 13,18 ± 0,10 0,62 ± 0,05 6,65 ± 0,00 3,36 ± 0,02 6,01 ± 0,02 1,13 ± 0,03 0,29 ± 0,04 117,1 ± 0,3 35,0 ± 0,1
100g/hL 989,4 ± 0,2 12,97 ± 0,17 0,57 ± 0,02 6,44 ± 0,02 3,38 ± 0,03 6,54 ± 0,05 1,10 ± 0,02 0,27 ± 0,04 112,4 ± 0,4 35,2 ± 0,2
PVPP
10g/hL 989,9 ± 0,0 13,29 ± 0,11 0,59 ± 0,06 6,64 ± 0,01 3,36 ± 0,02 6,80 ± 0,03 0,87 ± 0,02 0,53 ± 0,00 115,1 ± 0,0 36,0 ± 0,1
80g/hL 990,0 ± 0,6 13,10 ± 0,10 0,58 ± 0,03 6,51 ± 0,03 3,36 ± 0,04 6,52 ± 0,02 0,90 ± 0,03 0,51 ± 0,00 116,4 ± 0,0 32,0 ± 0,0
VP
20g/hL 989,9 ± 0,2 13,26 ± 0,14 0,59 ± 0,03 6,60 ± 0,03 3,36 ± 0,02 6,69 ± 0,02 0,90 ± 0,04 0,52 ± 0,01 103,0 ± 0,3 36,0 ± 0,1
60g/hL 990,0 ± 0,2 13,20 ± 0,15 0,59 ± 0,05 6,50 ± 0,05 3,37 ± 0,01 6,65 ± 0,05 0,92 ± 0,05 0,50 ± 0,01 103,3 ± 0,1 37,0 ± 0,4
NT 989,3 ± 0,0 12,96 ± 0,17 0,53 ± 0,04 6,49 ± 0,03 3,36 ± 0,00 7,02 ± 0,05 1,20 ± 0,05 0,27 ± 0,00 115,2 ± 0,0 35,3 ± 0,6
Wine 3
Density
(g/L)
Ethanol
(% vol)
Volatile 
acidity  
(g/L H2SO4)
Tritable
acidity 
(g/L H2SO4)
pH
Glycerol  
(g/L)
Malic
Acid 
(g/L)
Lactic
Acid 
(g/L)
Total
SO2 
(mg/L)
Free
SO2
(mg/L)
BCV1
10g/hL 989,4 ± 0,0 15,60 ± 0,13 0,86 ± 0,02 7,69 ± 0,01 3,33 ± 0,00 7,21 ± 0,02 1,31 ± 0,01 0,75 ± 0,02 125,1 ± 0,1 52,0 ± 0,1
20g/hL 989,5 ± 0,3 15,53 ± 0,12 0,85 ± 0,01 7,63 ± 0,04 3,34 ± 0,01 7,23 ± 0,05 1,34 ± 0,03 0,73 ± 0,08 124,3 ± 0,3 53,0 ± 0,5
BCV5
10g/hL 989,5 ± 0,4 15,58 ± 0,18 0,86 ± 0,00 7,66 ± 0,01 3,33 ± 0,00 7,22 ± 0,02 1,28 ± 0,00 0,76 ± 0,05 124,5 ± 0,1 54,0 ± 0,4
20g/hL 989,7 ± 0,1 15,50 ± 0,16 0,86 ± 0,02 7,57 ± 0,05 3,33 ± 0,02 7,16 ± 0,00 1,23 ± 0,00 0,74 ± 0,00 126,0 ± 0,0 45,4 ± 0,3
Bent
10g/hL 989,7 ± 0,0 15,48 ± 0,20 0,95 ± 0,02 6,97 ± 0,03 3,32 ± 0,03 7,11 ± 0,06 1,12 ± 0,05 0,52 ± 0,05 128,7 ± 0,2 52,0 ± 0,2
60g/hL 989,7 ± 0,0 15,23 ± 0,16 0,93 ± 0,01 6,68 ± 0,00 3,34 ± 0,06 7,10 ± 0,06 1,07 ± 0,02 0,47 ± 0,01 130,6 ± 0,0 52,0 ± 0,1
Cas
20g/hL 989,8 ± 0,1 15,42 ± 0,15 0,95 ± 0,02 6,94 ± 0,02 3,33 ± 0,02 7,05 ± 0,05 1,16 ± 0,03 0,52 ± 0,03 122,1 ± 0,1 50,0 ± 0,0
100g/hL 989,8 ± 0,6 15,15 ± 0,11 0,91 ± 0,01 6,69 ± 0,04 3,35 ± 0,08 7,01 ± 0,03 0,99 ± 0,00 0,50 ± 0,06 123,4 ± 0,2 51,0 ± 0,2
PVPP
10g/hL 990,1 ± 0,0 15,43 ± 0,13 0,91 ± 0,03 7,58 ± 0,00 3,33 ± 0,05 7,13 ± 0,00 1,03 ± 0,01 0,78 ± 0,04 125,1 ± 0,0 52,0 ± 0,1
80g/hL 990,1 ± 0,3 15,33 ± 0,10 0,91 ± 0,02 7,50 ± 0,01 3,35 ± 0,05 7,14 ± 0,01 0,99 ± 0,00 0,74 ± 0,04 123,4 ± 0,0 53,0 ± 0,8
VP
20g/hL 990,2 ± 0,1 15,39 ± 0,12 0,91 ± 0,01 7,64 ± 0,00 3,33 ± 0,01 7,05 ± 0,01 1,07 ± 0,02 0,77 ± 0,03 122,5 ± 0,5 54,0 ± 0,3
60g/hL 990,3 ± 0,5 15,14 ± 0,10 0,90 ± 0,00 7,51 ± 0,01 3,33 ± 0,00 7,11 ± 0,00 1,05 ± 0,05 0,73 ± 0,01 130,2 ± 0,1 55,0 ± 0,1
NT 989,8 ± 0,0 15,49 ± 0,21 0,89 ± 0,02 7,64 ± 0,02 3,32 ± 0,02 7,56 ± 0,02 1,04 ± 0,03 0,78 ± 0,00 127,2 ± 0,2 51,0 ± 0,0
  
 
 
 
Fig. S3.2 - Chromatic characterization using CIELab system: Saturation (C*), Brilliance (L*), 
Green (-a*) and Yellow (b*) values. Results were obtained before and after treatment of wine 2 with 
YPE and different fining agents. Two dosages were tested by treatment (Min.-minimum; Max.-
maximum). 
 
 
Fig. S3.3 - Chromatic characterization using CIELab system: Saturation (C*), Brilliance (L*), 
Green (-a*) and Yellow (b*) values. Results were obtained before and after treatment of wine 3 with 
YPE and different fining agents. Two dosages were tested by treatment (Min.-minimum; Max.-
maximum). 
 
  
 
 
 
 
 
Fig. S3.4 - SDS-PAGE, 12,5%. Coomassie staining. Total protein precipitated from 1ml of each 
wine sample: 1) Not treated wine. Wines treated with fining agents (max. dosage): 2) BCV1; 3) BCV5; 
4) Bentonite; 5) Casein; 6) PVPP; 7) Vegetable protein. 
 
 
 
Table S3.1 - Conventional oenological parameters acquired by Infrared Fourier-transform 
spectrometer – Wine 1. Wines treated with: Yeast protein extracts: BCV1 and BCV5; Bent: 
Bentonite; Cas: Casein; PVPP: Polyvinylpolypyrrolidon; VP: Vegetable protein. Untreated wine: NT. 
Results are relative to fining experiments after fermentation, performed in triplicates. Values are 
presented as mean ± SD (n = 3). 
 
 
 
 
 
 
Wine 1
Density
(g/L)
Ethanol
(% vol)
Volatile 
acidity  
(g/L H2SO4)
Tritable
acidity 
(g/L H2SO4)
pH
Glycerol  
(g/L)
Malic
Acid 
(g/L)
Lactic
Acid 
(g/L)
Total
SO2 
(mg/L)
Free
SO2
(mg/L)
BCV1
10g/hL 987,5 ± 0,2 13,56 ± 0,17 0,64 ± 0,05 7,47 ± 0,05 3,29 ± 0,01 6,81 ± 0,05 0,93 ± 0,02 1,09 ± 0,01 105,1 ± 0,0 44,9 ± 0,4
20g/hL 987,6 ± 0,3 13,50 ± 0,15 0,63 ± 0,02 7,41 ± 0,01 3,30 ± 0,05 6,79 ± 0,01 0,91 ± 0,01 1,07 ± 0,00 104,3 ± 0,0 45,2 ± 0,4
BCV5
10g/hL 987,5 ± 0,3 13,54 ± 0,15 0,63 ± 0,01 7,47 ± 0,02 3,30 ± 0,04 6,75 ± 0,00 0,95 ± 0,02 1,08 ± 0,00 103,5 ± 0,2 45,0 ± 0,3
20g/hL 987,6 ± 0,3 13,51 ± 0,15 0,63 ± 0,00 7,46 ± 0,00 3,29 ± 0,02 6,80 ± 0,00 1,02 ± 0,03 1,07 ± 0,00 105,0 ± 0,0 45,4 ± 0,5
Bent
10g/hL 987,7 ± 0,5 13,44 ± 0,15 0,68 ± 0,01 7,03 ± 0,10 3,27 ± 0,01 6,75 ± 0,02 0,96 ± 0,06 1,05 ± 0,01 104,7 ± 0,0 45,8 ± 0,2
60g/hL 988,2 ± 0,2 13,19 ± 0,16 0,68 ± 0,02 7,08 ± 0,03 3,29 ± 0,01 6,82 ± 0,03 1,00 ± 0,01 1,07 ± 0,01 103,6 ± 0,1 45,1 ± 0,3
Cas
20g/hL 987,8 ± 0,4 13,34 ± 0,10 0,70 ± 0,06 6,83 ± 0,05 3,28 ± 0,02 6,93 ± 0,01 1,12 ± 0,00 1,12 ± 0,00 105,1 ± 0,5 44,9 ± 0,2
100g/hL 988,1 ± 0,3 13,11 ± 0,11 0,69 ± 0,05 6,63 ± 0,07 3,31 ± 0,04 7,02 ± 0,00 1,17 ± 0,02 1,08 ± 0,00 103,4 ± 0,1 45,2 ± 0,1
PVPP
10g/hL 987,9 ± 0,3 13,47 ± 0,15 0,68 ± 0,05 7,43 ± 0,10 3,28 ± 0,00 6,87 ± 0,02 0,89 ± 0,01 1,12 ± 0,02 105,1 ± 0,1 44,8 ± 0,2
80g/hL 988,0 ± 0,6 13,31 ± 0,15 0,68 ± 0,04 7,28 ± 0,04 3,28 ± 0,01 6,82 ± 0,03 0,90 ± 0,00 1,08 ± 0,02 105,4 ± 0,5 45,3 ± 0,0
VP
20g/hL 987,9 ± 0,2 13,47 ± 0,15 0,68 ± 0,00 7,39 ± 0,10 3,28 ± 0,05 7,01 ± 0,01 0,91 ± 0,03 1,10 ± 0,00 104,0 ± 0,8 45,2 ± 0,5
60g/hL 988,0 ± 0,1 13,38 ± 0,15 0,68 ± 0,01 7,32 ± 0,02 3,30 ± 0,01 6,85 ± 0,00 0,91 ± 0,00 1,08 ± 0,00 103,3 ± 0,1 45,2 ± 0,6
NT 988,3 ± 0,2 13,04 ± 0,15 0,70 ± 0,10 6,69 ± 0,02 3,31 ± 0,00 7,21 ± 0,02 1,22 ± 0,05 1,05 ± 0,00 105,2 ± 0,1 45,3 ± 0,5
 
 
 
 
  
 
 
Annex VI - Chapter 6. Supplementary figures and tables 
 
 
Table S6.1. Multiple reactions monitoring parameters for each polyphenol and internal standards; 
and analytical parameters for the calibration curves. 
 
 
 
 
 
 
 
 
 
Table S6.2. List of the red wine tested in this study and respective details. 
 
 
 
  
 
 
 
Fig. S6.1 - Physicochemical and polyphenolic comparison between different red wines (n=22).  
A-B). Comparison between blends and mono-varietal wines. Significant differences are presented 
as regards to Total acidity and Ethanol content. Asterisks represent: * p<0.05; ** p<0.005. Bars 
indicate mean ± SD. Blends (n = 17), monovarietal wines (n = 5). T-test shows significant differences 
(P<0.05); C) Principal component analysis based in all the enological parameters tested (PC1 
variation 32.7%; PC2 variation 18.5%).  
  
 
Table S.6.3. Results of the conventional oenological measurements performed on the red wines 
tested in this study. 
 
 
